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Motivation	of	the	Thesis	
Human	 blood	 is	 a	 chemically	 rich	 medium,	 crowded	 with	 clinically	 relevant	
biomolecules	 that	 have	 the	 potential	 of	 becoming	 biomarkers	 for	 the	most	 relevant	
disease	of	the	XXI	century	-	cancer.	The	detection	of	biomarkers	in	blood	is	a	task	that	
concerns	 not	 only	 scientists	 working	 in	 the	 field	 of	 biomedicine,	 but	 also	 a	 broad	
scientific	 community	 covering	 research	 fields	 within	 physics,	 chemistry	 and	
engineering.	 Thus,	 only	 by	 joining	 forces	 from	 different	 disciplines	 and	 introducing	
interdisciplinary	 approaches,	 we	 can	 develop	 feasible	 methods	 for	 biomarkers	
detection,	thereby	allowing	the	emergence	of	future	biosensing	technologies.	
The	 present	 thesis	 emerged	with	 this	 optimistic	 vision	 in	mind.	We	 aimed	 at	
using	 available	 tools	 in	materials	 chemistry,	 colloid	 chemistry	 in	 particular,	 to	 face	 a	
specific	 problem	 relevance	 in	 current	 biomedicine	 –	 discrimination	 of	 mutations	 in	
DNA	sequences	that	are	associated	with	lung	and	breast	cancer.	By	finding	a	common	
ground	 (and	 first	 of	 all	 a	 common	 language),	 a	 close	 scientific	 relationship	 was	
established	 between	 the	 Bionanoplasmonics	 Laboratory	 (CIC	 biomaGUNE)	 and	 the	
Oncology	 Area	 (Biodonostia	 Institute).	 Long	 sessions	 of	 stimulating	 scientific	
discussions	 allowed	 us	 to	 extract	 in	 mid	 2013	 the	 overarching	 aim	 of	 the	 present	
thesis,	which	reads	as	follows:				
The	 present	 thesis	 seeks	 to	 develop	 a	 colloidal	 colorimetric	 assay	 based	 on	
plasmonic	 nanoparticles	 for	 rapid	 detection	 (~10	 min)	 of	 single	 nucleotide	
polymorphism	 in	 long,	 double-stranded	 DNA	 sequences	 (>100	 pair	 bases),	 in	 the	
concentration	range	below	1	nM,	in	physiological	media.	
It	 should	 be	 clarified	 here	 that	 not	 all	 of	 the	 proposed	 objectives	 were	
successfully	met.	For	example,	the	detection	of	DNA	mutations	in	physiological	media	
remains	unresolved	at	the	time	of	writing	the	thesis;	which	was	presumably	due	to	the	
chemical	complexity	of	human	plasma	(presence	of	proteins)	hindering	the	detection	
of	DNA	sequences	through	aggregation	of	plasmonic	nanoparticles.	This	is	probably	a	
task	that	remains	for	younger	colleagues.		
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Of	 course,	 the	 complexity	 of	 the	 proposed	 objective	 required	 a	 reductionist	
approach.	 Our	 studies	 were	 strategically	 conveyed	 to	 face	 one	 experimental	
parameter	of	the	assay	at	a	time,	thus	providing	a	topic	for	each	chapter.		
In	 Chapter	 2,	 gold	 nanoparticles	 of	 different	 sizes	 were	 synthesized	 and	
functionalized	 with	 DNA	 sequences,	 and	 subsequently	 used	 for	 the	 selective	
hybridization	with	 the	 target	 single	 stranded	 DNA.	 The	 best	 sensitivity	 (10	 pM)	 and	
rapid	 selectivity	 within	 10	 minutes	 were	 achieved	 for	 larger	 nanoparticles	 with	 a	
diameter	 of	 63	 nm.	 By	 studying	 the	 effect	 of	 particle	 size,	 the	minimum	number	 of	
target	 DNA	 (match	 and	 mismatch)	 was	 established	 to	 induce	 the	 colorimetric	
detection.	
The	 detection	 of	 mutations	 in	 long,	 single-stranded	 DNA	 sequences	 is	 the	
subject	of	Chapter	3.	An	assay	based	on	gold	nanoparticles	(65	nm)	stabilized	with	DNA	
was	 capable	 of	 discriminating	 single	 nucleotide	 polymorphism	 in	 long	 biological	
sequences	(up	to	140	bases),	related	to	lung	cancer.	Pre-incubation	of	AuNPs	and	the	
target	sequence	allowed	us	to	progressively	untie	the	secondary	structure	of	the	target	
DNA	fragment.	
In	 Chapter	 4,	 an	 amplification-free	 methodology	 was	 proposed	 for	 the	
detection	of	single	base	mutation	in	binary	mixtures	containing	double-stranded	DNA	
sequences,	both	wild-type	and	mutated,	by	using	aggregating	gold	nanoparticles	as	the	
only	 transducer.	 A	 blocking	 strategy	 was	 developed	 by	 the	 combination	 of	 high-
temperature	 denaturation	 and	 subsequent	 selective	 blocking	 of	 the	 denatured	
antisense	strands,	thereby	allowing	specific	nanoparticle	aggregation.	
This	Ph.D.	thesis	is	expected	to	represent	an	advancement	in	the	use	of	metal	
nanoparticles	 for	 biosensing	 of	 relevant	 DNA	 sequences.	 Various	 improvements	 and	
approaches	have	been	proposed	 to	 facilitate	 the	detection	of	different	biomolecules	
with	no	need	for	complex	procedures	and	expensive	instrumentation.	
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Chapter	1.			Introduction	
1.1	Cancer,	Biomarkers	and	Sensing	Approaches	
Cancer	is	a	leading	cause	of	death	and	accounted	for	about	8.8	million	deaths	in	
20151.	 Its	origin	 is	 linked	to	genetic	mutations	that	accumulate	stepwise,	triggering	a	
network	 of	 processes	 responsible	 of	 carcinogenesis2.	 The	 analysis	 of	 tumor-linked	
substances	 is	 increasingly	 used	 for	 diagnosis	 and	 prognosis	 purposes.	 Biomolecules	
that	 carry	 the	 chemical	 information	 relevant	 for	 cancer	 diagnosis	 are	 known	 as	
biomarkers,	 which	 are	 described	 as	 follows:	 “a	 substance	 or	 activity	 that	 can	 be	
objectively	measured	 and	 evaluated	 as	 an	 indicator	 for	 a	 normal	 biological	 process,	
pathogenic	process,	or	pharmacological	response	to	a	therapeutic	intervention”.	Thus,	
cancer	 biomarkers	 are	 present	 in	 tumor	 tissues	 or	 serum	 and	 encompass	 a	 wide	
variety	 of	 molecules,	 including	 DNA,	 mRNA,	 enzymes,	 metabolites,	 transcription	
factors,	 and	 cell	 surface	 receptors3.	 The	 research	 field	 of	 cancer	 biomarkers	 aims	 at	
developing	 reliable	and	cost-effective	detection	and	monitoring	 strategies	 for	 cancer	
risk	indication,	early	cancer	detection,	and	tumor	classification.	
Standard	clinical	protocols	 for	 the	evaluation	of	oncogenic	mutations	 through	
biomarkers	are	usually	based	on	 tissue	biopsy,	which	consists	of	 sampling	cells	 from	
the	 human	 body.	 This	 procedure	 constitutes	 a	 significant	 barrier	 for	 monitoring	 of	
oncogenic	 mutations.	 In	 addition,	 it	 can	 potentially	 introduce	 clinical	 risks	 for	 the	
patient,	 is	 costly,	 and	 patient	 compliance	 with	 this	 procedure	 is	 variable,	 given	 its	
invasive	nature	as	well	as	discomfort.	A	number	of	technical	limitations	have	also	been	
associated	 with	 this	 approach4,	 the	 most	 important	 of	 which	 is	 the	 difficulty	 in	
accounting	 for	 tumor	cells	heterogeneity,	so	biopsies	often	suffer	 from	sample	bias5.	
Another	 important	 technical	 limitation	 relates	 to	difficult	 tumor	sampling	 from	some	
cancer	types,	resulting	in	inadequate	amounts	of	tissue	for	genetic	testing.	In	the	case	
of	advanced	or	metastatic	non-small	cell	lung	cancers	(NSCLC)	as	many	as	31%	of	cases	
do	not	have	accessible	tissue6.	
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The	 above-mentioned	 limitations	 have	 prompted	 the	 development	 of	 new	
methods	 for	 the	 harvesting	 of	 cancer	 biomarkers	 in	 a	 simpler	 and	more	 convenient	
way,	 compared	 to	 tissue	 biopsy.	 The	 science	 of	 non-invasive	monitoring	 of	 diseases	
has	greatly	advanced	since	the	first	report	on	cell-free	DNA	in	body	fluids	by	Mandel	
and	 Metais	 in	 19487,	 which	 set	 the	 milestone	 of	 the	 “liquid	 biopsy”.	 The	 core	
advancement	was	 based	 on	 the	 observation	 that	 the	 levels	 of	 circulating	DNA	were	
higher	in	individuals	with	cancer	than	in	healthy	ones,	opening	the	possibility	to	screen	
the	 presence	 of	 the	 disease	 through	 a	 simple	 blood	 test.	 Thus,	 liquid	 biopsy	 has	
emerged	 as	 a	 potential	 complement	 of	 the	 traditional	 biopsy	 for	 early	 cancer	
diagnosis,4	 in	 which	 biological	 fluids	 are	 sampled	 to	 monitor	 the	 level	 of	 cancer	
biomarkers	available	in	the	chosen	medium.	It	is	commonly	agreed	that,	liquid	biopsy	
on	blood	samples	can	provide	the	genetic	landscape	of	all	cancerous	lesions	(primary	
and	metastases),	 as	well	 as	offering	 the	opportunity	 to	 systematically	 track	 genomic	
evolution.	
Nowadays,	a	vast	number	of	biomarkers	 in	blood	are	classified	with	potential	
implications	for	cancer	diagnosis	and	treatment.	These	include	circulating	tumor	cells	
(CTCs)8,	 circulating	 membranous	 structures	 (microvesicles,	 exosomes)	 containing	
molecular	 biomarkers9,	 circulating	 cell-free	 nucleic	 acids4,	 RNA,	 microRNA10	 and	
proteins	 (Figure	1.1)11.	 In	 this	context,	circulating	cell-free	DNAs	 (released	 from	both	
normal	 and	 tumor	 cells)	 and	 circulating	 tumor	 DNA	 (ctDNA,	 i.e.,	 DNA	 released	 only	
from	 tumor	 cells)	 offer	 a	 number	 of	 advantages	 that	 have	 attracted	 enormous	
attention	over	the	last	5	years.	
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Figure	 1.1.	 Schematic	 representation	 of	 tumor-linked	 molecular	 markers,	 cells,	 and	
membranous	 structures	 circulating	 in	 the	 blood.	 	 Cancer	 cells	 release	 tumor	
biomarkers	in	blood	through	various	physiological	events,	such	as	apoptosis,	necrosis,	
and	secretion.	Adapted	from	12.	
	
1.1.1	Circulating	Tumor	and	Circulating	Cell-Free	DNA	-	Characteristics	
	
All	cells,	including	tumor	cells	and	non-malignant	cells,	shed	circulating	cell-free	
DNA	 (ccfDNA),	 into	 the	 circulatory	 system13.	 Circulating	 tumor	 DNA	 (ctDNA),	 on	 the	
other	hand,	is	a	subclass	of	ccfDNA	which	is	shed	exlusively	from	tumor	cells	into	the	
circulatory	 system	 (Figure	 1.2).	 	 There	 are	 several	mechanisms	 ruling	 the	 release	 of	
DNA	from	tumor	cells	into	blood:	(1)	secretion	from	tumor	cells	as	free	DNA	or	in	cell-
derived	vesicles	 -	exosomes;	 (2)	 secretion	 from	phagocytized	 tumor	cells;	 (3)	 release	
via	 cell	 death	 through	 apoptosis	 and	 necrosis13–17.	 The	 ctDNA	 is	 distinguished	 from	
ccfDNA	by	the	presence	of	somatic	mutations,	making	up	only	a	small	fraction	(often	
only	<1%)	in	solid	malignancies18–20.	In	hematological	malignancies	(e.g.,	leukemia)	the	
blood	 contains	 higher	 percentages	 of	 ccfDNA	 derived	 from	 cancer	 cells.	 The	
contributing	 fraction	 of	 ctDNA	 to	 the	 total	 ccfDNA	 increases	 with	 increasing	 tumor	
1.1	Cancer,	Biomarkers	and	Sensing	Approaches	 	
	
	
6	
	
burden21	 and,	 therefore,	 the	 amount	 recovered	 may	 vary	 greatly	 among	 patients.	
Importantly,	 the	fragment	size	of	ccfDNA	ranges	 in	 length	from	few	hundreds	to	few	
thousands	of	base-pairs.	The	ctDNA	fragments	of	about	145–180	bp	are	supposed	to	
be	 generated	 from	 cell	 apoptosis,	 whereas	 longer	 fragments	 (up	 to	 10	 kbp)	 are	
generated	from	cell	necrosis13,18,19,22–25.	
	
Figure	 1.2.	 Circulating	 cell-free	 DNA	 can	 be	 released	 into	 the	 bloodstream,	 either	
through	 cell	 death,	 i.e.	 apoptosis	 (yellow)	 or	 necrosis	 (green),	 or	 by	 viable	 cells	
(purple).	 Circulating	 cell-free	 DNA	 can	 be	 present	 in	 the	 form	 of	 unbound	 DNA,	
nucleosomes,	vesiclebound	DNA,	or	virosomes.	Adapted	from	14.	
	
Cancer	detection	 that	 is	based	on	monitoring	 ccfDNA	and	ctDNA	 in	plasma	 is	
considered	 technically	 challenging	 because	 of	 their	 low	 concentration.	 Typically,	
median	 ccfDNA	 concentrations	 lower	 than	 20	 ng/mL	 are	 found	 in	 plasma	 obtained	
from	 cancer	 patients,	 whereas	 healthy	 individuals	 show	 even	 lower	 median	
concentrations	(<	7	ng/mL	in	plasma)	which	overlaps	with	the	concentration	ranges	for	
cancer	 patients26,27.	 Additional	 challenges	 are	 related	 to	 the	 fact	 that	 ctDNA	 is	 a	
fraction	of	the	total	ccfDNA	in	cancer	patients,	with	percentages	depending	on	cancer	
type	 and	progression	 stage28.	 In	 general,	mean	numbers	 of	mutated	DNA	 fragments	
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(ctDNA)	per	mL	 ranging	 from	 few	units	 to	 104	 have	been	 found	 in	plasma	of	 cancer	
patients,	 accounting	 for	 few	 units	 percent	 of	 ccfDNA.	 Overall,	 the	 knowledge	 over	
quantitative	 characteristics	 of	 the	 circulating	 cell-free	 DNA	 in	 real	 samples	 (length,	
concentration)	 is	 essential	 in	 the	design	of	biosensors	because	of	 the	 limiting	 values	
that	one	needs	to	approach.		
1.1.2	Single	Nucleotide	Polymorphism	
	
Single	 nucleotide	 polymorphism	 (SNP)	 is	 one	 of	 the	 most	 common	 forms	 of	
genetic	 variation	 in	 the	 human	 genome	and	 it	 is	 the	 single	 nucleotide	 variation	 in	 a	
genetic	 location,	 occuring	 at	 a	 frequency	 of	 1	 in	 every	 1000	 bases,	 approximately29.	
Nowadays,	 a	 total	 of	 1.42	million	 single	 base	mutations	 have	 been	 identified30.	 The	
variations	in	coding	regions	of	the	gene	may	modify	the	sequences	of	aminoacids	and	
in	fact	modify	the	role	of	the	corresponding	protein	(Figure	1.3)31.	Taking	into	account	
the	importance	of	SNP,	it	emerges	as	a	next	generation	genetic	biomarker	in	the	field	
of	 prognosis	 and	 clinical	 diagnosis.	 Especially	 important	 is	 the	 presence	 of	 SNP	 in	
ctDNA	since	it	offers	a	valuable	indication	of	the	probability	of	cancerous	disease.	
	
Figure	 1.3.	 Single	 nucleotide	 polymorphisms	 are	 genetic	 mutations	 where	 the	 DNA	
sequences	 of	 many	 individuals	 vary	 by	 a	 single	 base	 that	 leads	 to	 the	 modified	
sequence	of	an	aminoacid,	causing	thus	a	malfunction	of	the	corresponding	protein.	
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Table	1.1	displays	the	most	relevant	single-nucleotide	polymorphisms	that	are	
currently	being	exploited	as	biomarkers	for	cancer	detection,	and	some	of	them	being	
the	 model	 biomarkes	 in	 the	 present	 thesis.	 SNPs	 that	 relate	 to	 lung	 cancer	 are	
currently	considered	as	the	most	emergent	biomarkers,	because	of	the	high	mortality	
among	patients	diagnosed	with	 this	 type	of	cancer.	The	emergence	of	non-small	 cell	
lung	cancer	(NSCLC),	leads	to	overexpression	of	the	epidermal	growth	factor	receptor	
(EGFR),	 a	 transmembrane	 protein	 that,	 upon	 activation,	 binds	 the	 corresponding	
epidermal	growth	factor.	The	binding	of	ligands	induces	a	conformational	change	that	
leads	to	unregulated	activation	of	an	enzyme	(tyrosine	kinase)	that	in	turns	results	in	
uncontrolled	 cell	 division32.	 It	 has	 been	 found	 that	 EGFR-mutated	 lung	 tumors	
correlate	 with	 a	 specific	 mutation	 (L858R)	 at	 relatively	 high	 frequency	 (43%)33.	
Therefore,	 the	 EGFR	 gene	 is	 a	 prime	 biomarker	 candidate	 for	 the	 development	 of	
targeted	 therapeutics.	 Hence,	 its	 detection	 through	 plasmonic	 nanoparticles	 will	 be	
exploited	in	the	context	of	this	thesis.	
Another	 important	SNP	relates	 to	breast	cancer,	which	 is	 the	most	 frequently	
diagnosed	cancer	and	the	leading	cause	of	cancer	death	in	females	worldwide.	Breast	
cancer	 1	 gene	 (BRCA1)	 induces	 the	 formation	 of	 proteins	 that	 act	 as	 a	 tumor	
suppressor.	These	proteins	help	preventing	cells	from	growing	and	dividing	too	rapidly	
in	an	uncontrolled	way.	The	appearance	of	mutations	in	the	BRCA1	gene	induces	the	
production	of	an	abnormally	short	version	of	the	BRCA1	protein.	As	a	result,	 there	 is	
no	sufficient	protein	to	help	repair	 the	damaged	DNA	or	to	 fix	mutations.	 It	 is	worth	
mentionining	that	in	total	over	1800	mutations	have	been	identified	in	this	particular	
gene	 and	 many	 of	 these	 mutations	 were	 related	 with	 an	 increased	 risk	 of	 breast	
cancer.		
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Cancer	 Biomarker	(Gene	Mutation)	 Reference	
Prostate	 Androgen	Receptor	
AR	c.2105T>A	(L702H)	
34	
	 AR	c.2632A>G	(T878A)	 35	
Breast	 Serine/Threonine-Protein	Kinase	
AKT1	c.49G>A	(E17K)	
36	
	 Human	Epidermal	Receptor	Growth	Factor	
2	
HER2	(ERBB2)	c.2264T>C	(L755S)	
37	
	 Phosphatidyl	3-Kinase	
PIK3CA	c.1633G>A	(E545K)	
38	
Lung	 Epidermal	Growth	Factor	Receptor	
EGFR	c.2573T>G	(L858R)	
33	
	 Kirsten	Rats	Sarcoma	Virus	Gene	
KRAS	c.34G>T	(G12C)	
39	
Bladder	 Fibroblast	Growth	Factor	Receptor	3	
FGFR3	c.742C>T	(R248C)	
40	
	 FGFR3	c.746C>G	(S249C)	 41	
Epithelial	Ovarian	 Serine/Threonine-Protein	Kinase	
BRAF	c.1799T>A	(V600E)	
42	
	 Phosphatidyl	3-Kinase	
PIK3CA	c.3140A>G	(H1047R)	
43	
Thyroid	 Serine/Threonine-Protein	Kinase	
BRAF	c.1799T>A	(V600E)	
44	
Colorectal	 Signal	Transduction	Protein	
SMAD4	c.1082G>A	(R361H)	
45	
Table	1.1.	The	most	relevant	cancer	biomarkers.	
	
The	 last	 years	 of	 intense	 studies	 led	 to	 the	 development	 of	 state-of-the-art	
analytical	techniques	for	the	genotyping	of	known	SNP	and	for	detection	of	new	and	
unknown	SNPs.	Although	DNA	sequencing	 is	 considered	as	a	conventional	method46,	
its	long	operation	times	and	the	complex	procedures	render	the	use	of	this	technique	
non	optimal.	Conformation	changes47,	mass	spectroscopy48,	polymerase	chain	reaction	
(PCR)49,	 and	 DNA	 hybridization50	 are	 considered	 as	 alternative	 approaches.	 But	 still,	
low	 throughput	 and	 low	 specificity	 limit	 their	 wider	 application.	 Although	 recent	
alternatives	 such	 as	 DNA	 microarrays	 and	 denaturing	 high	 performance	 liquid	
chromatography	have	been	developed	for	analysis	of	single	base	mutations51,52,	these	
methods	 need	 expensive	 facilities	 and	 fluorescent	 tags.	 Thus,	 rapid,	 simple,	 and	
specific	technology	is	urgently	needed	for	high	throughput	analysis.	
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1.2	Biosensors	
	
1.2.1	Historical	Overview	and	General	Definition	
	
The	term	biosensor	 is	defined	by	the	 International	Union	of	Pure	and	Applied	
Chemistry	 (IUPAC)	 as	 a	 “device	 that	 uses	 specific	 biochemical	 reactions	mediated	 by	
isolated	 enzymes,	 immunosystems,	 tissues,	 organelles,	 or	 whole	 cells	 to	 detect	
chemical	compounds	usually	by	electrical,	thermal,	or	optical	signals”53.		This	definition	
has	evolved	through	the	years	on	the	basis	of	intense	studies,	since	the	development	
of	 the	 first	 biosensor	 by	 L.	 C.	 Clark	 in	 1956,	 who	 suggested	 a	 probe	 for	 measuring	
oxygen	in	blood.	Later	in	1962,	the	enzyme	electrode	was	described,	consisting	of	an	
oxygen	 probe	 and	 two	 dialysis	membranes	 carrying	 a	 small	 portion	 of	 the	 aqueous	
solution	 of	 glucose	 oxidase	 in	 between	 them.	 The	 strategy	 of	 electrochemical	
detection	 of	 oxygen	 or	 hydrogen	 peroxide	 allowed	 the	 detection	 of	 glucose	 in	
biological	samples54.	
Since	then,	important	progress	in	the	field	of	biosensors	has	been	made,	both	
in	 technology	 and	 applications.	 Between	 1980	 and	 2000,	 the	 development	 of	
biosensors	 has	 gone	 hand	 in	 hand	 with	 the	 progress	 in	 the	 characterization	 of	
biochemical	 compounds	 (see	 next	 section).	 Biochemicals	 have	 been	 involved	 in	
sensitive	 biological	 elements	 and	 the	 transducer	 in	 the	 final	 assembling	 of	 the	
biosensor.	 A	 progressive	 shift	 is	 being	 made	 toward	 transduction	 systems	 of	
biosensors,	 which	 ensure	 feasability	 due	 to	 the	 recent	 progress	 in	 the	 fields	 of	
biotechnology,	nanotechnology	and	bioelectronics55.	
1.2.2	Components	of	Biosensors	
	
From	a	compositional	point	of	view,	a	biosensor	consists	of	a	biological	sensing	
element,	a	physico-chemical	transducer	and	a	detecting	system	(Figure	1.4).	In	such	a	
configuration,	 the	 measurement	 of	 the	 target	 analyte(s)	 is	 achieved	 by	 selective	
transduction	 of	 a	 parameter	 of	 the	 biomolecule-analyte	 reaction	 into	 a	 quantifiable	
signal.	 In	 addition,	 it	 has	 been	 shown	 that	 such	 a	 configuration	 is	 able	 to	meet	 the	
Chapter	1.	Introduction	 	
	
	
11	
	
desired	 characteristics	 of	 biosensors:	 sensitive,	 fast,	 cost-effective,	 low-reagent-
consumption	and	ease-of-use.	
	
Figure	1.4.	Schematic	representation	of	a	biosensor.	
	 	
1.2.2.1	Sensitive	Biochemical	Elements	
	
The	 sensitive	 biochemical	 elements	 are	 classified	 into	 enzyme	 and	 affinity	
types.	The	enzyme	type	relates	to	the	system	involving	enzymatic	reactions	while	the	
affinity	 type	 includes	 immunosensors	 and	DNA	 sensors.	 The	main	difference	 in	 their	
behavior	is	related	to	the	signal	nature;	enzyme	sensors	belong	to	the	kinetic	methods	
of	analysis.	The	signal	reflects	the	rate	of	substrate	conversion,	which	is	high	in	the	first	
minutes	 of	 the	 reaction	 and	 then	 decreases.	 Affinity	 biosensors,	 on	 the	 other	 hand,	
exploit	reversible	biochemical	interactions	like	antigen–antibody	or	DNA–protein.	They	
reach	maximal	response	corresponding	to	the	equilibrium	state.	The	difference	in	time	
response	 of	 these	 two	 classes	 of	 biochemical	 elements	 dictates	 the	 design	 of	 the	
whole	 sensor,	 covering	 the	aspect	of	mass	 transfer	as	 the	 flow	rate	 in	 flow-injection	
analysis	or	solution	stirring	in	batch	conditions.	It	should	be	mentioned	that	the	more	
complicated	the	biochemical	component,	the	more	variational	the	response	it	shows,	
so	that	the	term	‘‘equilibrium’’	is	hardly	applicable	to	biological	cells.	In	most	cases,	a	
signal	 that	 is	 independent	 on	 time	 is	 classified	 as	 stationary.	Figure	 1.5	 displays	 the	
classification	of	biosensors	according	to	the	biochemical	component.	
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Figure	1.5.	Biochemical	components	used	in	biosensor	design.	
	
Enzymatic	 biosensors,	 also	 called	 enzyme	 sensors,	 take	 advantage	 of	 the	
properties	of	the	enzymes	implemented	in	the	surface	layer	of	a	transducer.	In	some	
cases,	the	number	of	individual	enzymes	can	be	specified	(bi-enzymatic,	tri-enzymatic	
sensors)	but	only	in	the	case	where	alternative	constructions	of	biosensors	exist.	Thus,	
glucose	 can	 be	 determined	with	 enzymatic	 sensors	 including	 glucose	 oxidase,	which	
catalyzes	 the	 oxidation	 of	 a	 substrate	 to	 gluconic	 acid.	 Meanwhile,the	 bi-enzyme	
sensor	 involves	peroxidase	as	 an	auxiliary	enzyme,	 intended	 for	 the	 simplification	of	
the	 signal	 measurement56.	 Tri-enzyme	 sensors	 are	 described	 for	 the	 detection	 of	
starch57,	ATP58	and	lactate59.	
Stability	 and	 specificity	 of	 the	 molecular	 recognition	 systems	 (e.g	
antibody/antigen)	 serves	 as	 a	 fundamental	 bassis	 for	 the	 development	 of	
immunosensors	that	rely	on	the	affinity	between	an	immobilized	ligand	on	solid-state	
devices,	in	which	the	immunochemical	reaction	is	coupled	to	a	transducer60.	
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The	 DNA	 sensor	 (genosensors)	 has	 been	 exploited	 for	 its	 inherent	
physicochemical	 stability	 and	 suitability	 to	 discriminate	 different	 organism	 strains.	
These	 biosensors	 involve	 elements	 derived	 from	 DNA,	 i.e.,	 natural	 oligonucleotide	
sequences	 (DNA	 probes)	 or	 aptamers.	 The	 biosensors	 based	 on	 such	 sequences	 are	
intended	to	detect	the	DNA	fragments	specific	for	appropriate	genes61.	Aptamers	also	
consist	of	nucleotides	but	have	no	analogy	in	the	native	DNA	structure.		
Listed	below	are	the	principal	advantages	of	DNA	biosensors62,63:	
1) Hybridization	 in	 solution.	 DNA	 can	 be	 detected	 in	 liquid	 phase	 reaction	 by	
recording	the	changes	of	sound,	light,	electricity	signals,	etc.	
2) Real-time	 detection	 of	 DNA.	 In	 combination	 with	 microfluidic	 chips,	 it	 is	
possible	to	monitor	the	dynamic	reaction	process	of	DNA	in	real-time.	
3) DNA	dynamic	detection	in	vivo.	DNA	sensors	provide	the	possibility	for	studying	
dynamic	processes	of	nucleic	acid	metabolism	transfer	in	vivo.	
4) Multiplex	detection.	Several	DNA	samples	can	be	detected	at	the	same	time	by	
the	development	of	multi-functional	or	intelligent	DNA	sensors.	
5) High	sensitivity.	DNA	sensors	can	directly	detect	 the	target	materials.	 If	 these	
sensors	 are	 combined	 with	 polymerase	 chain	 reaction	 (PCR)	 or	 other	
amplification	 techniques,	 a	 great	 improvement	 of	 the	 sensitivity	 can	 be	
achieved.	
6) High	 specificity.	 A	 DNA	 sensor	 is	 based	 on	 the	 principle	 of	 complementary	
combination.	
7) Clean	 and	 safe.	 It	 does	 not	 need	 isotopic	 labeling,	 and	 avoids	 harmful	
substances.	
Most	of	the	recently	reported	DNA	sensors	exhibit	hybridization	times	between	
10	and	120	min,	which	are	low	as	compared	to	traditional	overnight	hybridization	(20	
h),	but	still	too	long	for	practical	implementation	for	in	point-of-care	devices.	The	time	
required	 for	 the	 hybridization	 process	 (hybridization	 time)	 and	 the	 sensitivity	 of	 the	
assay	 is	 in	 itself	 a	 pair	 of	 contradictory	 elements.	 The	 decrease	 of	 the	 hybridization	
time	 in	 the	premise	of	ensuring	adequate	sensitivity	 remains	as	a	major	challenge	 in	
the	field	of	DNA-based	biosensors.	
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Deoxyribozymes	 (DNAzymes)	 are	 single-stranded	 oligonucleotides	 that	 exert	
catalytic	 activity	 similar	 to	 that	 of	 enzymes64.	 Although	 the	 first	 DNAzyme	 was	
synthesized	in	1994,	they	have	recently	been	introduced	in	the	biosensor	assembly	for	
the	 specific	 detection	 of	 organic	 species.	 DNAzymes	 are	 synthesized	 using	 the	
protocols	 developed	 for	 aptamers	 and	 are	 commonly	 intended	 for	 the	 hydrolysis	 of	
phosphodiester	bonds	or	for	mimicking	peroxidase	activity65.	
Whole	 cells,	 whether	 microorganisms	 or	 cultured	 tissues	 of	 multicellular	
organisms,	 have	 an	 intermediate	 rank	 between	 biomolecules	 (proteins	 and	 nucleic	
acids)	 and	 biological	 tissues.	 Due	 to	 a	 rather	 simple	 and	 cost-effective	 culture,	
microorganisms	are	used	as	an	an	inexpensive	source	of	appropriate	enzyme	activity66.	
The	application	of	microbial	biosensors	 is	 closely	 related	 to	 the	main	microbiological	
technologies	producing	starch,	saccharides,	ethanol,	organicacids,	etc.	
1.2.2.2 	Transducing	and	Detection	Systems	
	
An	important	component	in	biosensor	design	is	the	transduction	system,	which	
makes	use	of	a	physical	change	accompanying	the	reaction	and	defines	the	detection	
system:	 electrochemical	 (amperometric,	 conductimetric,	 impedance	 and	
potentiometric	 biosensors)	 or	 optical	 (colorimetric,	 fluorimetric,	 IR).	 While	
electrochemical	 biosensors	 offer	 high	 specificity,	 low	 limit	 of	 detection	 and	 relative	
freedom	from	matrix	 interference,	optical	biosensors	exhibit	 low	signal-to-noise	ratio	
and	 low	reagent	volume	requirements,	are	 immune	to	electromagnetic	 interferences	
and	 capable	 of	 performing	 remote	 sensing,	 while	 providing	 multiplexed	 detection	
within	 a	 single	 device22.	 Some	 advantages	 of	 this	 type	 of	 biosensors	 are	 its	 high	
sensitivity,	 ease	 of	 operation,	 high	 accuracy	 and	wide	 detection	 capacity.	 Figure	 1.6	
shows	the	general	classification	of	biosensors	according	to	the	type	of	transducer.		
Except	 for	 test	 strips,	 or	 indicating	 tubes	 with	 visual	 detection	 of	 color	
change67,	optical	biosensors	did	not	receive	adequate	interest	until	very	recently.	This	
type	 of	 sensors	 shows	 important	 advantages	 compared	 to	 other	 sensing	
methodologies,	 including	 better	 stability	 in	 aggressive	 environments,	 ability	 of	
providing	label-free	measurements	combined	with	their	potential	for	multiplexing	and	
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miniaturization.	Among	the	different	optical	sensing	platforms,	those	based	on	the	use	
of	 plasmonic	 materials	 meet	 many	 of	 these	 benefits,	 and	 as	 a	 consecuence,	 are	
considered	to	be	key	components	for	the	creation	of	advanced	biosensing	platforms.	
The	most	extensively	employed	optical	biosensors	are	those	based	on	surface	plasmon	
resonances	 (SPR),	 which	 provide	 a	 tunable	 control	 over	 the	 dynamic	 biochemical	
interactions	that	affect	the	total	reflectance	of	the	laser	emission	in	an	ultra-thin	gold	
layer	 modified	 with	 biochemical	 receptor	 molecules.	 These	 commercially	 available	
systems	 are	 rather	 expensive	 and	 limted	 to	 research	 laboratories	 for	 biochemical	
studies68.	However,	optical	nanobiosensors	can	be	also	devised	using	nanostructured	
metals,	rather	than	thin	films,	the	home	pregnancy	test	being	an	excellent	example	of	
how	nanoparticles	can	be	used	in	diverse	fields	like	clinical	diagnosis.	
Recent	 progress	 in	 the	 development	 of	 advanced	 techniques	 such	 as	
reflectance	 Fourier-transform	 infrared	 spectroscopy	 (FTIR)	 and	 surface	 enhanced	
Raman	 spectroscopy	 (SERS),	 which	 can	 be	 used	 on	 a	 solid	 interface,	 increased	 the	
interest	in	optical	biosensors69.	This	is	particularly	true	for	the	use	of	nanoparticles	and	
nanopore	materials	 (artificial	 ion	 channels)	 that	offer	opportunities	 for	an	enormous	
increase	in	sensitivity	that	is	of	great	importance	for	single	DNA	detection.	
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Figure	 1.6.	 Classification	 of	 biosensors	 according	 to	 transducer/signal	 transduction	
principles.	
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1.2.2.3	Characteristics	of	Biosensors	
	
In	 analitycal	 chemistry,	 the	 validation	 of	 a	 given	 method	 is	 a	 crucial	 step	 in	
demonstrating	that	the	results	are	close	enough	to	the	unknown	value	of	the	analyte.	
A	method	can	be	validated	by	 its	 figure	of	merit,	which	 includes	concepts	 related	 to	
the	method	and	to	the	analyte	(i.e.	sensitivity,	selectivitiy,	limit	of	detection	and	signal-
to-noise	ratio)	and	concepts	concerning	the	final	results	(i.e.	traceability,	uncertainty,	
representativity).	
1.2.2.4	Sensitivity	and	Selectiviy	
	
The	sensitivity	toward	a	given	analyte	 is	defined	as	the	slope	of	the	analytical	
calibration	curve.	Therefore,	the	sensitivity	of	an	analytical	method	increases	when	a	
small	change	in	analyte	concentration	induces	a	significant	change	in	the	response	of	
the	sensor.	Selectivity,	on	the	other	hand,	 is	defined	as	the	ratio	of	the	slopes	of	the	
calibration	lines	of	the	analyte	of	interest	and	the	interferences.	Therefore,	a	method	
is	 selective	 when	 the	 response	 of	 the	 analyte	 can	 be	 differentiated	 from	 other	
responses	-	only	the	analyte	of	interest	contributes	to	the	measured	signal.	
1.2.2.5 	Limit	of	Detection	
	
The	 limit	 of	 detection	 (LoD)	 is	 the	 concentration	 derived	 from	 the	 smallest	
signal	 that	 can	 be	 detected	 with	 an	 acceptable	 degree	 of	 uncertainty	 for	 a	 given	
analytical	procedure.	Such	a	lowest	amount	is	the	signal	corresponding	to	n	times	the	
standard	deviation,	s,	of	the	blank	above	the	mean	blank	value.	The	LoD	can	be	used	
as	a	figure	of	merit	to	describe	the	ability	of	a	biosensor	to	discriminate	the	signal	from	
the	noise	 level,	 thus	defining	 the	 signal-to-noise	 ratio,	 i.e.	 the	distance	between	 the	
analytical	signal	of	the	analyte	and	the	instrumental	noise.	
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1.2.2.6	Repeatibility	and	Reproducibility	
	
According	to	the	IUPAC,	repeatability	and	reproducibility	refer	to	the	closeness	
of	 the	 agreement	 between	 the	 results	 of	 successive	 measurements	 of	 the	 same	
measurement	and	carried	out	in	the	same	(repeatability)	or	different	(reproducibility)	
conditions	 related	 to	 operator,	 apparatus,	 laboratories	 and/or	 intervales	 of	 time	
analysis.	
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1.3	Nanoparticles	
	
Wet-chemistry	 methods	 for	 the	 synthesis	 of	 nanoparticles	 have	 been	 widely	
developed	 during	 the	 last	 three	 decades,	 resulting	 in	 the	 possibility	 of	 preparing	
nanoparticles	 in	the	size	range	1-100	nm,	with	a	broad	variety	of	shapes	and	surface	
chemistry.	The	physical	properties	of	 these	new	materials	 resemble	neither	 those	of	
the	bulk	metal	nor	 those	of	molecular	 compounds,	but	 they	 strongly	depend	on	 the	
size,	which	is	related	to	a	significant	increase	of	the	fraction	of	surface	atoms	per	unit	
volume.	 The	 ratio	 of	 surface	 atoms	 to	 interior	 atoms	 changes	 dramatically	 if	 one	
successively	divides	a	macroscopic	object	into	smaller	parts.	For	example,	for	a	cube	of	
iron	of	1	cm3,	the	percentage	of	surface	atoms	would	be	only	10-5	%.	When	the	cube	is	
divided	 into	 smaller	 cubes	with	an	edge	of	10	mm,	 the	percentage	of	 surface	atoms	
will	increase	to	10%.	In	a	cube	of	iron	of	1	nm3,	every	atom	would	be	a	surface	atom.	
Figure	1.7	shows	how	the	percentage	of	surface	atoms	changes	with	the	diameter	of	
palladium	clusters.	Such	an	increase	in	the	ratio	of	surface	atoms	to	interior	atoms	in	
nanostructures	and	nanomaterials	might	 illustrate	why	variations	 in	the	size	range	of	
nanostructures	 are	 expected	 to	 lead	 to	 great	 changes	 in	 the	 physical	 and	 chemical	
properties	 of	 the	materials.	 For	 example,	metallic	 nanoparticles	 have	 lower	melting	
temperatures	 as	 compared	 with	 their	 bulk	 forms,	 when	 the	 particle	 size	 decreases	
below	100	nm.	The	 lowering	of	 the	melting	point	 is	 in	general	explained	by	 the	 fact	
that	the	surface	energy	increases	with	a	decreasing	size.	The	melting	point	of	bulk	gold	
is	1337	K	and	decreases	rapidly	for	nanoparticles	with	sizes	below	5	nm,	as	shown	in	
Figure	 1.7.	 Such	 a	 size	 dependence	 has	 also	 been	 found	 in	 other	materials	 such	 as	
copper,	tin,	indium,	lead,	and	bismuth,	in	the	form	of	particles	and	films.	
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Figure	 1.7.	 (Left)	 The	 percentage	 of	 surface	 atoms	 changes	 with	 the	 diameter	 of	
palladium	clusters.	Adapted	 from	70.	 (Right)	The	melting	point	of	bulk	gold	 is	1337	K	
and	decreases	rapidly	for	NP	with	diameter	below	5	nm.	Experimental	data	(dots)	and	
results	of	a	least-squares	fit	(solid	line).	
	
1.3.1	Noble	Metal	Nanoparticles	
	
The	 high	 surface-to-volume	 ratio	 in	 metal	 nanoparticles	 also	 affects	 their	
optical	 properties,	 making	 this	 material	 a	 promising	 candidate	 for	 a	 variety	 of	
applications.	However,	it	has	not	been	until	recent	years	that	the	optical	properties	of	
metal	nanoparticles	have	been	 fully	exploited.	For	centuries,	gold,	 silver,	and	copper	
nanoparticles	 have	 been	 used	 in	 stained	 glass	 to	 produce	 colored	 drinking	 cups	
(Lycurgus	 cup,	Figure	 1.8a)71	 or	 stained	 glass	windows	 (Canterbury	 cathedral,	Figure	
1.8b).	 Michael	 Faraday	 was	 the	 first	 who	 ascribed	 the	 colors	 of	 stained	 glass	 or	 in	
solution	to	metal	nanoparticles	(Figure	1.8c).	
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Figure	 1.8.	 a)	 The	 Lycurgus	 Cup	 at	 the	 British	Museum	 in	 London.	 b)	 Stained	 glass	
window	 at	 Canterbury	 cathedral.	 c)	 Faraday’s	 gold	 colloidal	 solutions	 at	 the	 Royal	
Society	in	London.	
	
In	his	article	published	 in	1857,	Faraday	concluded72:	 “I	 think	 that	 in	all	 these	
cases	 the	 ruby	 tint	 is	 due	 simply	 to	 the	 presence	 of	 diffused	 finely-divided	 gold.”	
Approximately	 50	 years	 later,	 in	 1908,	 Gustav	Mie	 explained	 the	 appearance	 of	 the	
colors	theoretically.	He	applied	Maxwell’s	equations	in	spherical	coordinates	to	a	small	
sphere	 in	 a	 homogeneous	 environment73,74.	 The	 theory	 showed	 that	 the	 total	
extinction	 cross-section	 comprises	 contributions	 from	 the	 scattering	 and	 absorption	
cross-sections,	i.e.	the	extinction	cross-section,	σext=σabs+σscat	(absorption	cross-section	
+	scattering	cross-section).		
1.3.2	Optical	Propertie	of	Noble	Metal	Nanoparticles	
	
Today	 it	 is	 well	 known	 that	 the	 intense	 colors	 of	 metal	 colloids	 arise	 from	
surface	 plasmons.	 Surface	 plasmons	 exhibit	 unique	 characteristics	 due	 to	 the	
oscillation	of	conduction	electrons	near	the	metal	surface,	upon	excitation	by	incident	
light.	 At	 the	 nanometer	 range,	 metallic	 nanoparticles	 possess	 high	 surface	 area	 to	
volume	ratios	and	show	distinctly	different	optical	properties	compared	to	their	bulk	
and	molecular	counterparts75,76.	Surface	plasmons	strongly	confined	on	the	surface	of	
metallic	 nanoparticles	 are	 termed	 localized	 surface	 plasmon	 resonances	 (LSPR)77.	
When	 the	 incident	 electromagnetic	 field	 interacts	 with	 the	 metal	 nanoparticle,	 the	
conduction	electrons	oscillate	collectively	and	coherently,	 in	resonance	with	the	 light	
frequency,	with	 respect	 to	 the	 nanoparticle	 lattice,	 due	 to	 the	 coulombic	 attraction	
between	 electrons	 and	 metallic	 nuclei	 (Figure	 1.9).	 This	 collective	 oscillation	 of	
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electrons	in	resonance	with	the	incident	light	frequency	creates	an	LSPR	on	the	metal	
nanoparticle	surface.	
	
	
Figure	 1.9.	 Schematic	 diagram	 illustrating	 a	 localized	 surface	 plasmon.	 A	 dipole	 is	
induced,	which	oscillates	in	phase	with	the	electric	field	of	the	incoming	light.	Adapted	
from	78.	
	
As	mentioned	above,	the	surface	plasmon	resonance	of	spherical	particles	with	
radius	 R	 was	 predicted	 by	Mie	 theory,	 through	 expressions	 for	 the	 extinction	 cross	
section.	When	the	size	of	the	nanoparticles	is	significantly	smaller	than	the	wavelength	
of	light	(λ≫2r,	where	r	is	the	radius	of	the	nanoparticle),	the	exact	condition	for	LSPR	
can	 be	 solved	 using	 the	Mie	 theory	 or	 a	 simple	 oscillator	model79,	 as	 the	 extinction	
cross-section	is	expressed	by,	
𝜎#$% = 9 𝜔𝑐 𝜀+,#- ./𝑉 𝜀1#%2-"𝜀1#%2-4 + 2𝜀+,#- 7 + 𝜀1#%2-" 7 																									𝐸𝑞	(1.1)	
	
where	V	is	the	volume	of	the	particle,	?@ 𝜋𝑅@,	ω	is	the	angular	frequency	of	the	exciting	
light,	c	is	the	velocity	of	light,	𝜀+,#- 	is	the	dielectric	function	of	the	medium	surrounding	
the	NP,	 and	 ε’,	 ε’’	 are	 the	 real	 and	 imaginary	 parts	 of	 the	 dielectric	 function	 of	 the	
nanoparticle,	 respectively,	 i.e.	 ε=ε’+iε’’.	 The	 origin	 of	 the	 strong	 color	 changes	
displayed	 by	 small	 particles	 lays	 in	 the	 denominator	 of	 Eq	 (1.1),	 which	 predicts	 the	
existence	of	a	maximum	when	ε’=−2𝜀+,#-.	
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1.3.3	 The	 Effect	 of	 Size	 and	 Aggregation	 on	 the	 Optical	 Properties	 of	 Gold	
Nanoparticles	–	the	pillars	of	colorimetric	sensors.	
	
Since	the	LSPR	can	be	excited	by	incident	light,	the	plasmon	can	also	re-radiate	
its	energy	into	the	far	field	as	scattering,	with	the	size	of	the	particle	determining	the	
relative	contribution	of	absorption	or	scattering.	Figure	1.10a-c	shows	the	spectra	for	
spherical	gold	colloids	of	13,	46	nm	63	nm	in	diameter,	respectively.	 In	general,	 light	
absorption	 dominates	 the	 extinction	 spectrum	 for	 particles	 of	 relatively	 small	 radius	
(<20	nm),	while	light	scattering	becomes	progressivelly	the	dominant	process	for	larger	
nanoparticles.	Overall,	with	increasing	the	size	of	the	nanoparticle,	the	contribution	of	
absorption	 and	 scattering	 components	 strongly	 enhances	 the	 total	 cross-section	
(compare	 the	 three	 plots	 in	 Figure	 1.10),	 rendering	 larger	 particles	 convenient	 for	
optical	 biosensors.	 As	 the	 particles	 increase	 in	 size,	 the	 LSPR	 are	 usually	 shifted	
towards	 higher	 wavelengths	 (535	 and	 540	 nm	 are	 the	 LSPR	 maxima	 in	 the	 case	 of	
particles	with	a	diameter	of	46	and	63	nm,	respectively).	
	
Figure	1.10.	Calculated	optical	coefficients	 for	a	spherical	gold	particle	with	radius	of	
13,	 46	 and	 63	 nm.	 (ext.	 stands	 for	 extinction,	 abs.	 for	 absorption	 and	 sca.	 for	
scattering).	The	Cross-section	spectra	were	calculated	via	online	widget	tools	available	
at	http://garciadeabajos-group.icfo.es.			
	
The	 extremely	 intense	 and	 highly	 confined	 electromagnetic	 fields	 induced	 by	
the	 LSPR	 provide	 a	 highly	 sensitive	 probe	 to	 detect	 small	 changes	 in	 the	 dielectric	
environment	 around	 the	 nanocrystal,	 which	 is	 particularly	 attractive	 for	 sensing	
applications.	 Depending	 on	 the	 origin	 of	 LSPR	 maximum	 change,	 it	 is	 possible	 to	
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distinguish	two	types	of	sensors:	aggregation	sensors	and	refractive	index	sensors.	The	
first	 group	 is	 based	 on	 the	 drastic	 color	 change	 induced	 by	 the	 aggregation	 of	
nanoparticles	 due	 to	 near-field	 electromagnetic	 coupling.	 In	 general,	 for	 two	 metal	
NPs,	 the	 resonance	 peak	 red-shifts	 when	 the	 interparticle	 separation	 distance	
decreases	below	the	particle	diameter	(Figure	1.11	left)80.		
On	 the	 other	 hand,	 the	 redshift	 of	 the	 LSPR	 induced	 by	 an	 increase	 of	 the	
refractive	 index	 around	 metal	 surface	 is	 the	 basis	 of	 the	 refractive	 index	 sensors	
(Figure	 1.11	 right).	 Local	 refractive	 index	 changes	 such	 as	 those	 induced	 by	
biomolecular	 interactions	at	 the	 surface	of	 the	nanostructures	 can	be	monitored	via	
the	LSPR	band	shift.	
	
Figure	 1.11.	 (Left)	 Theoretical	 Extinction	 cross-section	 spectra	 of	 gold	 dimers	 for	
different	distances	between	the	spheres	surfaces.	Adapted	from	81.	(Right)	The	redshift	
of	 the	extinction	 cross-section	 spectra	of	 20	AuNP	and	ellipsoids	with	 aspect	 ratio	 2	
upon	changes	in	the	refractive	index	of	the	medium.	Adapted	from	82.	
	
Other	 appealing	 sensing	 schemes	 can	 be	 devised	 taking	 advantage	 of	 the	
extremely	 large	 electromagnetic	 fields	 created	 in	 the	 so-called	 “hot	 spots”,	 which	
occur	within	nanoparticle	aggregates	or	at	sharp	edges	and	tips	in	single	nanoparticles.	
Within	these	regions,	the	cross-section	of	inelastic	optical	processes	can	be	amplified	
by	many	orders	of	magnitude,	giving	rise	to	surface	enhanced	Raman	scattering	(SERS),	
surface	enhanced	fluorescence	(SEF)	and	other	related	phenomena.	
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1.3.4	Synthesis	of	Gold	Nanoparticles	(AuNPs)	
	
In	 1857,	Michael	 Faraday	 reported	 for	 the	 first	 time	 a	 synthetic	 method	 for	
metal	nanoparticles	by	 the	 reduction	of	a	metal	 salt	by	white	phosphorus,	 in	carbon	
disulfide72.	 The	preparation	of	AuNPs	with	 controlled	 sizes	 and	 shapes	has	 attracted	
much	attention	during	the	second	half	of	the	XXth	century.	A	significant	advancement	
was	 made	 by	 Turkevich	 in	 195183,	 who	 proposed	 the	 so-called	 citrate	 reduction	
method	 (see	 Figure	 1.12	 for	 a	 typical	 TEM	 image	 of	 colloidal	 gold	 prepared	 by	
Turkevich’s	 method),	 which	 was	 improved	 by	 Frens	 in	 197384.	 Then,	 Mulvaney	
proposed	the	synthesis	of	AuNPs	stabilized	by	thiols	in	199385,	and	Brust	and	Schiffrin	
reported	 a	 biphasic	method	 to	 produce	 thiol-stabilized	AuNPs86.	During	 the	 last	 two	
decades,	these	methods	were	progressively	improved,	providing	today	a	wide	range	of	
available	nanoparticles	for	a	variety	of	applications.	
	
Figure	 1.12.	 Gold	 nanospheres.	 TEM	 image	 of	 ≈13	 nm	 AuNPs	 obtained	 through	
Turkevich’s	method.	
	
Nowadays,	we	can	distinguish	two	main	mechanisms	for	the	synthesis	of	metal	
nanoparticles:	 nucleation	 and	 growth	 method	 and	 autocatalytic	 reduction	 on	
preformed	nanoparticles,	also	called	seeded-growth	(Figure	1.13).	
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Figure	1.13.	Two	mechanisms	for	the	synthesis	of	metallic	NPs.	In	the	nucleation	and	
growth	mechanism	metal	 ions	are	reduced	to	zero-valent	nuclei	by	a	strong	reducing	
agent,	followed	by	growth	into	nanoparticles.	In	the	seeded	growth,	a	reducing	agent	
gets	 oxidized	 on	 a	 seed	 surface,	 facilitating	 the	mild	 reduction	 of	metal	 ions	 on	 the	
surface	to	produce	particles	with	the	desired	size	or	shape.	Adapted	from	87.	
	
The	 model	 of	 nucleation	 and	 growth	 was	 exploited	 by	 Faraday	 to	 prepare	
solutions	 containing	 ‘‘finely	 dispersed	 metals’’.	 In	 this	 approach,	 dispersed	
nanoparticles	are	produced	by	the	reduction	of	a	metal	salt	by	a	strong	reducing	agent.	
Organic	 molecules	 present	 in	 solution	 adsorb	 onto	 the	 surface	 of	 the	 particles,	
providing	 colloidal	 stability	 and	 thus	 preventing	 aggregation	 and	 sedimentation.	
Subsequent	advancements	by	Turkevich	and	Frens	allowed	additional	 control	on	 the	
size	of	 the	particles,	 through	 the	molar	 ratio	between	 the	 stabilizing/reducing	 agent	
and	 the	 metal	 precursor84.	 By	 that	 time,	 LaMer	 proposed	 a	 general	 model	 for	 the	
synthesis	 of	 monodispersed	 colloids88,	 which	 found	 general	 acceptance	 in	 the	
synthesis	of	noble	metal	nanoparticles.	Briefly,	to	obtain	monodispersed	particles	one	
should	 increase	 the	 nucleation	 rate	 so	 that	 after	 the	 first	 nucleation	 no	 additional	
nuclei	are	formed	and	a	saturation	point	is	reached	at	which	individual	precursors	only	
deposit	on	existing	particles,	the	growth	process.	Since	the	saturation	point	is	achieved	
faster	 at	 high	 concentration	 of	 the	 metal	 precursor,	 this	 approach	 permits	 the	
synthesis	of	large	amounts	of	particles	without	loss	of	quality.		
The	 first	 autocatalytic	 approach	 for	 selective	 reduction	 of	 gold	 on	 spherical	
seeds	 of	 the	 same	 metal	 was	 proposed	 by	 Turkevich83.	 In	 this	 approach,	 citrate-
stabilized	 nanoparticles	 were	 used	 as	 seeds	 that	 catalyzed	 HAuCl4	 reduction	 by	
hydroxylamine	hydrochloride	exclusively	on	the	surface	of	seeds.	As	a	result,	spherical	
nanoparticles	 were	 obtained,	 with	 fine	 control	 over	 the	 final	 diameter.	 The	 size	
prediction	was	defined	by	the	following	equation:	Df	=	Dn((Aun	+	Aug)/Aun)1/3	where	Df	
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is	the	final	diameter,	Dn	is	the	diameter	of	the	seed,	Aun	the	amount	of	metallic	gold	in	
the	 seed	 particles	 and	 Aug	 is	 the	 amount	 of	 gold	 in	 the	 growth	medium89.	 In	 other	
words,	this	expression	defines	the	final	particle	diameter	by	changing	the	molar	ratio	
between	metal	precursor	and	seeds.	Another	advantage	of	this	approach	is	the	control	
over	the	final	concentration	of	nanoparticles,	which	is	strictly	related	to	the	amount	of	
seeds.	
1.3.5	Surface	Chemistry	
	
The	 surface	 functionalization	 of	 NPs	 causes	 changes	 in	 the	 properties	 to	 fit	
targeted	applications.	The	modification	of	the	metal	surface	with	functional	molecules	
and	polymers	(Figure	1.14)90	has	different	tasks	to	fulfill:		
• stabilize	 the	 nanoparticles	 to	 control	 the	 growth	 of	 the	 initial	 particles	 and	
determine	their	shape	during	the	growth	process;		
• provide	functional	groups	at	the	surface	for	further	derivatization;		
• enhance	the	NPs	stability	in	various	solvents	to	extend	their	applications;		
• modify	the	electronic,	optical,	spectroscopic	and	chemical	properties	to	provide	
a	plethora	of	controllable	nanotools;		
• alter	the	capability	to	assemble	the	particles	in	specific	arrays	or	the	ability	to	
target	desired	chemical,	physical,	or	biological	environments;		
• improve	the	mechanical	and	chemical	performance	of	the	nanoparticle	surface,	
e.g.,	protection	against	oxidation.	
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Figure	1.14.	Gold	nanostructures	can	be	conjugated	with	a	wide	varietey	of	functional	
moieties.	Adapted	from	91.	
	
1.3.6	Spherical	Nucleic	Acids	
	
Among	the	variety	of	biomolecules	that	can	be	 incorporated	onto	the	surface	
of	plasmonic	nanoparticles,	DNA	is	a	unique	system	in	the	detection	of	cancer-related	
biomarkers	which	 is	vital	 in	meeting	the	objective	of	 the	present	thesis.	 In	1996,	 the	
group	of	Mirkin	and	coworkers92	 reported	 for	 the	 first	 time	the	use	of	13	nm	AuNPs	
functionalized	with	 thiol-capped	 short	 single-stranded	DNA	 (ssDNA).	 Two	 batches	 of	
AuNPs	 were	 functionalized	 with	 non-complementary	 DNA	 oligonucleotides	 capped	
with	thiol	groups.	When	the	complementary	sequence	was	added	to	the	solution,	the	
NPs	aggregated,	inducing	a	color	change	from	red	(for	dispersed	AuNPs	in	solution)	to	
purple/blue	 (for	 aggregates).	 These	 aggregates	 dehybridized	 cooperatively	 with	 an	
increase	 of	 the	 temperature	 displaying	 narrow	melting	 transitions	 compared	 to	 the	
free	DNA	(Figure	1.15)93.	DNA	attached	to	the	surface	of	the	nanoparticle	ensures	the	
behavior	 of	 the	 particles	 and	 their	 stability	 in	 complex	 media.	 Usually,	 a	 construct	
between	 the	 nanoparticle	 and	 the	 DNA	 sequence	 requires	 a	 binding	 group	 (mostly	
thiol	 groups),	 a	 spacer	 group	 and	 the	 single-stranded	 DNA	 sequence.	 The	 spacer	
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provides	 the	 freedom	 of	 DNA	 probes	 in	 its	 environment.	 In	 general,	 the	 spacer	 is	
formed	by	a	single	or	double-stranded	DNA	sequence.	Gold	nanoparticles	capped	with	
a	dense	monolayer	of	radially	distributed	DNA	exhibit	properties	that	differ	from	the	
DNA	that	they	derive	from.	Nanoparticles	functionalized	with	a	radial	DNA	shell	have	
higher	binding	constants	than	free	oligonucleotides94,	present	cooperative	binding	and	
thus	 sharp	melting	 transitions95	 (Figure	1.15).	 Therefore,	 such	 structures	 received	 its	
own	name	-spherical	nucleic	acids	(SNA)	-	in	which	DNA	strands	are	highly	oriented.		
	
Figure	1.15.	Schematic	representation	of	 the	strategy	 for	colorimetric	DNA	detection	
using	 DNA	 conjugated	 AuNPs.	 The	 addition	 of	 a	 complementary	 target	 to	 DNA	
oligonucleotide-functionalized	AuNPs	leads	to	aggregation,	resulting	in	a	color	change	
from	red	to	blue.	The	aggregates	dehybridized	in	a	very	narrow	temperature	range,	in	
comparison	with	free	DNA.	Adapted	from	93.	
	
Although	the	protocols	for	binding	DNA	to	the	surface	of	gold	nanoparticles	are	
well	established92,	there	are	some	important	issues	during	the	ligand	exchange	process	
that	may	affect	not	only	the	colloidal	stability	of	the	nanoparticles	but	also	the	proper	
performance	of	the	DNA	shell.	For	example,	during	the	incubation	step,	apart	from	Au-
S	binding,	non-specific	binding	of	the	DNA	sequences	can	also	occur.	These	unspecific	
interactions	between	gold	and	DNA	are	mediated	by	amine	groups	 in	the	purine	and	
pyrimidine	rings	of	the	nucleotides96,97.	Therefore,	the	choice	of	a	proper	sequence	for	
the	 DNA	 spacer	 is	 critical	 to	 avoid	 unspecific	 interactions.	 A	 spacer	 formed	 by	 the	
oligonucleotide	timine	has	been	found	to	present	by	far	the	lowest	unspecific	binding	
affinity98.		
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Another	important	parameter	is	the	extent	of	grafting	density	that	defines	the	
unspecific	 interactions	between	 the	DNA	 strands	 and	 the	 gold	 surface.	 To	 cover	 the	
surface	 of	 the	 particles	 with	 short	 oligonucleotides,	 a	 conventional	 ligand	 exchange	
process	 is	 usually	 applied,	 involving	 Au-S	 bond	 formation	 and	 leading	 to	 a	 limited	
number	 of	 DNA	 strands	 attached	 to	 the	 metallic	 core.	 Electrostatic	 repulsion	 of	
negatively	 charged	 DNA	 strands	 prevents	 dense	 packing,	 leading	 to	 limited	 colloidal	
stability.	 A	 great	 improvement	 was	 the	 introduction	 of	 a	 salt	 aging	 process.	 The	
progressive	 increase	 of	 the	 concentration	 of	 sodium	 ions	 (0.15	 M)	 screened	
electrostatic	 repulsion	 between	 neighboring	 strands,	 promoting	 higher	 densities	 of	
oligonucleotides	on	the	surface	of	the	nanoparticles	(Figure	1.16).	In	general,	the	salt	
concentration	 in	 the	 salt	 aging	 process	 is	 proportional	 to	 the	 DNA	 density	 on	 the	
particle	 surface	 until	 steric	 hindrance	 inhibits	 further	 adsorption.	 Of	 course,	 the	
maximum	surface	coverage	of	DNA	strands	depends	on	the	particle	size	and	shape.	For	
spherical	 particles,	 in	 general,	 smaller	 particles	 can	 support	 a	 higher	 oligonucleotide	
density	than	larger	particles	because	the	radius	of	curvature	is	greater,	which	provides	
a	 deflection	 angle	 between	 neighboring	 oligonucleotides.	 This	 deflection	 angle	
produces	additional	space	in	the	volume	surrounding	the	DNA	strands,	and	decreases	
as	the	particle	size	increases.	
	
Figure	1.16.	Preparation	of	spherical	nucleic	acids.	Particles	stabilized	with	citrate	are	
incubated	 with	 alkylthiol-functionalized	 oligonucleotides	 in	 water.	 Subsequently,	
incubating	 the	 nanoparticles	 in	 aqueous	 solution	 with	 successively	 higher	
concentrations	of	 salt	 and	 surfactant,	 a	 high-density	 shell	 of	DNA	 strands	 is	 formed.	
Adapted	from	99.	
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1.3.7	Colorimetric	Biosensing	based	on	Nanoparticles	Aggregation	
	
Historically,	 colloidal	 aggregation	 is	 the	 core	 feature	 of	 sensitive	 label-free	
assays	 that	can	even	be	visualized	with	a	 ‘‘naked’’	eye.	Early	biosensing	experiments	
for	detection	of	a	variety	of	biomolecules	(e.g.,	proteins)	employed	the	change	of	color	
that	emerged	during	the	aggregation	of	gold	nanoparticles.	As	a	result,	the	detection	
of	DNA	strands	through	selective	particle	aggregation,	became	a	powerful	colorimetric	
biosensing	strategy	(Figure	1.15).	Currently,	 there	are	three	types	of	mechanisms	for	
the	 colorimetric	 detection	 of	 DNA	 strand	 through	 colloidal	 aggregation:	 (A)	
aggregation	 of	 unmodified	 nanoparticles	 in	 the	 presence	 of	 dsDNA	 and	 salt,	 (B)	
aggregation	through	selective	DNA	crosslinking	and,	(C)	aggregation	without	selective	
crosslinking	 of	 DNA.	 Figure	 1.17	 describes	 schematically	 the	 three	 detection	
mechanisms.		
The	first	method	is	based	on	the	assumption	that	ssDNA	molecules	have	higher	
affinity	 toward	gold	surface	than	dsDNA.100	The	adsorption	of	ssDNA	on	gold	surface	
prevents	 the	 aggregation	 at	 elevated	 salt	 concentrations	 that	 would	 usually	 screen	
their	 electrostatic	 repulsion.	 Therefore,	 colloidal	 samples	 that	 contain	 dsDNA	 in	
solution	 irreversibly	 aggregate	 when	 the	 salt	 concentration	 is	 increased,	 while	
solutions	with	ssDNA	remain	stable	(Figure	1.17A).		
The	second	method	 involves	 the	mixing	of	 two	 type	metal	nanoparticle,	each	
grafted	 with	 a	 different	 and	 non-complementary	 thiol-terminated	 single-stranded	
DNA.	Addition	of	a	third	oligonucleotide,	which	is	complementary	to	both	immobilized	
ssDNA	 (one	 at	 each	 end),	 induces	 aggregation	 through	 hybridization	 between	 the	
complementary	oligonucleotides.	Aggregation	is	then	accompanied	by	a	color	change	
of	the	colloidal	solution,	from	red	to	purple-blue.	The	aggregation	can	be	reversed	by	
simply	changing	the	ionic	strength	of	the	solution	or	raising	the	temperature	above	the	
melting	 point	 of	 DNA,	 thus	 inducing	 dehybridization.	 Such	 a	 color	 change	 in	 the	
colloidal	 solution	 allowed	 for	 differentiation	 between	 complementary	 strands	 and	
strands	with	one	or	more	mutations	(Figure	1.17B)93,101.		
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The	third	method	involves	nanoparticles	aggregation	through	the	formation	of	
dsDNA	but	without	crosslinking	events.	The	increase	in	ionic	strength	causes	extensive	
aggregation	of	gold	nanoparticles	stabilized	with	ssDNA.	The	aggregation	is	prevented	
in	the	presence	of	a	complementary	target	that	binds	the	ssDNA	anchored	to	the	gold	
surface	(Figure	1.17B)102,103.	 	Among	these	three	strategies	described	above,	the	self-
assembly	 through	 a	 complementary	 target	 is	 the	most	 exploited	 approach,	which	 is	
due	to	a	rather	lower	risk	of	giving	a	false	positive.	
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Figure	 1.17.	 AuNP	 based	 colorimetric	 assays.	 a)	 colorimetric	 assay	 based	 on	 naked	
AuNPs:	 the	 presence	 of	 ssDNA	 stabilizes	 AuNPs	 against	 salt-induced	 aggregation,	
whereas	double-strand	DNA	does	not;	b)	crosslinking	hybridization	assay:	hybridization	
brings	 both	 AuNP-DNA	 probes	 in	 close	 vicinity,	 leading	 to	 aggregation	 and	 color	
change;	 c)	 non-crosslinking	 hybridization	 assay:	 an	 increase	 in	 ionic	 strength	 causes	
AuNP-DNA	probes	aggregation	(blue	solution),	which	is	prevented	by	the	presence	of	
the	complementary	target.	Adapted	from	104.	
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1.4	Detection	of	Single	Base	Mutation	based	on	the	Aggregation	of	
AuNPs:	State-of-Art	
	
The	aim	of	this	section	is	to	review	the	most	relevant	examples	on	colorimetric	
assays	 for	 detection	 of	 SNP	 using	 gold	 nanoparticles.	 The	 reviewed	 works	 will	 be	
organized	according	the	three	methods	describd	in	the	previous	section,	namely:	(Type	
A)	 assay	 based	 on	 the	 use	 of	 unmodified	 AuNPs,	 (Type	 B)	 crosslinking	 hybridization	
assay,	 and	 (Type	 C)	 non-crosslinking	 hybridization	 assay.	 The	 performance	 of	 each	
example	will	be	disscused	taking	into	account	parameters	such	as	the	time	required	for	
the	 detection	 process,	 the	 sensitivity	 (i.e.,	 LoD)	 and	 the	 single	 base	 mismatch	
selectivity.	In	addition,	the	emphasis	will	be	put	on	the	length	of	the	target	sequence,	
and	the	diameter	of	the	NPs	employed.		
Over	 two	decades	 ago,	Mirkin	 and	 co-workers	 reported	 for	 the	 first	 time	 the	
colorimetric	 detection	 of	 a	 DNA	 target	 (24-30	 bases)	 carrying	 a	 single	 nucleotide	
polymorphism,	 using	 an	 assay	 based	 on	 aggregating	 gold	 nanoparticles105.	 However,	
the	small	particle	size,	13	nm,	limited	the	colorimetric	LoD	sensitivity	and	single-base	
mutation	selectivity	to	60	nM.	Since	then,	various	strategies	were	reported,	which	are	
briefly	 summarized	 in	 this	 section.	 Table	 1.2	 lists	 relevant	 examples	 dealing	 with	
various	 methodologies	 for	 the	 colorimetric	 detection	 of	 single	 nucleotide	
polymorphism	by	aggregating	nanoparticles	without	any	amplification	system	or	use	of	
any	enzyme.		
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Table	 1.2.	 Colorimetric	 detection	 based	 on	 gold	 nanoparticles	 for	 the	 detection	 of	
single	 nucleotide	 polymorphism	 in	 relevant	 DNA	 sequences.
Reference	 DNA	Target	/	Length	 Limit	of	Detection	
NPs		
Diameter	
Colorimetric	assay	based	on	unmodified	AuNPs	(Type	A)	
Rothberg	and	Li	 24	bases	 4.3	nM	 13	nm	
Plaxco	and	coworkers	 27	bases	 1.25	pM	 20	nm	
Chakrabarti	and	
Klibanov	 12	bases	 -	 13	nm	
Zhu	et	al.	 14	bases	 250	nM	 13	nm	
Lee	and	coworkers	 20	bases	 10	ng/μL	 18	nm	
Zhou	and	coworkers	 41	bases	 5	nM	 13	nm	
Colorimetric	assay	with	crosslinking	(Type	B)	
Mirkin	and	coworkers	 30	bases	 60	nM	 13	nm	
Guo	et	al.	 22	bases	 1	pM	 43	nm	
Charrier	and	coworkers	 22	bases	 47.6	nM	 13	nm	
Duan	et	al.	 34	bases	 1	nM	 10	nm	
Graham	and	coworkers	 14	bases	 100	nM	 13	nm	
Colorimetric	assay	without	crosslinking	(Type	C)	
Maeda	and	coworkers	 15	bases	 500	nM	 13	nm	
Baptista	and	coworkers	 -	 117	nM	 13	nm	
Lee	and	coworkers	 12,	21	and	42	bases	 100	nM	 18	nm	
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The	Type	A	methods	 in	which	the	pre-functionalization	of	the	nanoparticles	 is	
exluded	has	 been	 exploited	 by	 	 Rothberg	 and	 Li100.	 In	 their	method,	 single-stranded	
DNA	 (ssDNA)	 or	 duplex	 DNA	 (dsDNA)	 was	 added	 to	 citrate-stabilized	 gold	
nanoparticles,	followed	by	the	addition	of	salt,	leading	to	the	selective	aggregation	in	
the	presence	of	dsDNA	 in	 the	nanoparticle	mixture.	 The	principle	of	 this	methods	 is	
based	on	the	assumption	that	the	binding	of	dsDNA	toward	the	gold	surface	is	much	
less	 efficient	 than	 ssDNA	 because	 the	 bases	 in	 dsDNA	 are	 buried	 in	 the	 helical	
structure.	The	bases	in	ssDNA,	on	the	other	hand,	are	more	accessible	toward	the	gold	
surface,	thereby	stabilizing	the	nanoparticles	in	the	presence	of	high	concentration	of	
salt.	Therefore,	a	red	to	purple	color	change	upon	salt	addition	indicated	the	presence	
of	 target	DNA.	This	assay	 involved	 the	use	of	13	nm	gold	nanoparticles	 that	allowed	
the	visual	detection	of	single	base	mismatches	with	impressive	limit	of	detection	down	
to	4.3	nM.		
A	new	method	improving	the	sensitivity	of	the	label-free	colorimetric	approach	
was	 developed	 by	 Plaxco	 and	 coworkers	 who	 used	 20	 nm	NPs	 and	 polyelectrolytes	
instead	 of	 salt	 (Figure	 1.18)106.	 In	 this	work,	 ssDNA	 or	 dsDNA	was	 added	 to	 citrate-
stabilized	 gold	 nanoparticles,	 followed	 by	 addition	 of	 cationic	 conjugated	
polyelectrolyte.	 However,	 the	working	 principle	 of	 this	 assay	was	 oposited	 as	 in	 the	
previous	example.	 That	 is,	 the	 addition	of	 polyelectrolyte	 to	 the	 ssDNA/nanoparticle	
mixture	 caused	 aggregation	 of	 ssDNA-decorated	 nanoparticles	 because	 of	 the	
interaction	 between	 ssDNA	 and	 polyelectrolytes.	 Opositely,	 the	 addition	 of	
polyelectrolyte	 to	 the	 dsDNA/nanoparticle	 mixture	 did	 not	 induce	 nanoparticle	
aggregation	because	the	interaction	of	dsDNA	with	polyelectrolytes	was	weaker	than	
that	of	ssDNA.	Althouth	the	sensitivy	was	improved	(1.25	pM)	the	selectivity	remained	
low	since	this	method	could	discriminated	only	three	or	more	mismatched	bases.		
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Figure	1.18.	Schematic	representation	of	a	colorimetric	assay	for	DNA	detection	using	
unmodified	AuNPs.	(a)	Scheme	of	the	addition	of	positively	charged	polyelectrolyte	to	
a	mixture	of	ssDNA	and	AuNPs,	leading	to	color	change,	while	no	color	change	occurs	
in	the	case	of	dsDNA.	(b)	Photographs	of	colloidal	solutions	of	AuNPs	in	the	presence	
of	ssDNA	(blue)	and	dsDNA	(red).	(c)	Extinction	spectra	of	AuNPs	with	double-stranded	
and	single-stranded	DNA.	(d)	Plot	of	target	DNA	concentration	vs.	the	A520/A700	ratio,	
showing	the	possibility	of	determining	the	target	concentration.	Adapted	from	106.	
	
Alternatively,	peptide	nucleic	acid	(PNA)	can	also	be	use	as	effective	coagulant	
of	 citrate-stabilized	 gold	 nanoparticles.	 Chakrabarti	 et	 al.107	 have	 demonstrated	 that	
PNA-stabilized	 AuNPs	 agglomerated	 in	 aqueous	 solutions	 in	 the	 presence	 of	 salt	
because	of	the	charge	neutrality	of	PNA.	The	addition	of	target	ssDNA	(12	bases)	to	the	
aggregated	solution	of	AuNP@PNA	resulted	in	the	redispersion	of	NPs,	which	was	due	
to	the	binding	of	negatively	charged	DNA	strands	to	neutral	PNA	on	the	nanoparticle	
surface	 NPs.	 The	 specificity	 of	 the	 PNA-DNA	 complex	 allowed	 for	 colorimetric	
discrimination	 of	 SNP	 in	 DNA	 sequence.	 In	 similar	 works,	 Kanjanawarut	 et	 al.108,109	
confirmed	 that	 the	 addition	 of	 PNA	 to	 citrate-stabilized	 AuNPs	 (13	 nm)	 induces	
aggregation	 of	 NPs	 through	 PNA	 binding	 to	 the	 gold	 surface.	 The	 presence	 of	
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complementary	target	DNA	(22	bases,	1µM)	prevented	aggregation	of	the	NPs	due	to	
the	 formation	 of	 PNA-DNA	 complex.	 The	 incorporation	 of	 the	 single	 base	mismatch	
into	the	DNA	allowed	for	visual	discrimiantion	of	the	mutation	in	the	analyte	DNA.		
	
Figure	 1.19.	 Schematic	 illustration	 of	 how	 different	 nucleic	 acids	 (PNA,	 PNA-DNA	
complexes,	 ssDNA,	dsDNA,	and	PNA/DNA	mixture)	 affect	AuNP	 intrinsic	 stability	 and	
AuNP	stability	against	salt.	Adapted	from	108.	
	
A	 mixture	 of	 single-stranded	 triplex-forming	 oligonucleotide	 (TFO),	 double-
stranded	 DNA	 and	 citrate-stabilized	 AuNPs	 (13	 nm),	 was	 proposed	 by	 Zhu	 et	 al.	 to	
discriminate	 SNP110.	 The	 TFO	 sequences	 interacted	 with	 AuNPs	 through	 nitrogen-
containing	bases,	 thus	protecting	AuNPs	 from	salt-induced	aggregation.	The	addition	
of	duplex	DNA	to	the	mixture	led	to	the	triplex	DNA	formation,	consequently	exposing	
the	 particles	 to	 the	 high	 ionic	 strength	 environment,	 thus	 causing	 aggregation.	 The	
color	 transition	 from	 red	 to	 blue	 indicated	 the	 formation	 of	 triplex	 DNA.	 The	
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introduction	 of	 a	 mutation	 into	 the	 TFO	 sequence	 prevented	 the	 triplex	 DNA	
formation,	and	thus	particle	aggregation	at	a	given	salt	concertation.	
The	detection	of	mutations	 in	the	epidermal	growth	factor	receptor	(EGFR)	of	
non-small	cell	lung	cancer	cells	using	selective	AuNPs	aggregation	(18	nm)	was	studied	
by	 Lee	 and	 coworkers111.	 Mutations	 in	 exon	 19	 and	 exon	 21	 of	 EGFR	 gene	 were	
detected	in	non-amplified	genomic	DNAs	that	were	isolated	from	both	the	lung	cancer	
cell	 lines	and	the	cancer	tissues	of	non-small	cell	 lung	cancer	patients.	At	the	optimal	
salt	 concentration,	 the	 addition	 of	 the	 mutant	 DNA	 that	 was	 hybridized	 with	 the	
complementary	 probe	 of	 20	 bases	 into	 the	 suspension	 of	 unmodified	 gold	
nanoparticles	caused	the	substantial	aggregation	of	the	AuNPs	and	color	change	of	the	
solution.	Gold	nanoparticles,	however,	did	not	exhibit	significant	aggregation,	and	the	
solution	color	 remained	unchanged	with	 the	addition	of	 the	wild-type	DNA	 that	was	
hybridized	 with	 the	 probe.	 In	 the	 eight	 specimens	 from	 non-small	 cell	 lung	 cancer	
patients,	deletion	mutant	 in	exon	19	and	 the	L858R	point	mutation	 in	exon	21	were	
detected	in	a	concentration	of	10	ng/μL.	
A	colorimetric	biosensing	strategy	to	discriminate	single-nucleotide	mutation	in	
DNA	with	high	selectivity	using	unmodified	AuNPs	as	indicators	was	reported	by	Zhou	
and	coworkers112.	 In	the	AuNPs-based	colorimetric	strategy,	binary	DNA	probes	were	
produced	 by	 splitting	 the	 DNA	 probe	 in	 the	 middle	 for	 sensitive	 differentiation	 of	
single-base	mismatch	(Figure	1.20).		Upon	the	addition	of	target	DNA	to	the	solution	of	
binary	DNA	probes	and	13	nm	citrate-protected	AuNPs,	hybridization	between	target	
DNA	and	binary	DNA	probes	 reduced	 the	ability	 to	protect	AuNPs	 from	 salt-induced	
aggregation,	leading	to	color	change.	Whereas	the	presence	of	a	single	base	mismatch	
did	 not	 induce	 the	 AuNPs	 aggregation	 and	 the	 solution	 remained	 stable.	 Regarding	
assay	performance,	this	approach	presented	a	detection	limit	of	5	nM.	
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Figure	 1.20.	 Schematic	 illustration	 of	 AuNPs-based	 colorimetric	 system	 using	
binary	 DNA	 probes	 for	 sensitive	 discrimination	 of	 single-base	 mismatches.	 Adapted	
from	112.	
	
The	examples	 covering	 the	Type	A	methods	 (based	on	 the	use	of	unmodified	
AuNPs)	present	a	good	sensitivity	but	their	main	drawback	 is	the	high	risk	of	of	false	
positives.	 So,	 other	 possibility	 for	 the	 detection	 of	 DNA	 sequences	 and	 the	
discrimination	 of	 SNP	 is	 based	 on	 colorimetric	 assays	 with	 crosslinking.	 The	 most	
relevant	approaches	are	explained	below.	An	assay	for	SNP	detection	through	oriented	
nanoparticle	 aggregation	 in	 the	 presence	 of	 DNA	 target	 have	 developed	 by	 Guo	 et	
al.113.	Upon	target	binding,	the	43	nm	AuNPs	were	asymmetrically	functionalized	with	
DNA	probes	formed	into	a	Y-shaped	DNA	duplex,	which	pulls	the	two	linked	NPs	to	a	
minimum	 separation	 distance	 (Figure	 1.21a).	 The	 extinction	 spectra	 of	 the	 oriented	
sensor	 exhibited	 a	 sharp	 peak	 at	 600	 nm,	 indicating	 the	 formation	 of	 AuNP	 dimers	
(Figure	1.21b),	whereas	the	non-oriented	version	exhibited	a	broad	band	after	target	
binding	(Figure	1.21c).	This	approach	allowed	for	the	detection	of	DNA	sequences	with	
only	one	base	variation	in	targets	with	a	length	of	22	bases.	With	this	method,	the	limit	
of	 detection	 was	 improved	 10,000	 times,	 up	 to	 1	 pM,	 and	 the	 dynamic	 range	 of	
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detection	 was	 more	 than	 two	 orders	 of	 magnitude	 wider	 compared	 with	 the	 non-
oriented	nanoparticle	aggregation	version.	
	
Figure	1.21.	a)	Schematic	illustration	of	the	oriented	colorimetric	biosensor.	B)	and	c)	
represent	typical	extinction	spectra	of	oriented	(b)	and	non-oriented	(c)	sensors.	The	
target	concentrations	for	the	spectra	from	1	to	6	are	0,	1	pM,	10	pM,	100	pM,	1	nM	
and	10	nM	for	b),	and	0,	10	nM,	30	nM,	100	nM,	300	nM	and	1000	nM	for	c).	Adapted	
from	113.	
	
A	2D	assay	based	on	the	aggregation	of	oligonucleotide-modified	AuNP	probes	
attached	to	the	surface	was	reported	by	Charrier	and	coworkers	(Figure	1.22)114.	Gold	
nanoparticles	(13	nm)	were	adsorbed	on	a	fluid	lipid	bilayer	supported	on	a	substrate.	
The	 target	 ssDNA	 (22	 bases)	 crosslinked	 the	 NPs,	 resulting	 in	 the	 formation	 of	
aggregates	 in	 the	 plane	 of	 the	 substrate.	 Subsequent	 desorption	 of	 non-crosslinked	
nanoparticles	by	dextran	 sulfate	allowed	 to	maintain	 the	aggregates	attached	 to	 the	
lipid	 bilayers.	 The	 detection	 limit	 for	 SNP	 discrimination	 was	 improved,	 reaching	 a	
concentration	value	of	47.6	nM.	
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Figure	1.22.	Schematic	representation	of	a	2D	assay.	a)	The	system	comprises	
three	 layers:	 the	 solid	 substrate,	 the	 lipid	 layer	 and	 the	 oligonucleotide-modified	
AuNPs	–	signal	transducer.	b)	Crosslinking	of	single-stranded	DNA	through	target	DNA	
leads	to	the	selective	aggregation	of	nanoparticles.	c)	A	top	view	of	the	system	before	
and	after	hybridization.	Adapted	from	114.	
	
A	 simple	 colorimetric	 method	 based	 on	 the	 enzyme-free	 toehold-mediated	
strand	displacement	 reaction	was	proposed	by	Duan	et	al.115.	 In	 this	method,	AuNPs	
acted	 as	 signal	 generators	 for	 the	 real-time	 detection	 of	 the	 product	 of	 the	 strand	
displacement	 cascade	 of	 34	 bases	 of	 length.	 This	 assay	 could	 also	 be	 applied	 in	
complex	mixtures,	fetal	bovine	serum,	and	to	detect	single	base	mismatches	achieving	
a	limit	of	detection	of	1	nM	(Figure	1.23).	
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Figure	 1.23.	 Colorimetric	 method	 for	 monitoring	 the	 enzyme-free	 strand	
displacement	cascade.	The	product	of	 the	catalytic	 strand	displacement	cascade,	 the	
C3	strand,	is	consumed	by	the	disassembly	of	the	AuNP	aggregates.	Adapted	from	115.	
	
Locked	Nucleic	Acids	 (LNA)	 can	 be	 also	 employed	 for	 the	 functionalization	 of	
AuNPs.	With	 this	approach,	 these	conjugates	display	 remarkable	binding	affinity	and	
selectivity	towards	22	bases	DNA	target116.	The	use	of	LNA/DNA	chimeras	by	Graham´s	
group	ensured	the	enhanced	stability	of	duplexes	formed	using	AuNP	conjugates	and	
offered	discrimination	between	mismatch	and	complementary	target	DNA.	Despite	the	
relatively	good	selectivity	between	the	match	and	mismatch,	the	limit	of	detection	was	
rather	low,	100	nM.	
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The	last	method	in	colorimetric	assays	depicted	in	Figure	1.17	is	related	with	a	
non	 crosslinking	 method.	 A	 non	 crosslinking	 assay	 was	 proposed	 for	 SNP	 detection	
based	 on	 the	 aggregation	 of	 AuNPs	 (13	 nm),	 through	 the	 hybridization	 of	 15	 bases	
target	DNA117.	The	single-base	mutation	was	located	on	the	5’	terminus,	ensuring	the	
stability	of	the	particles	at	high	salt	concentration.	On	the	contrary,	the	perfect	match	
sequence	(no	mutation	at	5’	terminus)	formed	a	double	strand	on	the	particle	surface,	
leading	 to	 gradual	 aggregation	 at	 high	 salt	 concentration	 (Figure	 1.24).	 Maeda	 and	
coworkers	claimed	that	double	strands	on	the	particles’	surface	affect	the	electrostatic	
repulsion	 between	 the	 particles,	 due	 to	 the	 charge	 screening.	 Overall,	 this	 method	
allowed	 the	 authors	 to	 achieve	 the	 sensitivity	 of	 500	nM	 for	 the	discrimination	of	 a	
single	 base	mutation.	 The	 desing	 of	 this	 assay	 is	 very	 simple,	 easy	 and	 it	 allows	 to	
discriminate	between	two	DNA	sequences	with	a	difference	of	only	one	base;	but	the	
main	drawback	is	the	low	sensitivity.	
	
Figure	 1.24.	Aggregation	behaviors	of	DNA-AuNPs	at	 various	NaCl	 concentrations,	 at	
room	temperature:	(A)	without	a	target	DNA,	(B)	with	the	complementary	target,	and	
(C)	 with	 a	 target	 containing	 a	 single	 base	 mismatch	 at	 its	 5¢ terminus.	 The	 final	
concentrations	of	the	particle,	the	probe	DNA,	and	the	targets	were	2.3,	500,	and	500	
nM,	respectively.	Adapted	from	117.	
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Au-nanoprobes	were	used	for	the	specific	identification	of	SNPs	within	the	beta	
subunit	of	the	RNA	polymerase	(rpoB	locus),	responsible	for	resistance	to	rifampicin	in	
over	 95%	 of	 rifampicin-resistant	 M.	 tuberculosis	 strains	 (Figure	 1.25).	 This	
methodology	 developed	 by	 the	 group	 of	 Baptiste	 and	 coworkers118	 was	 applied	 to	
pathogen	 identification	 and	 SNP	 discrimination	 based	 on	 the	 differential	 non-
crosslinking	aggregation	of	Au-nanoprobes	with	a	limit	of	detection	of	117	nM.	As	the	
first	step,	a	PCR	amplification	of	a	fragment	of	rpoB	gene	was	performed,	followed	by	
the	hybridization	process.	In	the	presence	of	the	respective	complementary	target,	the	
Au-nanoprobes	 are	 protected	 against	 the	 salt-induced	 aggregation	 and	 the	 solution	
remains	stable;	whereas	 the	presence	of	noncomplementary	 target	does	not	protect	
the	Au-nanoprobes	from	the	aggregation	and	the	solution	turns	blue.		
	
Figure	1.25.	A	strategy	 for	detection	of	MTBC	 (Mycobacterium	tuberculosis	complex)	
members	 and	mutations	 associated	with	RIF	 resistance.	 Schematic	 representation	of	
the	 detection	 with	 Au-nanoprobes.	 The	 colorimetric	 assay	 consists	 of	 visual	
comparison	of	test	solutions	before	and	after	salt	induced	Au-nanoprobe	aggregation:	
Au-nanoprobe	alone	(blank),	Au-nanoprobe	in	the	presence	of	a	complementary	DNA	
sequence	 (POS),	 and	 Au-nanoprobe	 in	 the	 presence	 of	 a	 non-complementary	 DNA	
sequence	(NEG).	Adapted	from	118.	
1.4	Detection	of	Single	Base	Mutation	based	on	the	Aggregation	of	AuNPs:	State-of-Art	 	
	
	
46	
	
A	 colorimetric	 method	 for	 the	 detection	 of	 mutations	 in	 the	 tyrosine	 kinase	
receptor	 c-Kit	was	 reported	 by	 Lee	 and	 coworkers119.	 To	 detect	 a	 point	mutation	 in	
codon	 559	 and	 in-frame	 deletion	 in	 codon	 557/558	 of	 c-Kit,	 the	 authors	 designed	 a	
target	with	different	lengths	(12-,	21-,	and	42-mer)	derived	from	the	wild-type	and	the	
mutant-type	 c-Kit	 sequences.	 AuNPs	 were	 then	modified	 with	 the	 PNA	 probes	 that	
were	perfectly	complementary	 to	 the	wild-type	 target	 sequence.	This	made	 the	PNA	
modified	 AuNPs	 neutrally	 charged,	 leading	 to	 destabilization	 and	 aggregation	 of	
AuNPs.	 The	 addition	 of	 the	 target	 to	 the	 PNA-modified	 AuNPs	 induced	 the	
hybridization	 between	 the	 PNA	 probes	 on	AuNPs	 and	 the	 target,	which	 renders	 the	
AuNPs	 negatively	 charged	 because	 of	 the	 phosphate	 backbone	 in	 the	 target	 DNA	
sequences	 (Figure	 1.26).	 The	diameter	of	 the	particles	used	 in	 the	assay	was	18	nm	
and	three	targets	with	different	lengths,	12,	21	and	42	bases	were	tested.	The	limit	of	
detection	achieved	in	the	case	of	the	21	bases	target	was	100	fmol/μL.	
	
	
Figure	 1.26.	 Scheme	 for	 the	 detection	 of	 wild	 type	 oligonucleotides	 with	 the	 PNA-
modified	AuNPs.	Adapted	from	119.	
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	 Taking	into	account	the	publications	in	the	field,	there	are	some	problems	that	
need	to	be	solved	and	certain	parameters	to	improve.	For	example,	the	sensitivity	and	
selectivity,	as	well	as	the	need	for	simple	and	easy-to-apply	approaches.	Also,	in	all	the	
cases	the	diameter	of	the	particles	is	approximately	around	15	nm;	so,	if	large	particles	
are	 employed	 as	 transducers,	 the	 intensity	 of	 the	 plasmon	 will	 be	 higher	 and	 the	
sensitivity	 of	 the	 assay	will	 be	 improved.	 On	 the	 other	 hand,	 in	 a	 real	 scenario	 the	
length	of	the	target	sequences	that	we	want	to	detect	 is	normally	around	140	bases.	
But,	in	the	most	of	the	cases	the	length	of	the	targets	is	between	20	and	30	bases,	so	
far	 of	 a	 real	 application.	 Another	 important	 point	 is	 that	 all	 the	 articles	 reported	
different	 approaches	 to	 detect	 single	 stranded	 DNA,	 but	 in	 a	 real	 case,	 the	 DNA	 is	
double	stranded.	As	final	point	to	consider	for	the	desing	of	an	assay	is	the	importance	
of	the	physiological	media.	This	environment	is	rich	in	a	huge	variety	of	biomolecules	
such	as	proteins,	membranes,	phospholipids,	endocytic	vesicles,	organelles	which	will	
inevitabily	 interact	 with	 the	 nanoparticle	 surface	 and	 the	 detection	 process	 will	 be	
affected.	
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Chapter	2.	Sensitivity	Limit	of	Nanoparticle	Biosensors	in	
the	Discrimination	of	Single	Nucleotide	Polymorphism	
	
Abstract	
Selective	 aggregation	 of	 nanoparticles	 offers	 a	 rapid	 determination	 of	 cancer	
biomarkers,	 detectable	 by	 the	 naked	 eye.	 The	 number	 of	 available	 target	 DNA	
molecules	 per	 particle	 is	 the	 limiting	 factor	 of	 sensitivity	 of	 such	 colloidal	 sensors.	
Although	the	particle	size	is	an	important	experimental	parameter	of	in	the	design	of	
the	 assay	 towards	 the	 modulation	 of	 the	 target-to-particle	 ratio	 at	 constant	 metal	
concentration,	the	NPs	size	is	often	omitted	due	to	the	issues	with	colloidal	stability	of	
large	 particles	 functionalized	with	 DNA.	 In	 this	 chapter,	 the	 gold	 nanoparticles	 with	
increasing	diameter	 from	13,	46,	 to	63	nm	are	used	as	 colloidal	 signal	 transducer	 to	
find	 the	optimal	 ratio	between	 the	 analyte	 and	nanoparticls	 in	 the	discrimination	of	
SNP.	 It	 has	 been	 found	 that	 5-fold	 increase	 in	 particle	 size,	 at	 constant	 gold	
concentration,	 leads	 to	 an	 improvement	 in	 the	 limit	 of	 detection	 by	 3	 orders	 of	
magnitude,	 which	 is	 5,	 0.1,	 and	 0.05	 nM	 for	 13,	 46,	 and	 63	 nm,	 respectively.	
Interestingly,	regardless	of	particles	diameter	a	target-to-particle	ratio	equal	to	4	sets	
the	limit	of	detection	and	sensitivity	of	presented	colloidal	assay.	
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2.1	Introduction	
	
Back	 in	 1997,	 Mirkin’s	 group	 has	 demonstrated	 the	 feasibility	 of	 using	
plasmonic	 nanoparticles	 for	 single-nucleotide	detection1,2.	 A	 sandwich	 approach	was	
stablished	 in	which	gold	nanoparticles	capped	with	different	DNA	strands	underwent	
aggregation	 in	 the	 presence	 of	 a	 mutually	 complementary	 DNA	 sequence.	
Interestingly,	 by	 introducing	 a	 single-base	 mutation	 into	 the	 analyte	 sequence,	 the	
aggregation	 was	 less	 pronounced.	 Since	 then,	 progress	 in	 the	 field	 has	 allowed	 an	
increasing	 complexity	 in	 colorimetric	 assays,	 thus	 improving	 their	 performance	 in	
parameters	 such	 as	 sensitivity,	 selectivity,	 and	 detection	 time3–5.	 In	 most	 of	 these	
studies,	 13	 nm	gold	 nanoparticle	 signal	 transducers	were	 used,	 primarily	 due	 to	 the	
simplicity	of	the	Turkevich	synthesis	method6.	Although	these	nanoparticles	are	useful	
for	conceptual	definition	of	the	assay,	their	extinction	coefficient	 is	 low	compared	to	
particles	with	larger	diameter	(𝜎"#$	∝	D6)7,	rendering	limited	capacity	of	transducing	a	
chemical	event	into	an	optical	signal.	The	central	hypothesis	of	this	chapter	relates	to	
the	fact	that	the	physical	 limitation	of	any	colloidal	(bio)sensor	relates	to	the	ratio	of	
target	 molecules	 (here	 DNA)	 to	 nanoparticles.	 Therefore,	 with	 increasing	 the	
nanoparticles	diameter	at	constant	metal	concentration,	the	number	of	nanoparticles	
decreases,	lowering	thus	the	amount	of	molecules	required	to	aggregate	and	therefore	
transduce	 the	 signal.	 In	 addition,	 the	 lower	 curvature	 of	 larger	 particles	 would	
facilitate	multiple	binding	events	by	DNA	to	connect	NP	probes8.	Figure	1	describes	the	
composition	of	the	colloidal	assay	used	in	this	chapter	for	the	discrimination	of	SNP.		
The	 effect	 of	 particle	 size	 on	 the	 discrimination	 of	 single	 nucleotide	
polymorphism	was	evaluated	in	the	case	of	BRCA1	gene.	This	gene	is	one	of	the	most	
studied	 one	 in	 the	 context	 of	 the	 single	 base	 mutation.	 To	 ensure	 relatively	 facile	
discrimination	 of	 the	 mutation,	 the	 match	 and	 the	 mismatch	 sequences	 were	
parametrized	according	to	the	nearest-neighbor	model9,	which	dictates	the	following	
structural	 requirements:	 1)	 central	 position	 of	 the	 mutation	 in	 the	 sequence;	 2)	
relatively	short	sequences	(19	bases);	3)	low	CG	content	(26%	for	mismatch	and	31%	of	
match);	4)	mismatch	type	affecting	the	C−G	base	pair	instead	of	A−T	(see	Figure	2.1).	
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Figure	2.1.	Scheme	displaying	the	sequences	of	thiolated	oligonucleotides	and	target	
DNA	(match	and	mismatch),	together	with	particles	of	different	sizes.		
2.2	Experimental	Part	
	
2.2.1	Chemicals	
	
Hydrogen	 tetrachloroaurate	 (III)	 hydrate	 (HAuCl4·	 3H2O)	 was	 purchased	 from	
Alfa	 Aesar.	 Sodium	 dodecyl	 sulfate	 (SDS)	 (98%),	 sodium	 chloride	 (NaCl)	 (99.5%),	
sodium	citrate	tribasic	dihydrate	(98%),	and	phosphate	buffer	(PB)	1	M,	pH	7.4,	were	
purchased	 from	Sigma-Aldrich.	To	quantify	 the	concentration	of	DNA	 loaded	on	NPs,	
the	 Quant-iT	 Oli	 Green	 ssDNA	 Kit	 was	 purchased	 from	 Thermo	 Fisher	 Scientific.	
Phosphate	buffered	saline	(PBS)	0.01	M,	pH	7.4,	containing	0.138	M	NaCl	and	2.7	mM	
KCl	 (Sigma-	Aldrich)	was	used	 to	mimic	physiological	 conditions.	DNA-targets	 (match	
and	 mismatch)	 and	 thiolated-oligonucleotides	 (Figure	 2.1)	 were	 purchased	 from	
Biomers	(Germany).	
2.2.2	Instrumentation	
	
UV−vis	spectra	were	measured	at	room	temperature	on	an	Agilent	8453	UV−vis	
spectrophotometer,	 using	 UV	 Micro	 cuvettes	 with	 1.0	 cm	 optical	 path	 length.	
Transmission	 electron	 microscopy	 (TEM)	 was	 measured	 in	 a	 JEOL	 JEM-1400	 PLUS,	
operating	 at	 120	 kV,	 equipped	 with	 a	 GATAN	 US1000	 CCD	 camera	 (2k×2k).	
Fluorescence	 measurements	 were	 performed	 in	 a	 MicroPlate	 Reader	 with	 an	
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excitation	wavelength	of	485	nm,	an	emission	wavelength	of	535	nm,	number	of	reads:	
10	and	40	μs	of	integration	time.		
2.2.3	Synthesis	of	Gold	Nanoparticles		
	
13	nm	AuNPs.	13	nm	AuNPs	were	prepared	according	to	the	standard	Turkevich	
method6.	In	brief,	a	solution	of	HAuCl4	(500	mL,	0.5	mM)	was	heated	up	to	boiling	in	
an	1	L	Erlenmeyer	flask,	followed	by	the	addition	of	trisodium	citrate	solution	(25	mL,	
1%	w/v)	under	vigorous	stirring.	After	15	min	of	boiling,	the	solution	was	set	aside	to	
cool	 down	 to	 room	 temperature	 and	 stored	 at	 4	 °C	 for	 further	 use.	 The	 final	
concentration	of	metallic	gold	was	0.5	mM.		
46	and	63	nm	AuNPs.	46	and	63	nm	AuNPs	were	synthesized	following	an	Au-
assisted	seeded	growth	method10.	Synthesis	of	Au	seeds:	a	solution	of	trisodium	citrate	
(150	mL,	2.2	mM)	was	heated	for	15	min	under	vigorous	stirring	until	boiling,	followed	
by	injection	of	a	solution	of	HAuCl4	(1	mL,	25	mM).	The	color	of	the	solution	changed	
from	yellow	to	bluish	gray	and	then	to	light	pink	in	10	min.	Seeded	Growth:	The	seeded	
growth	process	comprised	cyclic	addition	of	metal	precursor	and	extraction	of	particles	
product.	 In	 a	 typical	 process,	 the	 seed	 solution	was	 cooled	down	 to	 90	 °C	 and	 then	
HAuCl4	solution	(1	mL,	25	mM)	was	added,	followed	by	a	second	addition	after	30	min.	
After	a	further	30	min	period,	part	of	the	growth	solution	(55	mL)	was	extracted	and	to	
the	remaining	solution	(98	mL)	water	(53	mL)	and	sodium	citrate	(2	mL,	60	mM)	were	
added.	 This	 addition/extraction	 process	 was	 repeated	 3	 times	 to	 obtain	 gold	
nanoparticles	 with	 46	 nm	 diameter	 (55	 mL).	 Subsequent	 repetitions	 of	 the	 process	
yielded	63	nm	AuNPs	(55	mL).	The	final	concentration	of	metallic	gold	was	0.8	mM	in	
both	samples.	
2.2.4	Functionalization	of	AuNPs	
	
AuNPs	 were	 functionalized	 with	 thiolated	 oligonucleotides	 (1Triplex	 and	
2Triplex)	 according	 to	 the	 method	 reported	 by	 Hurst	 et	 al11.	 Briefly,	 to	 the	 AuNPs	
colloid	 (1.11	 mL)	 containing	 SDS	 (0.1%)	 and	 PBS	 (0.01	 M)	 was	 added	 a	 solution	 of	
oligonucleotides	 to	 reach	 a	 final	 concentration	 of	 1	 OD/mL.	 An	 excess	 of	
oligonucleotides	was	used	in	all	the	samples,	estimated	as	2,	3,	and	4	oligonucleotides	
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per	 nm2	 of	 gold	 surface,	 for	 13,	 43,	 and	 63	 nm	AuNPs,	 respectively.	 The	mixture	 of	
oligonucleotides	 and	 AuNPs	 was	 incubated	 at	 room	 temperature	 for	 20	 min.	 To	
improve	 oligonucleotide	 binding	 onto	 the	 gold	 surface	 a	 salt	 aging	 process	 was	
implemented.	 A	 solution	 containing	NaCl	 (2	M),	 SDS	 (0.01%),	 and	 PBS	 (0.01	M)	was	
added	 sequentially	 to	 the	 mixture	 containing	 AuNPs	 and	 oligonucleotides	 in	 the	
following	 aliquots:	 5,	 5,	 15,	 25,	 and	 50	 μL,	 ultimately	 reaching	 a	 final	 NaCl	
concentration	 of	 0.2	 M.	 After	 each	 addition	 the	 mixture	 was	 sonicated	 for	 10	 s	
followed	by	a	20	min	incubation	period.	The	final	solution	was	incubated	for	12	h.	To	
remove	excess	oligonucleotides,	the	solutions	were	centrifuged	three	times	(13	nm	at	
13000	rpm	for	20	min;	46	nm	at	8500	rpm	for	15	min;	63	nm	at	8500	rpm	for	10	min),	
each	time	redispersed	 in	SDS	 (1	mL,	0.01%).	The	 final	concentration	of	nanoparticles	
was	0.4	mM	in	terms	of	metallic	gold	for	all	the	samples.	
2.2.5	Quantification	of	Oligonucleotides	Loaded	on	Gold	Nanoparticles	
	
The	assay	procedure	 is	designed	 for	use	with	standard	microplate	 reader	 in	a	
total	 volume	 of	 200	 μL.	 First,	 commercially-available	 oligonucleotide	 standard	 (100	
μg/mL)	was	diluted	50-fold	in	TE	buffer	(10	mM	Tris-HCl,	1	mM	EDTA,	pH	7.5)	to	give	
working	 solution	 (2	 μg/mL).	 The	working	 solution	was	 diluted	 20-fold	 to	 yield	 a	 100	
ng/mL	 oligonucleotide	 stock	 solution.	 For	 the	 standard	 curve,	 both	 oligonucleotide	
stock	solutions	(2	μg/mL	and	100	ng/mL)	were	diluted	into	the	96-well	microplate	as	
shown	 in	 Table	 2.1,	 followed	 by	 mixing	 and	 incubation	 for	 5	 minutes	 at	 room	
temperature,	protected	from	light.	After	 incubation,	measure	the	fluorescence	in	the	
microplate	 reader	 with	 standard	 fluorescenin	 wavelengths	 (excitation	 485	 nm	 and	
emission	535	nm).	
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Volume	of	TE	
buffer	
Volume	of	2	μg/mL	
oligomer	stock	
Volume	of	diluted	
Quant-iT	OliGreen	
reagent	
Final	oligomer	
concentration	in	
Quant-iT	OliGreen	
Assay	
90	μL	 10	μL	 100	μL	 100	ng/mL	
95	μL	 5	μL	 100	μL	 50	ng/mL	
99	μL	 1	μL	 100	μL	 10	ng/mL	
	
Volume	of	TE	
buffer	
Volume	of	100	
ng/mL	oligomer	
stock	
Volume	of	diluted	
Quant-iT	OliGreen	
reagent	
Final	oligomer	
concentration	in	
Quant-iT	OliGreen	
Assay	
90	μL	 10	μL	 100	μL	 5	ng/mL	
99	μL	 1	μL	 100	μL	 0.5	ng/mL	
Table	2.1.	Protocol	for	preparing	a	low-range	standard	curve.	
	
For	 the	 sample	 analysis,	 the	 DNA	 was	 chemically	 displaced	 from	 the	
nanoparticle	 surface	 using	 DTT.	 The	 displacement	 was	 achieved	 by	 adding	 equal	
volumes	of	oligonucleotide-functionalized	gold	nanoparticles	 (200	μL)	and	1.0	M	DTT	
in	0.18	M	PB,	pH	8.0	(200	μL).	The	oligonucleotides	were	released	into	solution	during	
3h	 incubation,	and	 the	gold	precipitate	was	 removed	by	centrifugation	 (6500	 rpm,	5	
min).	To	determine	oligonucleotide	concentration,	supernatant	(25	μL)	was	placed	in	a	
96-well	plate	containing	75	μL	of	1x	TE	buffer	and	100	μL	of	Quant-iT	OliGreen	reagent.	
The	fluorescence	was	measured	and	compared	to	the	standard	curve.	The	number	of	
oligonucleotides	 per	 particle	 for	 each	 aliquot	 was	 calculated	 by	 dividing	 the	
concentration	of	oligonucleotides	by	the	concentration	of	nanoparticles.	
2.2.6	Hybridization	of	AuNP-DNA	Probes	and	Detection	of	ssDNA	Targets	
	
Equal	volumes	(62.5	μL)	of	two	batches	containing	Au@DNA	(Au@1Triplex	and	
Au@2Triplex)	were	combined	 into	the	UV	mikro	cuvette,	 followed	by	the	addition	of	
PBS	(×1,	325	μL).	To	this	solution	was	added	50	μL	of	a	mixture	containing	PB	(0.01	M)	
and	NaCl	(2	M)	to	reach	the	final	volume	of	0.5	mL.	Finally,	an	aliquot	of	target	ssDNA	
(either	match	or	mismatch	of	 the	desired	 concentration)	was	added	 to	 the	 solution.	
Immediately	after	the	addition	of	target	ssDNA,	UV−vis	spectra	were	recorded	during	
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30	at	0.5	min	intervals.	Since	the	stock	solutions	containing	Au@DNA	([Au0]	=	0.4	mM)	
were	stored	in	0.01%	SDS,	the	final	concentration	of	the	surfactant	was	0.001%	while	
the	final	concentration	of	metallic	gold	was	0.1	mM.	The	pH	of	the	mixture	was	7.4.		
2.2.7	Hybridization	of	AuNP-DNA	Probes	and	Detection	of	ssDNA	Targets	in	
Binary	Mixtures	
	
Equal	volumes	(62.5	μL)	of	two	batches	of	NPs	(Au@1Triplex	and	Au@2Triplex)	
were	combined	into	a	eppendorf,	followed	by	the	addition	of	PBS	(x1,	325	μL).	To	this	
solution	was	added	50	μL	of	a	mixture	containing	PB	(0.01	M)	and	NaCl	(2	M)	to	reach	
the	 final	 volume	 of	 05mL.	 Finally,	 an	 aliquot	 of	 23bases	 target	 ssDNA	 (match	 and	
mismatch	in	different	molar	ratios)	in	a	total	concentration	of	5	nM	was	added	to	the	
solution.	UV-Vis	spectra	were	recorded	each	hour	to	study	the	aggregation	process.	
2.2.8	Dynamic	Light	Scattering	Measurements	
	
The	conditions	for	the	DLS	experiments	were:	6	measurements	with	5	runs	of	5	
sec	 each	 one.	 The	 study	 was	 carried	 out	 at	 25ºC	 with	 an	 equilibration	 time	 of	 the	
sample	of	30s.	
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2.3	Results	and	Discussion	
	
It	 is	well-known	 that	 gold	nanoparticles	 stabilized	with	 sodium	citrate	 can	be	
readily	 functionalized	 with	 other	 thiolated	 ligands.	 Initially	 AuNPs	 were	 synthesised	
with	 an	 average	 diameter	 of	 13.3	 ±	 1.2	 nm,	 using	 the	 Turkevich	 method.	 These	
nanoparticles	were	used	as	seeds	to	grow	larger	AuNPs	(45.9	±	5.8	and	62.4	±	6.5	nm	
in	diameter),	as	described	by	Bastuś	et	al.10	(for	simplicity,	we	label	the	corresponding	
AuNPs	as	13,	46,	and	63	nm).	Detailed	TEM	analysis	revealed	that	all	AuNPs	displayed	
relatively	 low	 polydispersity	 values	 of	 9%,	 13%,	 and	 11%,	 for	 13,	 46,	 and	 63	 nm,	
respectively	(Figure	2.2).		
	
Figure	 2.2.	 Gold	 nanoparticles	 used	 in	 this	 study.	 TEM	 images	 of	 initial	 AuNPs	with	
different	diameters:	a)	13	nm,	b)	46	nm,	and	c)	63	nm.	
	
The	 replacement	 of	 citrate	 by	 the	 corresponding	 ssDNA	 was	 carried	 out	 as	
described	by	Mirkin’s	group11,	by	mixing	AuNPs	of	different	sizes	with	excess	of	thiol-
terminated	oligonucleotides	(1	OD/mL).	To	maximize	surface	coverage	of	the	particles	
with	oligonucleotides,	the	salting-out	process	was	applied	at	higher	NaCl	concentration	
(0.2	M).		
The	maxima	of	the	localized	surface	plasmon	resonance	(LSPR)	bands	of	AuNP	
colloids	were	519,	535,	and	538	nm,	 for	13,	46,	and	63	nm	AuNPs,	 respectively.	The	
presence	of	 ssDNA	on	 the	particles	 surface	 caused	a	 slight	 LSPR	 redshift	 of	 2−5	nm,	
regardless	 of	 the	 particle	 size	 (Figure	 2.3a),	 that	 was	 due	 to	 the	 increase	 in	 local	
refractive	index.	The	presence	of	ssDNA	on	the	particle	surface	was	confirmed	by	DLS	
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measurements	 before	 and	 after	 functionalization.	 As	 expected,	 the	 hydrodynamic	
diameters	 increased	by	≈10	nm	(Figure	2.3b).	 In	 the	case	of	46	nm	AuNPs,	however,	
the	increase	of	the	recorded	hydrodynamic	diameter	was	less	pronounced,	likely	due	
to	a	higher	polydispersity	(13%)	of	the	sample.	
	
Figure	 2.3.	 a)	UV−vis	 spectra	 of	 AuNPs	 stabilized	with	 citrate	 and	DNA	 (1Triplex).	 b)	
Average	hydrodynamic	diameters	of	 initial,	citrate-	stabilized	AuNPs	(black	bars),	and	
AuNP-1Triplex	(red	bars).	
	
Once	the	nanoparticles	were	functionalized	with	DNA	strands,	a	quantification	
of	the	oligonucleotides	was	carried	out	with	the	Quant-iT	OliGreen	ssDNA	kit.	First,	a	
calibration	curve	was	established	in	a	concentration	range	between	0.5	and	100	ng/mL	
(Figure	2.4).	Then	DNA	strands	were	displaced	from	AuNPs	surface	by	using	DTT	(see	
experimental	 part)	 and	 the	 resulting	 supernatant	 was	 subjected	 for	 quantative	
determination	of	 the	DNA,	 using	 calibration	 curve	 as	 a	 reference.	 It	 has	 been	 found	
that	with	the	increase	of	nanoparticle	diameter	the	number	of	DNA	ligands	increased	
in	 the	 following	 order:	 80,	 450	 and	 850	 DNA	 per	 13	 nm,	 46	 nm,	 	 63	 nm	 AuNP,	
respectively.	The	results	reported	in	ref11	are	in	agree	with	the	data	obtained	from	the	
fluorescence	measurements.		
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Figure	2.4.	Linear	quantification	of	a	synthetic	24	bases	from	0.5	to	500	ng/mL	using	
the	 Quant-iT	 OliGreen	 ssDNA	 reagent.	 Samples	 were	 excited	 at	 485	 nm.	 The	
fluorescence	emission	intensity	was	measured	at	535	nm	and	plotted	as	a	function	of	
oligonucleotide	concentration.	
	
To	 discriminate	 the	mutation,	 a	 sandwich	 assay	was	 performed	 involving	 the	
addition	 of	 a	 target	 sequence	 (either	 match	 or	 mismatch)	 to	 the	 mixture	 of	 probe	
nanoparticles,	AuNP-	1Triplex	and	AuNP-2Triplex.	The	bridging	of	both	probes	on	the	
surface	 of	 nanoparticles	 by	 the	 complementary	 target	 was	 expected	 to	 promote	
aggregation	 of	 the	 nanoparticles,	 in	 turn	 affecting	 the	 optical	 properties	 of	 the	
colloid12,13.	 In	 particular,	 the	 LSPR	bands	 are	 expected	 to	 redshift	 and	broaden,	 as	 a	
result	 of	 aggregation	 and	 plasmon	 coupling	 (Figure	 2.5a,b).	 The	 aggregation	 of	 the	
particles	 was	 monitored	 over	 time	 by	 UV−Vis	 spectroscopy,	 using	 the	 unitless	
magnitude	 R	 =	 Abs620/Absmax,	 as	 a	 measure	 of	 the	 degree	 of	 aggregation14.	 Before	
target	 addition,	 the	 R	 value	 was	 ≈	 0.2.	 Once	 the	 target	 was	 added	 to	 the	 probes	
solution,	R	 increased	to	reach	a	maximum	value	of	≈	1.2	 (best	scenario).	 In	addition,	
upon	aggregation,	 the	characteristic	absorption	band	 for	oligonucleotides,	 located	at	
260	 nm,	was	 found	 to	 gradually	 decrease	 (Figure	 2.5c),	 due	 to	 delocalization	 of	 the	
excitonic	states	in	denatured	DNA15,	wich	is	an	additional	sign	of	hybridization	events.	
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Figure	2.5.	 a)	Digital	 images	of	 the	solution	containing	gold	nanoparticles	 (63	nm)	 in	
the	 absence	 of	 target	 molecules	 (left),	 in	 the	 presence	 of	 the	 mismatch	 sequence	
(middle)	 and	 in	 the	 presence	 of	 the	 match	 sequence	 (right).	 In	 all	 cases,	 target	
concentration	 was	 5	 nM.	 b)	 UV-Vis	 spectra	 of	 the	 assay	 mixture	 containing	 63	 nm	
AuNPs	and	match	sequence	in	a	concentration	of	5	nM	at	0	and	10	minutes	after	the	
hybridization	started.	c)	time-dependent	changes	of	absorbance	at	260	nm	as	a	sign	of	
DNA	hybridization.	
	
To	properly	evaluate	the	sensitivity	of	the	assay	for	different	particle	sizes,	the	
concentration	 [Au0]	 =	 0.1	 mM	 was	 kept	 constant	 in	 all	 experiments.	 Therefore,	
changes	 in	 particle	 diameter	 affect	 to	 the	 number	 of	 particles	 (expressed	 in	 molar	
concentration)	for	each	assay.	The	concentration	of	particles	was	1.5,	0.033,	and	0.013	
nM	for	13,	46,	and	63	nm,	respectively.	Note	that	adjusting	the	assays	 to	a	constant	
number	 of	 particles	 (as	 opposite	 to	Au0	 concentration)	was	 not	 practical	 due	 to	 the	
dramatic	difference	in	extinction	cross	section	for	different	particle	sizes	(Figure	2.6a).	
For	example,	bringing	the	concentration	of	13	nm	AuNPs	down	to	0.013	nM	made	 it	
impossible	 to	 record	 a	 meaningful	 UV−vis	 spectrum	 (Figure	 2.6b).	 In	 addition,	 the	
difference	 in	 absorbance	 affected	 the	 value	 of	 R,	 which	 hindered	 a	 comparative	
analysis	(Figure	2.6c).	
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Figure	2.6.	a)	UV-Vis	spectra	of	the	colloids	containing	AuNP	of	different	sizes,	but	with	
constant	 number	 of	 NPs	 (0.013	 nM).	 The	 spectral	 features	 of	 the	 smallest	
nanoparticles	are	barely	visible.	b)	UV-Vis	spectra	of	the	solutions	containing	different	
concentrations	 of	 gold	 nanoparticles.	 b)	 Variation	 of	 R	 (Abs620/Abs538)	 for	 various	
particle	concentrations	obtained	from	a.	
	
An	important	experimental	parameter	was	the	concentration	of	NaCl	used	in	an	
assay.	 It	 is	 commonly	 known	 that	 an	 extra	 amount	 of	 NaCl	 is	 required	 to	 favour	
particles	aggregation	through	the	icrease	of	ionic	strength.	In	the	absence	of	NaCl	the	
particles	remain	colloidally	stable	even	in	the	large	excess	of	DNA.	Opositely,	at	large	
mount	of	NaCl	 the	 ionic	 strength	can	abruptly	cause	particles	aggregation	 regardless	
the	presence	of	match	or	mismatch	 sequences,	 therefore	 affecting	 the	 selectivity	 of	
the	 assay.	 It	was	mandatory	 to	 find	 an	 optimal	 concentration	 of	NaCl	 to	 reach	 best	
sensitivity	 and	 selectivity	 of	 the	 assay.	 Four	 different	 concentrations	 of	NaCl	 (0,	 0.2,	
0.33	 and	 0.4	M)	were	 used	 in	 colloidal	 assay	 using	match	 and	mismatch	 sequences	
(Figure	 2.7).	 	 The	 raw	 spestra	obtained	 in	 Figure	7	were	 further	 analysed	by	ploting	
aggregation	rate	values	(R)	vs.	time	(Figure	2.8).	It	has	been	found	that	the	0.33	M	of	
NaCl	was	the	most	optimal	salt	concentration	at	which	the	highiest	selectivity	toward	
single	base	mutation	was	achieved.	
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Figure	 2.7.	 Effect	 of	 NaCl	 concentration	 on	 the	 aggregation	 of	 the	 particles.	 a-d)	
Aggregation	of	13	nm	AuNPs	(1.5	nM)	in	the	presence	of	match	sequence	(50	nM)	with	
NaCl	concentration	increasing	in	following	order	0,	0.2,	0.33	and	0.4	M.	e-h)	The	same	
experimental	conditions	as	in	a-d	but	using	mismatch	sequence	instead	of	match.	
	
Figure	2.8.	Effect	of	NaCl	concentration	on	the	specificity	and	hybridization	rate	of	the	
assay	 towards	single	base	mutation.	Left)	Aggregation	of	particles	 in	 the	presence	of	
match	 sequence	 obtained	 from	 Figure	 2.7a-d.	 Right)	 Aggregation	 of	 particles	 in	 the	
presence	of	mismatch	sequence	obtained	from	Figure	2.7e-h.	The	greatest	difference	
in	particles	aggregation	for	match	and	mismatch	sequences	was	observed	at	0.33	M	of	
NaCl.	
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The	aggregation	degree	was	studied	for	the	three	nanoparticles	diamenters	and	
the	different	concentrations	of	match	and	mismatch	sequences	ranging	 from	0.05	to	
50	nM.	Figure	9	shows	raw	UV-Vis	spectra	of	all	 solutions	at	given	aggregation	time,	
showing	 how	 the	 concentration	 of	 the	 target	 DNA	 molecules	 (match	 or	 mismatch)	
affects	the	colloidal	stability	of	the	nanoparticles.		
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Figure	 2.9.	 a-b)	 UV-Vis	 spectra	 for	 13	 nm	 AuNPs	 with	 match	 sequence	 in	 a	
concentration	of	50	and	5	nM,	respectively.	c-d)	UV-Vis	spectra	for	13	nm	AuNPs	with	
mismatch	 sequence	 in	 a	 concentration	 of	 50	 and	 5	 nM,	 respectively.	 e-h)	 UV-Vis	
spectra	for	46	nm	AuNPs	with	match	sequence	in	a	concentration	of	50,	5,	0.5	and	0.25	
nM,	 respectively.	 i-l)	 UV-Vis	 spectra	 for	 46	 nm	AuNPs	with	mismatch	 sequence	 in	 a	
concentration	of	50,	5,	0.5	and	0.25	nM,	respectively.	m-q)	UV-Vis	spectra	for	63	nm	
AuNPs	 with	 match	 sequence	 in	 a	 concentration	 of	 50,	 5,	 0.5,	 0.1	 and	 0.05	 nM,	
respectively.	 r-v)	 UV-Vis	 spectra	 for	 63	 nm	 AuNPs	 with	 mismatch	 sequence	 in	 a	
concentration	of	50,	5,	0.5,	0.1	and	0.05	nM,	respectively.	
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Further	 analysis	 of	 the	 data	 in	 Figure	 2.9,	 allowed	 for	 the	 presentation	 of	
aggregation	rate	vs.	time	(Figure	2.10),	clearly	indicating	the	selectivity	of	the	colloidal	
assay	toward	single	base	mutation	(copare	left	and	right	columns).	As	expected,	with	
increasing	particle	size,	the	sensitivity	of	the	assay	also	 increased.	The	smaller	AuNPs	
(13	nm)	aggregated	in	the	presence	of	match	sequence,	within	a	concentration	range	
between	 50	 and	 5	 nM.	 For	 the	mismatch	 sequence,	 however,	 aggregation	was	 only	
observed	for	concentrations	above	50	nM	(Figure	2.10a).	The	intermediate	AuNPs	(46	
nm)	 aggregated	 in	 the	 presence	 of	 the	match	 sequence	 at	 a	 broader	 concentration	
range	 between	 50	 and	 0.25	 nM.	 For	 the	 mismatch	 sequence,	 aggregation	 was	
detected	 for	 target	 concentrations	 above	 5	 nM.	 Finally,	 the	 larger	 particles	 (63	 nm)	
were	 sensitive	 to	 an	 even	 widerconcentration	 range	 (50-0.05	 nM)	 of	 the	 match	
sequence,	but	only	between	5	and	50	nM	for	the	mismatch	sequence.	
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Figure	2.10.	Sensitivity	of	the	assay	for	AuNPs	with	different	diameters.	Comparison	of	
the	 aggregation	 degree	 for	 match	 (left	 column)	 and	 mismatch	 (right	 column)	
sequences,	with	AuNPs	of	different	sizes:	(a)	63	nm,	(b)	46	nm,	(c)	13	nm.	[Au0]	=	0.1	
mM	for	all	cases,	while	[AuNPs]	varied	as	1.5,	0.033,	and	0.013	nM,	for	13,	46,	and	63	
nm,	respectively.		
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These	 results	 clearly	 suggest	 that	 the	 sensitivity	 of	 the	 assay	depends	on	 the	
available	 number	 of	 target	 molecules	 per	 particle.	 A	 careful	 comparison	 of	 the	
concentrations	 of	 target	 and	 particles	 revealed	 that	 it	 was	 necessary	 to	 add	 ≈4	
molecules	of	match	sequence	per	particle	to	induce	meaningful	changes	in	the	R	value	
(Table	 2.2).	 Interestingly,	 the	 concentration	 of	 the	 mismatch	 sequence	 that	 was	
required	 to	 induce	 aggregation	 was	 20-40	 times	 higher	 than	 the	 concentration	 of	
nanoparticles,	 showing	 that	 the	 single	 base	 mutation	 has	 a	 large	 impact	 on	 the	
aggregation	process.	
[ssDNA	Target]	
Number	of	target	ssDNA	per	NPs	
	 AuNP	13	nm	 AuNP	46	nm	 AuNP	63	nm	
50	nM	 34	 1505	 3867	
5	nM	 3.4	 150.5	 386.7	
0.5	nM	 n.a	 15.05	 38.67	
0.25	nM	 n.a	 7.53	 19.34	
0.1	nM	 n.a	 3.01	 7.73	
0.05	nM	 n.a	 n.a	 3.87	
Table	2.2.	Number	of	target	sDNA	per	particle	at	different	sizes.	
 
To	further	evaluate	the	aggregation	process,	DLS	technique	was	 implemented	
to	measured	 the	 time-dependent	growth	of	 the	aggregates.	A	 fixed	concentration	 (5	
nM)	 of	 match	 and	 mismatch	 sequences	 were	 used	 for	 aggregation,	 yielding	 the	
following	 target-to-particle	 ratios:	 ≈3	 (13	 nm),	 ≈150	 (46	 nm),	 and	 ≈380	 (63	 nm).	 A	
possible	 hypothesis	 is	 that	 the	 small	 nanoparticles	 should	 remain	 stable,	 since	
insufficient	target	was	provided,	while	the	bigger	particles	should	aggregate.	As	shown	
in	Figure	 2.11a,	b,	when	exposed	 to	 the	match	 sequence,	 the	aggregates	 containing	
NPs	of	46	and	63	nm	were	2.5-fold	larger	than	those	from	the	same	particles	after	1	h	
in	the	presence	of	the	mismatch	sequence.	After	60	min	of	aggregation	in	the	presence	
of	the	match	sequence,	the	clusters	were	ca.	550	nm	in	diameter	for	both	46	and	63	
nm	AuNPs,	corresponding	to	≈150	and	≈320	particles	per	cluster,	respectively.	 In	the	
case	 of	 small	 NPs,	 no	 aggregation	was	 observed	when	 the	mismatch	 sequence	was	
used	 (Figure	2.11c).	 In	 the	presence	of	 the	match	sequence,	 the	measured	diameter	
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increased	up	to	20	nm,	which	is	 likely	related	to	intercalation	of	target	DNA	with	the	
complementary	 DNA	 attached	 to	 the	 particle	 surface.	 No	 further	 aggregation	 was	
observed	upon	extended	incubation,	probably	due	to	an	insufficient	number	of	target	
molecules	per	particle	(≈3).		
TEM	analysis	 of	 the	 aggregates	 (in	 the	presence	of	 the	match	 sequence)	was	
performed	at	1,	10,	and	15	min	after	target	addition	(Figure	2.11d-f).	The	number	of	
particles	 per	 aggregate	 increased	 from	3−5	 to	 15−20	 for	 1	 and	10	min,	 respectively.	
After	15	min,	the	diameter	of	the	aggregates	was	nearly	1	μm,	i.e.,	>100	AuNPs.	Note	
that	the	diameter	of	the	aggregates	on	TEM	grids	appears	larger	than	in	solution	due	
to	flattening	upon	drying.	
 
Figure	2.11.	a−c)	DLS	measurements	for	the	hybridization	process	using	the	match	and	
mismatch	sequences	at	5	nM	concentration	for	AuNPs	of:	a)	63	nm,	b)	46	nm,	and	c)	
13	 nm.	 d−f)	 TEM	 images	 of	 aggregates	 formed	 upon	 hybridization	 with	 the	 match	
sequence	at	a	concentration	of	5	nM	for	AuNP	of	63	nm	at:	d)	1	min,	e)	10	min,	and	f)	
15	min.	
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Several	control	experiments	were	additionally	conducted.	No	aggregation	was	
observed	in	the	absence	of	the	target	ssDNA	for	63	nm	AuNPs	(Figure	2.12a).	A	melting	
profile	 analysis	 confirmed	 the	 selective	 role	 of	 the	match	 sequences	 in	 the	 particle	
aggregation.	For	the	match	sequence,	a	sharp	transition	in	the	profile	was	observed	at	
43	 °C,	 whereas	 for	 the	mismatch	 sequence	 no	 change	 in	 particle	 size	was	 detected	
(Figure	2.12b).	The	heating	process	had	no	effect	on	 the	stability	of	 the	particles,	as	
cyclic	aggregation	kinetics	showed	a	similar	degree	of	aggregation	during	three	cycles	
of	heating	(Figure	2.12c,	d).		
	
Figure	 2.12.	 a)	Time	dependent	DLS	measurements	of	 the	control	 solution	of	63	nm	
AuNPs	assay	in	the	absence	of	match	target	sequence	showing	stability	of	the	particles	
over	the	experiment	time-scale.	b)	Melting	profile	of	the	aggregates	containing	AuNPs	
of	63	nm,	 in	 the	presence	of	match	and	mismatch	sequences	 (5	nM).	c)	Aggregation	
degree	 for	 three	 hybridization	 cycles	 after	 several	 heating	 processes.	 d)	 Absorbance	
values	recorded	at	535	nm	during	the	hybridization	and	heating	processes.	
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The	next	step	was	to	evaluate	the	effect	of	particle	size	on	the	selectivity	of	the	
assay.	 The	 R	 values	 for	 the	match	 and	mismatch	 after	 10	min	 of	 aggregation	 were	
compared	(see	vertical	dashed	line	in	Figure	2.10).	The	values	of	R	for	selected	particle	
sizes	 and	 target	 concentrations	 are	 shown	 in	 Figure	 2.13a,	 demonstrating	 that	 the	
values	 of	 R	 converge	 for	 match	 and	 mismatch	 sequences	 when	 decreasing	 the	
concentration	of	the	target.	Further	analysis	of	the	selectivity	allows	differentiating	the	
value	 of	 Rmatch	 from	 Rmismatch	 after	 10	 min	 of	 aggregation	 (Figure	 2.13b).	 A	 target	
concentration	window	can	be	identified	for	the	bigger	particles,	at	which	they	display	
the	 best	 sensing	 performance.	 For	 example,	 in	 the	 case	 of	 the	 63	 nm	 particles	 it	 is	
possible	 to	 differentiate	 between	 the	 match	 and	 mismatch	 down	 to	 0.05	 nM.	
However,	when	the	concentration	of	the	target	was	increased	the	difference	becomes	
less	pronounced.	This	behavior	is	due	to	a	cooperative	effect,	meaning	that	the	lower	
curvature	of	the	larger	particles	facilitates	aggregation	through	binding	more	than	one	
DNA	 target	molecule	per	particle.	Note	 that	at	50	nM	 target	 concentration,	each	63	
nm	 particle	 carries	 ≈4000	 target	 molecules	 for	 either	 match	 or	 mismatch	 DNA.	
Therefore,	 the	 differentiation	 between	 match	 and	 mismatch	 is	 less	 pronounced	 if	
multiple	binding	events	take	place16.	In	the	case	of	the	particles	with	a	diameter	of	46	
nm,	the	selectivity	between	the	match	and	mismatch	at	higher	concentration	(50	nM)	
is	better	 than	that	 for	63	nm	particles	 (Figure	2.13b).	The	higher	curvature	 in	46	nm	
particles	minimizes	 the	cooperative	effect	and	 favors	 the	specificity	of	 the	system	at	
higher	 target	 concentrations.	 However,	 at	 lower	 target	 concentrations	 (<1	 nM)	 the	
system	 becomes	 less	 specific	 due	 to	 the	 smaller	 number	 of	 available	 DNA	 target	
molecules	 per	 particle.	 Accordingly,	 for	 the	 small	 (13	 nm)	 particles	 the	 specificity	
increases	with	increasing	target	concentration,	but	with	no	selectivity	below	5	nM.	
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Figure	 2.13.	 Selectivity	 between	 match	 and	 mismatch	 sequences	 for	 different	
concentrations	 of	 target,	 using	 AuNPs	 of	 different	 sizes.	 a)	 Differences	 in	 the	
aggregation	 degree	 (Abs620/Absmax)	 for	 the	 different	 particle	 sizes,	 at	 a	 target	
concentration	range	from	50	to	0.05	nM.	The	points	circled	in	red	represent	the	limit	
of	selectivity	(match/mismatch)	and	correspond	to	a	target-to-particle	ratio	equal	to	4.	
b)	Difference	between	R	values	for	match	and	mismatch	versus	target	concentration,	
showing	 better	 specificity	 for	 larger	 particles.	 c)	 Target	 concentration	 at	 Rmatch	 -	
Rmismatch	=	0.3	versus	particle	size,	showing	a	linear	dependence	in	a	logarithmic	scale.	
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To	 further	 show	 how	 the	 particle	 dimension	 affects	 the	 performance	 of	 the	
assay,	 the	 selectivity	 of	 the	 assay	was	 correlated	with	 particle	 diameter	 at	 constant	
specificity.	 A	 plot	 of	 target	 concentration	 at	 Rmatch	 -	 Rmismatch	 =	 0.3	 versus	 particle	
diameter	shows	a	linear	dependence	in	a	semilog	plot	(Figure	2.13c).	This	relationship	
indicates	 that	 a	 5-fold	 increase	 in	 particle	 size	 leads	 to	 an	 improvement	 of	 SNP	
differentiation	 by	 3	 orders	 of	 magnitude.	 In	 other	 words,	 by	 using	 particles	 with	
diameter	 of	 150	 nm,	we	 should	 be	 able	 to	 differentiate	 SNP	 down	 to	 10	 fM.	 These	
results	show	that	the	design	of	the	colloidal	assay	for	biomolecule	detection	requires	a	
precise	knowledge	of	the	concentration	window	for	the	target	detection.	
To	 further	 evaluate	 the	 importance	 of	 the	 ratio	 between	 number	 of	 target	
molecules	 and	 the	 number	 of	 gold	 nanoparticles,	 three	 different	 assays	 were	
performed	 in	 which	 the	 concentration	 of	 target	 DNA	 and	 nanoparticles	 were	
correspondingly	decreased	to	maintain	the	tareget-to-particles	ratio	equal	to	4	(Figure	
2.14).	 For	the	63	nm	AuNPs	in	a	concentration	of	13	pM,	a	ratio	of	4	is	the	minimum	
required	to	appreciate	aggregation,	which	corresponds	to	50	pM	of	match	DNA	(Figure	
2.14a).	 With	 a	 further	 decrease	 of	 particle	 and	 target	 concentrations	 (keeping	 the	
target-to-particle	 ratio	 constant	≈4)	 the	 limit	of	detection	 could	be	 improved.	Figure	
2.14b	shows	the	time	evolution	of	R	using	10	pM	of	match	and	mismatch	DNA	with	an	
AuNP	concentration	of	3	pM.	A	meaningful	difference	between	match	and	mismatch	is	
observed	 after	 10	min	 of	 aggregation.	 Additionally,	 another	 experiment	was	 carried	
out	 using	 a	 target-to-particle	 ratio	 of	 0.8	 (Figure	 2.14c)	 to	 detect	 the	 same	
concentration	of	target,	10	pM,	but	with	a	higher	concentration	of	NPs,	13	pM.	With	
these	 conditions	 is	 not	 possible	 to	 see	 differences	 between	 the	 match	 and	 the	
mismatch	 aggregation.	 The	 results	 confirm	 that	 the	 limits	 in	 colorimetric	 assays	 are	
related	 to	 the	 minimum	 number	 of	 target	 molecules	 available	 to	 induce	 particle	
aggregation,	 clearly	 indicating	 that	 the	 target	 concentration	 should	 always	 be	 larger	
than	that	of	nanoparticles.	Finally,	when	decreasing	the	target	concentration	down	to	
5	pM	while	keeping	the	target-to-particle	ratio	equal	to	4,	a	significant	fluctuation	of	
the	 R	 value	 was	 observed	 for	 both	 match	 and	 mismatch	 making	 impossible	 to	
distinguish	between	them	(Figure	2.14d).	
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Figure	2.14.	Comparation	of	 the	aggregation	degree	with	different	concentrations	of	
target	sequences	and	NPs	a,b)	target-to-particle	ratio	was	4.	c)	target-to-particle	was	
0.8,	 showing	 no	 differentiation.	 d)	 target-to-particle	 was	 4,	 but	 at	 nanoparticle	
concentration	below	detection	limit	of	the	spectrophotometer.		
	
An	important	parameter	for	clinical	assays	is	the	ability	to	detect	a	single	base	
mutation	 (point	 mutation)	 in	 a	 mixture,	 containing	 both	 match	 and	 mismatch	
sequences	 in	 different	 concentrations.	 	 Different	 mixtures	 were	 investigated	 with	
different	match/mismatch	molar	 ratio,	keeping	constant	 the	 total	 concentration	at	5	
nM.	 The	 hybridization	 rate	 for	 0:100,	 30:70,	 50:50,	 70:30,	 90:10	 and	 100:0	 M:MM	
mixtures	are	shown	in	Figure	2.15.	
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Figure	 2.15.	UV-Vis	 spectra	 for	 the	binary	mixtures	 comprising	match	 and	mismatch	
sequences	 in	 different	 ratios:	 a)	 100:0,	 b)	 90:10,	 c)	 70:30,	 d)	 50:50,	 e)	 30:70	 and	 f)	
0:100.	
	
	 The	raw	data	shown	 in	Figure	2.15	were	analyzed	by	plotting	the	aggregation	
rate	 vs.	 time,	 showing	 that	 the	 extend	 of	 nanoparticles	 aggregation	 increases	 with	
decreasing	 the	 amount	 of	 mismatch	 sequences	 in	 the	 solution	 (Figure	 2.16a).	 The	
100%	 of	 match	 or	 mismatch	 sequences	 defines	 the	 upper	 and	 lower	 limits	 of	 the	
aggregation	 rate	 for	 given	 time.	 The	 intermediate	 portion	 between	 match	 and	
mismatch	 falls	 witin	 such	 limit,	 as	 expected.	 In	 addition,	 the	 tendency	 of	 increased	
aggregation	 rate	 with	 decreasing	 the	 amount	 of	 mismatch	 sequences	 was	 clearly	
reflected.	 	This	observation	suggests	that	the	mismatch	target	acts	as	 interference	 in	
the	hybridization	process	of	 the	match	target,	behaving	as	a	competitor.	 In	addition,	
the	 linear	 relation	between	 the	aggregation	 rate	and	 the	concentration	of	mismatch	
(Figure	2.16b)	can	serve	as	a	calibration	curve	form	which	one	can	deduce	the	relative	
molar	ratios	between	the	match	and	mismatch	sequences.	
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Figure	2.16.	a)	Kinetic	analysis	of	binary	system	(match	and	mismatch)	as	a	function	of	
time	 for	different	molar	 ratios.	b)	Calibration	curve	 for	 the	aggregation	degree	at	10	
minutes	versus	the	concentration	of	mismatch	sequence	in	the	mixture.	
	
	
	
	
	
	
	
	
	
	
	
	
	
0 1 2 3 4 5 6
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
Ab
s 7
00
/A
bs
53
8
[MM] (nM)
a) b)
0 5 10 15 20 25 30 35
0.0
0.2
0.4
0.6
0.8
1.0
Ab
s 7
00
/A
bs
53
8
Time (min)
 Mismatch
 30:70
 50:50
 70:30
 90:10
 Match
Chapter	2.	Sensitivity	Limit	of	Nanoparticle	Biosensors	in	the	Discrimination	of	SNP	 	
	
	
85	
	
2.4	Conclusions	
	
In	this	chapter,	it	has	been	demonstrated	that	nanoparticle	size	is	an	important	
experimental	factor	defining	sensitivity	and	selectivity	of	a	colorimetric	detection	assay	
of	the	BRCA1	mutation.	It	was	shown	that	at	constant	gold	concentration	and	varying	
particle	 size,	 the	best	 sensitivity	was	obtained	when	using	 larger	particles	of	 63	nm.	
This	trend	was	explained	in	terms	of	a	higher	target-to-particles	ratio,	as	compared	to	
smaller	AuNPs.	Using	63	nm	particles	it	is	possible	to	differentiate	the	match	from	the	
mismatch	sequence	at	concentrations	down	to	10	pM.	Particle	size	was	also	found	to	
affect	the	selectivity	of	the	assay.	Larger	particles	were	more	selective	at	lower	target	
concentrations,	but	less	selective	at	larger	target	concentrations,	which	was	due	to	the	
lower	surface	curvature,	that	increased	the	probability	of	multiple	binding	events.	The	
results	of	the	study	show	that	colloidal	biosensors	based	on	AuNP	aggregation	have	an	
intrinsic	 limitation,	 related	 to	 the	 number	 of	 target	 molecules	 per	 particle.	
Furthermore,	 it	 is	 possible	 to	 know	 the	 molar	 ratio	 between	 the	 match	 and	 the	
mismatch	 sequence	 in	 a	 binary	 solution	 taking	 into	 account	 only	 the	 value	 of	 the	
aggregation	degree	at	10	minutes.	
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Chapter	 3.	 Nanoparticle-based	 Discrimination	 of	 Single	
Nucleotide	 Polymorphism	 in	 Long	 Single-Stranded	 DNA	
Sequence	
	
Abstract	
As	discussed	in	Chapter	1,	circulating	DNA	and	specifically	the	detection	cancer-	
associated	mutations	in	liquid	biopsies	promises	to	revolutionize	cancer	detection.	The	
main	difficulty	however	is	that	the	length	of	typical	ctDNA	fragments	(∼150	bases)	can	
form	secondary	structures	potentially	obscuring	the	mutated	fragment	from	detection.	
This	chapter	deals	with	an	assay	based	on	gold	nanoparticles	that	discriminate	single	
nucleotide	polymorphism	 in	 clinically	 relevant	 ssDNA	sequences	 (70−140	bases).	 The	
preincubation	 step	 was	 crucial	 to	 this	 process,	 allowing	 sequential	 bridging	 of	
Au@DNA,	 so	 that	 single	 base	 mutation	 can	 be	 discriminated,	 down	 to	 100	 pM	
concentration.	
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3.1	Introduction	
	
Tumor	cells	release	into	the	blood	circulating	tumor	DNA	(ctDNA)	that	contains	
the	mutations	of	the	original	tumor1.	These	sequences	can	be	either	single-	or	double-
stranded	 DNA,	 possessing	 cancer-related	 molecular	 characteristics,	 such	 as	 single	
nucleotide	mutations2,3,	methylation	 changes4,5	 and	 cancer-derived	 viral	 sequences6.	
As	demonstrated	in	Chapter	2,	as	well	as	other	groups	works,	the	detection	of	single	
nucleotide	 polymorphisms	 (SNP)	 in	 ssDNA	 sequences	 by	 selective	 aggregation	 of	
plasmonic	 nanoparticles	 provide	 the	 potential	 for	 rapid	 determination	 of	 cancer	
biomarkers7–9.	Although	the	literature	data	shows	that	detection	of	sequences	of	up	to	
40	bases	without	any	signal	amplification	is	feasible10,11,	the	average	size	of	circulating	
DNA	is	≈150	bases	in	length12,	and	these	longer	fragments	are	more	problematic	as	the	
increase	of	the	sequence	length	affects	the	plasmon	coupling	(larger	gaps	between	the	
particles),	that	decrease	the	limit	of	detection13.	In	addition,	long	DNA	sequences	form	
thermodynamically	 stable	 secondary	 structures	 that	 render	 the	detection	even	more	
difficult14.	Therefore,	 there	 is	an	obvious	need	 for	new	solutions	 to	detect	 long	DNA	
sequences.	 In	Chapter	 2,	 It	was	 shown	 that	 plasmonic	 assay	 comprising	DNA-coated	
gold	nanoparticles	 (AuNPs)	 could	discriminate	 SNP	 in	 less	 than	10	min.	 Even	 though	
relatively	 large	 particles	may	 lead	 to	 plasmon	 coupling	 upon	 aggregation,	 the	 assay	
was	limited	to	the	detection	of	rather	short	sequences	(up	to	23	bases).	Therefore,	to	
meet	 the	main	hypothesis	of	 the	presented	 thesis,	 large	plasmonic	particles	 (65	nm)	
functionalized	with	modified	DNA15	are	used	to	detect	single	base	mutation	in	clinically	
relevant	 sequences,	 that	 is,	 with	 140	 bases	 in	 length.	 Figure	 3.1	 describes	 in	
comparative	manner	the	detection	strategies	discussed	in	present	Chapter.	In	standard	
assay,	the	addition	of	the	target	DNA	to	the	mixture	of	two	batches	had	no	effect	on	
the	aggregation	(Figure	3.1a).	However,	premixing	the	AuNPs	(batch)	with	the	target	
DNA	was	sufficient	to	 induce	aggregation	upon	the	addition	of	batch	2	(Figure	3.1b),	
hence	preincubation	assay.	
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Figure3.1.	General	description	of	the	detection	strategy.	a)	Standard	sandwich	assay	in	
which	the	addition	of	the	long	DNA	target	to	the	mixture	of	two	different	AuNP-DNA	
probes	has	no	effect	on	the	aggregation.	b)	Preincubation	of	one	batch	of	AuNP-DNA	
probes	with	the	target,	followed	by	the	addition	of	the	second	batch	of	probes,	leads	
to	sensitive	detecrtion.	c)	Selected	sequence	of	DNA	stabilizing	gold	nanoparticles.	d,e)	
Possible	 secondary	 structure	 (Dynalign)	 of	 the	 target	 sequences	 sed	 in	 this	 study	
showing	the	complementary	sequences	to	those	on	the	nanoparticles	and	position	of	
the	mutation.	
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3.2	Experimental	Part	
	
3.2.1	Chemicals	
	
Hydrogen	 tetrachloroaurate	 (III)	 hydrate	 (HAuCl4·	 3H2O)	 was	 purchased	 from	
Alfa	 Aesar.	 Sodium	 dodecyl	 sulfate	 (SDS)	 (98%),	 sodium	 chloride	 (NaCl)	 (99.5%),	
sodium	citrate	tribasic	dihydrate	(98%),	and	phosphate	buffer	(PB)	1	M,	pH	7.4,	were	
purchased	 from	 Sigma-Aldrich.	 Phosphate	 buffered	 saline	 (PBS)	 0.01	 M,	 pH	 7.4,	
containing	 0.138	 M	 NaCl	 and	 2.7	 mM	 KCl	 (Sigma-Aldrich)	 was	 used	 to	 mimic	
physiological	 conditions.	 DNA-targets	 (match,	mismatch	 and	 random)	 and	 thiolated-
oligonucleotides	(Table	3.1)	were	purchased	from	Biomers	(Germany).	To	quantify	the	
concentration	of	DNA	loaded	on	NPs,	the	Quant-iT	Oli	Green	ssDNA	Kit	was	purchased	
from	Thermo	Fisher	Scientific.	
Name	 Oligonucleotide	Sequence	
Probe	DNA	conjugated	on	NPs	
MUT	 HS-5’-C6-TTT-TTT-TTT-TGT-TTG-GCC-CGC-CC-3’	
WT	 HS-3’-C6-TTT-TTT-TTT-TGT-GTC-TAA-AA-5’	
	 	
Target	DNA	for	hybridization	
Match	70mer	 5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCG-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-A-3’	
Mismatch	70mer	 5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCT-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-A	
Match	140mer	 5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCG-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-AGA-ATA-
CCA-TGC-AGA-AGG-AGG-CAA-AGT-GCC-TAT-CAA-GTG-GAT-GGC-
ATT-GGA-ATC-AAT-TTT-ACA-CAG-AAT-CT-3’	
Mismatch	
140mer	
5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCT-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-AGA-ATA-
CCA-TGC-AGA-AGG-AGG-CAA-AGT-GCC-TAT-CAA-GTG-GAT-GGC-
ATT-GGA-ATC-AAT-TTT-ACA-CAG-AAT-CT-3’	
Random	70mer	 5’-TTT-CTC-TTC-CGC-ACC-CAG-CAG-TTT-GGC-CCG-CCC-AAA-ATC-
TGT-GAT-CTT-GAC-ATG-CTG-CGG-TG-TTT-CAC-C-3’	
Table	3.1.	DNA	sequences	of	probes	and	targets	used	in	the	study.	
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3.2.2	Instrumentation	
	
UV−Vis	 spectra	 were	 measured	 at	 room	 temperature	 on	 an	 Agilent	 8453	
UV−Vis	 spectrophotometer	using	UV	Micro	cuvettes	with	1.0	cm	optical	path	 length.	
Transmission	 electron	 microscopy	 (TEM)	 was	 measured	 in	 a	 JEOL	 JEM-1400	 PLUS,	
operating	 at	 120	 kV,	 equipped	with	 a	GATAN	US1000	CCD	 camera	 (2k×2k).	Dynamic	
light	scattering	(DLS)	measurements	were	carried	out	in	a	Malvern	NanoSizer.	
3.2.3	Synthesis	of	Gold	Nanoparticles	
	
13,	 46	 and	 63	 nm	 AuNPs.	 13	 nm	 AuNPs	 were	 prepared	 according	 to	 the	
standard	Turkevich	method16,	while	46	and	63	nm	AuNPs	were	prepared	according	to	
method	reported	by	Puntes	and	co-workers17.	Detailed	description	of	the	experimental	
procedure	is	described	in	Chapter	2.	
3.2.4	Functionalization	of	AuNPs	
	
AuNPs	 were	 functionalized	 with	 thiolated	 oligonucleotides	 (MUT	 and	 WT)	
according	to	the	method	reported	by	Hurst	et	al15.	Briefly,	to	the	AuNPs	colloid	(1.11	
mL)	containing	SDS	(0.1%)	and	PBS	(0.01	M)	was	added	a	solution	of	oligonucleotides	
to	reach	a	final	concentration	of	1	OD/mL.	An	excess	of	oligonucleotides	was	used	in	all	
the	samples,	estimated	as	2,	3,	and	4	oligonucleotides	per	nm2	of	gold	surface,	for	13,	
43,	 and	 63	 nm	AuNPs,	 respectively.	 The	mixture	 of	 oligonucleotides	 and	AuNPs	was	
incubated	at	room	temperature	for	20	min.	To	 improve	oligonucleotide	binding	onto	
the	gold	surface,	a	salt	aging	process	was	carried	out.	A	solution	containing	NaCl	(2	M),	
SDS	 (0.01%),	 and	 PBS	 (0.01	 M)	 was	 added	 sequentially	 to	 the	 mixture	 containing	
AuNPs	and	oligonucleotides	in	the	following	aliquots:	5,	5,	15,	25,	and	50	μL,	ultimately	
reaching	 a	 final	 NaCl	 concentration	 of	 0.2	M.	 After	 each	 addition,	 the	 mixture	 was	
sonicated	 for	 10	 s	 followed	 by	 a	 20	 min	 incubation	 period.	 The	 final	 solution	 was	
incubated	for	12	h.	To	remove	excess	oligonucleotides,	the	solutions	were	centrifuged	
three	times	at	8500	rpm	for	10	min,	each	time	redispersed	in	SDS	(1	mL,	0.01%).	The	
final	 concentration	of	nanoparticles	was	0.4	mM	 in	 terms	of	metallic	gold	 for	all	 the	
samples.	
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3.2.5	Quantification	of	DNA	Loaded	on	Gold	Nanoparticles	
	
To	determine	the	number	of	oligonucleotides	per	particle,	the	concentration	of	
NPs	 was	 determined	 by	 the	 combination	 of	 TEM	 and	 UV-Vis	 spectroscopy	
measurements18.	 To	 quantify	 the	 concentration	 of	 surface	 DNA,	 the	 oligonucleotide	
was	detached	from	the	NP	and	quatified	by	fluorescence	assay	(for	details	see	Chapter	
2,	Section	2.5.5).The	amount	of	DNA	per	NP	was	calculated	dividing	the	concentration	
of	oligonucleotides	by	the	concentration	of	NPs.	
3.2.6	Hybridization	of	AuNP-DNA	Probes	–	Standard	Assay	
	
Equal	 volumes	 (62.5	 μL)	 of	 two	 batches	 of	NP	 (Au@WT	and	Au@MUT)	were	
combined	into	a	UV-Vis	mikro	cuvette,	followed	by	the	addition	of	PBS	(x1,	325	μL).	To	
this	solution	was	added	50	μL	of	a	mixture	containing	PB	(0.01	M)	and	NaCl	(2	M)	to	
reach	 the	 final	 volume	 of	 0.5	mL.	 Finally,	 an	 aliquot	 of	 70base	 target	 ssDNA	 (either	
match	or	mismatch)	in	a	concentration	of	5	nM	was	added	to	the	solution.	
3.2.7	Hybridization	of	AuNP-DNA	Probes	–	Preincubation	Assay	
	
To	the	solution	containing	Au@WT	(62.5	μL)	and	PBS	(x1,	325	μL)	was	added	50	
μL	 of	 a	mixture	 containing	 PB	 (0.01	M)	 and	NaCl	 (2	M).	 Subsequently,	 an	 aliquot	 of	
target	 ssDNA	 (either	match	or	mismatch	of	 the	desired	concentration)	was	added	 to	
the	 solution	 and	 left	 on	 for	 incubation	 in	 a	 roller	mixer.	 After	 1	 hour,	 AuNP@MUT	
(62.5	μL)	were	added	and	the	incubation	process	continues	for	the	next	3	hours.	UV-
Vis	spectra	were	recorded	each	hour	and	DLS	measurements	were	performed	to	study	
the	aggregation	process.	
3.2.8	Dynamic	Light	Scattering	Measurements	
	
The	conditions	for	the	DLS	experiments	were:	6	measurements	with	5	runs	of	5	
sec	 each	 one.	 The	 study	 was	 carried	 out	 at	 25ºC	 with	 an	 equilibration	 time	 of	 the	
sample	of	30s.	
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3.3	Results	and	Discussion	
	
The	goal	of	this	Chapter	is	the	detection	of	the	most	common	point	mutation	in	
non-small	cell	lung	cancer	(NSCLC),	the	L858R	mutation	which	occurs	in	the	Epidermal	
Growth	Factor	Receptor	(EGFR)	gene19.	Detection	of	this	mutation	is	an	FDA	and	EMA	
approved	 biomarker	 for	 the	 administration	 of	 TKI-therapy	 to	NSCLC	 patients.	 Figure	
3.1d,e	show	possible	secondary	structures	of	target	sequences	comprising	70	and	140	
bases,	with	 indication	 of	 the	 binding	 sites	 of	 Au@DNA	 and	 the	 location	 of	 a	 single-
point	 mutation.	 As	 a	 signal	 transducer,	 AuNPs	 with	 65	 nm	 in	 diameter	 were	 used.	
These	particles	were	stabilized	by	short	sequences	that	were	complementary	to	either	
a	mutation-free	region	in	the	target	DNA	(WT)	or	to	a	region	that	contained	a	single-
base	mutation	 (MUT)	 (Figure	 3.1c).	 Each	AuNP	was	 stabilized	by	≈1500	WT	or	MUT	
strands	grafted	to	the	surface	via	thiol	groups,	as	determined	by	a	fluorescence	kit.	As	
first	attempt,	a	standard	sandwich	approach	was	implemented	but	found	no	effect	on	
Au@DNA	 aggregation,	 meaning	 that	 the	 solution	 containing	 both	 Au@MUT	 and	
Au@WT	remained	stable	upon	the	addition	of	target	sequence	(5	nM),	in	the	presence	
of	PBS	and	NaCl,	as	confirmed	by	UV−Vis	and	DLS	characterization	(Figure	3.2).		
3.3	Results	and	Discussion		 	
	
	
96	
	
	
Figure	3.2.	Detection	of	70	bases	target	by	standard	assay,	target	(5nM)	added	to	the	
solution	 containing	 both	 types	 of	 nanoparticles	 (Au@WT	 and	 Au@MUT).	 UV-Vis	
spectra	in	the	presence	of	a)	match	and	b)	mismatch.	c)	Aggregation	rate	for	the	match	
and	the	mismatch.	d)	DLS	measurements	versus	time.	
	
However,	 aggregation	 is	 possible	 by	 tailoring	 the	 incubation	 process	 (Figure	
3.1b).	 Au@WT	 was	 preincubated	 with	 a	 target	 DNA	 (70	 bases),	 either	 match	 or	
mismatch,	 for	 1	 h	 under	 constant	 shaking.	 Subsequent	 addition	 of	 the	 second	
Au@MUT	batch	 led	 to	 selective	 aggregation	within	 3	 h.	 The	 concentration	 of	 target	
sequence	was	 5	 nM,	which	 translates	 into	 380	 copies	 of	 target	 DNA	 per	NP.	 Figure	
3.3a,b	 shows	 UV−Vis	 spectra	 at	 different	 times	 after	 addition	 of	 Au@MUT,	 that	 is,	
after	addition	of	a	second	batch.	The	localized	surface	plasmon	resonance	(LSPR)	band	
is	broadened	suggesting	more	pronounced	aggregation	of	the	AuNPs	in	the	presence	
of	 the	 match	 sequence	 than	 in	 the	 presence	 of	 the	 mismatch.	 By	 monitoring	 the	
aggregation	 degree	 (R	 =	 Abs700/Abs538),	 a	 difference	 of	 0.4	 was	 observed	 between	
match	 and	mismatch	 sequences,	 after	 1	 h	 of	 incubation,	 which	 increased	 up	 to	 0.6	
after	3	h	(Figure	3.3c).	These	data	support	the	hypothesis	that	the	preincubation	step	
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allows	a	colorimetric	detection	of	the	single-base	mutation.	DLS	measurements	(Figure	
3.3d)	confirmed	the	trends	observed	by	UV−Vis	spectroscopy.	The	average	diameter	of	
the	 initial	mixture	 in	1xPBS	 increased	from	81	to	262	nm	after	3	h	of	 incubation.	For	
the	 mismatch	 sequence,	 a	 diameter	 increaseof	 18	 nm	 was	 observed	 after	 3	 h	 of	
incubation.	In	the	case	of	the	control	(no	target),	the	size	remained	constant.	Next,	the	
focuse	was	 turn	 toward	 the	 performance	 of	 the	 assay	 for	 discrimination	 of	 a	 single	
base	mutation	in	even	longer	target	DNA	of	140	bases	(Figure	3.3e−h).	The	LSPR	of	the	
solution	containing	the	match	sequence	decreased	and	broadened	(Figure	3.3e).	In	the	
case	 of	 the	 mismatch	 sequence	 only	 a	 slight	 decrease	 of	 the	 plasmon	 band	 was	
observed	(Figure	3.3f).	Although	the	aggregation	degree	(Figure	3.3g)	was	similar	(0.4)	
for	match	and	mismatch	sequences	after	1	h	of	 incubation,	 the	difference	was	more	
pronounced	at	longer	incubation	times	(3	h),	clearly	showing	that	specificity	was	lower	
for	140	bases	long	sequences	as	compared	to	the	sequences	containing	70	bases.	The	
initial	average	diameter	of	the	Au@DNA	was	92	nm	and	increased	to	158	nm	after	3	h	
(Figure	 3.3h).	 For	 the	mismatch	 sequence,	 the	 final	 diameter	 after	3	h	was	114	nm,	
whereas	the	particle	size	in	the	control	experiment	remained	constant.	
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Figure	3.3.	Selective	discrimination	of	single	base	mutation	in	a	target	DNA	of	70	(a-d)	and	140	
(e-h)	 bases.	 (a,b)	 UV-Vis	 spectra	 of	 AuNPs	 in	 the	 presence	 of	 match	 (a)	 and	 mismatch	 (b)	
containing	70	bases	(c)	Aggregation	rate	for	match,	mismatch	and	control	(no	target).	 (d)	DLS	
monitoring	 of	 the	 aggregation	 process	 in	 the	 presence	 of	 target	 (70	 bases,	 5	 nM).	 (e-h)	
Selective	discrimination	of	single	base	mutation	in	a	target	of	140	bases.	(e,f)	UV-Vis	spectra	of	
AuNPs	 in	 the	 presence	 of	 match	 (e)	 and	 mismatch	 (f).	 (g)	 Aggregation	 rate	 for	 match,	
mismatch	and	control.	 (h)	DLS	characterisation	of	the	aggregation	process	 in	the	presence	of	
target	140	bases,	5	nM.	
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To	 further	 study	 the	 importance	 of	 the	 preincubation	 step,	 the	 order	 of	
premixing	was	reversed.	The	target	was	first	mixed	with	Au@MUT,	and	then	Au@WT	
was	added.	Although	selectivity	toward	SNP	was	indeed	appreciated,	the	difference	in	
aggregation	degree	was	much	lower	as	compared	to	the	preincubation	with	Au@WT.	
For	the	target	comprising	70	bases,	the	R	was	equal	to	0.15,	while	for	the	target	of	140	
bases,	we	found	R	=	0.05	(Figure	3.4).		
	
Figure	3.4.	Selective	discrimination	of	single	base	mutation	in	a	target	DNA	of	70	(a-c)	
and	 140	 (d-f)	 bases	 through	 reversed	 pre-incubation	 assay:	 first	 Au@MUT,	 second	
Au@WT.	(a,b)	UV-Vis	spectra	of	AuNPs	in	the	presence	of	match	(a)	and	mismatch	(b)	
containing	70	bases.	(c)	Aggregation	rate	for	match	and	mismatch.	(d-e)	UV-Vis	spectra	
of	AuNPs	in	the	presence	of	match	(d)	and	mismatch	(e).	(f)	Aggregation	rate	for	match	
and	mismatch.	
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These	 observations	 indicate	 that	 the	 target	 exhibits	 better	 accessibility	when	
conjugated	with	Au@WT.	Mirkin	and	co-workers20	have	shown	that	the	hybridization	
of	ssDNA	on	the	Au	surface	with	short	sequences	extends	the	non	hybridized	bases	of	
ssDNA,	making	them	more	accessible	to	the	incoming	target	sequence.	The	results	of	
the	 study	 suggest	 an	 analogous	 scenario	 in	 which	 the	 target,	 instead	 of	 the	 probe,	
undergoes	 a	 conformational	 change.	 The	 assay	 shows	 high	 selectivity	 toward	 single	
base	mutation.	It	has	been	shown21,22	that	the	discrimination	of	single	base	mutations	
is	related	to	the	stability	of	the	target	molecule.	In	other	words,	longer	targets	are	less	
discriminative	 with	 respect	 to	 point	 defects	 than	 shorter	 ones.	 It	 should	 be	 also	
mentioned	that	a	point	defect	in	sequences	containing	70	or	140	bases	represents	only	
1.5%	or	0.7%	of	the	complete	sequence,	respectively,	making	our	assay	a	convenient	
strategy	 for	 detection	 of	 the	 mutation	 in	 long	 sequences.	 Finally,	 to	 evaluate	 the	
sensitivity	of	the	assay,	aggregation	experiments	were	performed	for	70	bases	target	
(match	and	mismatch)	at	the	following	concentrations:	5,	1,	0.1,	and	0.01	nM.	Figure	
3.5	shows	the	discrimination	of	SNP	in	the	target	containing	70	bases	down	to	0.1	nM.	
At	10	pM	of	 target	concentration	no	differentiation	between	match	and	mismatch	 is	
observed.	
	
Figure	3.5.	Selective	discrimination	of	single	base	mutation	for	a	70	bases	target,	in	a	
concentration	range	from	1	nM	to	0.01	nM.	
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As	 it	 is	 shown	 in	 Figure	 3.5,	 the	 preincubation	 step	 allows	 the	 detection	 and	
discrimination	 of	 single	 nucleotide	 polymorphism	 in	 long	 DNA	 sequences	 at	 low	
concentrations,	0.1	nM.	However,	longer	detection	times	are	required:	5h	in	the	case	
of	0.1	nM	detection.	
To	further	determine	to	what	extend	the	target	molecules	hybridize	with	WT	or	
MUT	during	the	preincubation	step,	a	DLS	analysis	was	carried	out	(Figure	3.6).	Upon	
mixing	 of	 Au@WT	with	 the	match	 sequence,	 the	 hydrodynamic	 diameter	 increased	
from	93	to	104	and	106	nm	for	70	and	140	bases,	respectively,	after	1	h	of	incubation.	
On	the	other	hand,	the	hydrodynamic	diameter	of	Au@MUT	increased	from	86	to	89	
nm	(70	bases)	and	to	91	nm	(140	bases).	Note	that	the	initial	hydrodynamic	diameter	
of	Au@MUT	was	7	nm	smaller	as	compared	to	Au@WT,	owing	to	the	different	length	
and	conformation	of	both	sequences	(see	Figure	3.1c).	The	difference	in	the	increase	
of	hydrodynamic	diameter	for	Au@WT	(11	nm)	and	Au@MUT	(2	nm)	upon	incubation	
with	 the	 target	 sequence	 suggests	 that	 binding	 events	 on	 Au@DNA	 are	 sequence-
dependent.	Note	that	the	incubation	of	either	Au@WT	or	Au@MUT	with	a	non	target	
sequence	 of	 70	 bases	 had	 no	 effect	 on	 the	 hydrodynamic	 diameter	 of	 the	
nanoparticles	(Figure	3.6).	MUT	and	WT	are	complementary	to	different	areas	of	the	
target	 (Figure	 3.1)	 that	 initially	 can	 form	 a	 variety	 of	 secondary	 structures	 with	
multiple	loops	and	hairpins.	Upon	hybridization,	WT	on	AuNPs	unbinds	the	secondary	
structure	 of	 the	 target,	 allowing	 the	 tail	 sequence	 to	 point	 toward	 the	 solution,	
thereby	 increasing	 the	hydrodynamic	diameter.	 In	 the	case	of	MUT,	 the	same	target	
molecule	binds	in	the	opposite	direction,	forcing	the	tail	sequence	to	point	toward	the	
nanoparticles	(Figure	3.6).		
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Figure	3.6.	Hydrodynamic	diameter,	obtained	by	DLS,	of	either	Au@WT	or	Au@MUT	
before	and	after	incubation	with	the	target	sequences.	The	right-hand	panel	provides	a	
schematic	 representation	 of	 the	 effect	 of	 pre-incubation	 on	 the	 increase	 in	
hydrodynamic	diameter.	
	
Both	the	DLS	analysis	and	the	experiments	of	reversed	premixing	(Au@MUT	+	
target)	 suggest	 that	 the	 preincubation	 step	 disrupts	 the	 secondary	 structure.	 This	
reasoning	is	a	basis	for	the	statement	that	a	preincubation	step	is	crucial	to	open	and	
stabilize	the	target	molecules23,	making	the	sequences	more	accessible	toward	binding	
events	 with	 Au@MUT	 in	 the	 second	 batch,	 thus	 facilitating	 the	 formation	 of	 the	
sandwich	architecture20.	In	contrast,	the	target	DNA	exposed	to	both	types	of	particles	
(standard	 assay)	 is	 unable	 to	 selectively	 bridge	 the	 two	 particle	 types	 within	 a	
reasonable	 time-scale.	 The	competitive	 interaction	of	Au@WT	and	Au@MUT	 for	 the	
same	 target	 molecules	 sterically	 constrains	 the	 target	 in	 a	 stable	 coiled	
conformation24.	
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3.4	Conclusions	
	
This	Chapter	described	a	methodology	to	discriminate	single	base	mutation	in	
long	DNA	sequences	containing	70	or	140	bases.	Preincubation	of	the	target	sequence	
with	only	one	type	of	Au@DNA	facilitated	the	formation	of	a	sandwich	structure	upon	
addition	of	the	second	type	of	Au@DNA	and	discriminate	single	base	mutation	within	
1	h.	This	approach	shed	a	light	on	the	capability	of	spherical	nucleic	acids	to	disturb	the	
secondary	structure	of	long	DNA	sequences,	making	feasible	the	detection	of	relevant	
mutations	in	biological	targets.		
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Chapter	 4.	 Blocking	 Strategy	 for	 the	 Colorimetric	
Detection	 of	 Single	 Nucleotide	 Polymorphism	 in	 Long	
Double-Stranded	DNA	Sequences	
	
Abstract	
As	 mentioned	 in	 previous	 chapters,	 the	 rapid	 detection	 of	 single	 nucleotide	
mutations	in	circulating	tumor	DNA	has	become	an	attractive	strategy	for	early	cancer	
diagnosis.	 However,	 specificity	 remains	 a	major	 challenge	 as	 the	mutated	 sequence	
typically	 comprises	only	 a	 small	 fraction	 (<1%)	 compared	 to	 the	wild-type	 sequence.	
Furthermore,	 the	 use	 of	 hybridization	 based	 techniques	 requires	 the	 separation	 of	
dsDNA	into	ssDNA	for	efficient	binding	of	probes.	In	the	present	chapter,	it	is	proposed	
an	amplification-free	assay	 for	discrimination	of	 single	nucleotide	polymorphism	 in	a	
binary	mixture	containing	wild-type	and	mutated	dsDNA,	by	using	the	aggregation	of	
gold	 nanoparticles	 (AuNPs)	 as	 the	 only	 transducer.	 The	 method	 is	 based	 on	 the	
combination	 of	 high-temperature	 denaturation	 and	 selective	 blocking	 of	 the	
denatured	 strands,	 so	 that	 the	aggregation	of	AuNPs	becomes	highly	 specific.	 It	was	
possible	 to	 discriminate	 SNP	 in	 long	 dsDNA	 containing	 up	 to	 140	 bases	 and	
differentiate	5%	of	mutated	dsDNA	in	a	binary	mixture	containing	both	perfect	match	
and	mismatch	sequences	for	dsDNA	of	70	bases.	 	
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4.1	Introduction	
	
The	discovery	of	circulating	cell	 free	DNA	by	Mandel	and	Metais	 in	1948	 	has	
opened	the	possibilities	for	non-invasive	monitoring	of	cancer1.	But	not	earlier	than	in	
mid-90s,thefirst	evidences	that	tumor	cells	release	DNA	–	known	today	as	circulating	
tumor	 DNA	 (ctDNA)	 werereported2,3.	 Since	 then,	 the	 methodologies	 for	 cfDNA	
detection	 evolved	 drastically	 to	 enable	 the	 development	 of	 liquid	 biopsies	 in	 the	
clinical	 field.	Circulating	tumor	DNA	 is	released	from	tumor	cells	 into	biological	 fluids	
such	 as	 blood,	 and	 can	provide	 a	 useful	 source	of	 cancer-associated	biomarkers,	 for	
example	 as	 mutated	 sequences	 such	 as	 single	 nucleotide	 polymorphism4–8	 or	
methylation	 changes9,10.	 The	difficulty	 in	 the	detection	of	mutations	 and	particularly	
single	 nucleotide	 mutations	 in	 ctDNA	 relates	 to	 the	 length	 of	 circulating	 genetic	
fragments	 (~140	 base	 pairs)	 and	 their	 low	 concentration	 (from	 few	 to	 104	 units	 per	
mL).	On	top	of	that,	a	given	mutation	(single-base)	is	hindered	in	the	double-stranded	
DNA	(dsDNA),11		and	the	fraction	of	mutated	ctDNA	is	very	low	(<1	%)	as	compared	to	
the	wild-type	 sequence.	 Therefore,	 chemical	 complexity	 of	 the	 analyte	 biomolecule,	
inaccessibility	 of	 mutated	 base,	 as	 well	 as	 low	 concentration,	 require	 sophisticated	
detection	methodologies.	
Although	Polymerase	Chain	Reaction	(PCR)12–14	is	a	technique	that	enables	fast	
screening	 of	 mutations	 in	 DNA,	 its	 complexity	 and	 time-consuming	 analysis	 hinders	
implementation	 within	 point-of-care	 devices.15	 PCR,	 however,	 offers	 a	 conceptual	
framework	 for	 the	 development	 of	 assays	 relying	 on	 its	 principle,	 i.e.	 thermal	
annealing	of	dsDNA,	 splitting	complementary	 strands,	and	discrimination	of	mutated	
sequences	 through	 a	 given	 signal	 transduction	method.	 To	 detect	 dsDNA	 a	 thermal	
treatment	 it	 is	required	to	denature	the	double	helix.	To	avoid	the	rehybridization	of	
sense	 and	 the	 antisense	 strand	 upon	 cooling,	 a	 blocking	 strategy	 is	 typically	
implemented,	which	 is	based	on	the	use	of	short	DNA	sequences	(complementary	to	
the	antisense	DNA	sequence),as	presented		shown	in	Figure	4.116.	This	methodology	is	
based	on	the	strategy	of	asymmetric	PCR,	in	which	the	reaction	preferentially	amplifies	
one	DNA	strand	in	a	dsDNA	template.		
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Several	approaches	have	been	proposed	that	benefit	from	the	blocking	strategy	
used	 in	PCR.The	most	 relevant	one	 is	probably	 the	approach	 reported	by	Kelley	and	
coworkers,17,18	 who	 proposed	 an	 electrochemical	 clamp	 assay	 to	 detect	 mutated	
dsDNA	in	serum	with	no	need	for	enzymatic	amplification.	The	core	design	involves	the	
use	of	clutch	probes	(here	blocking	probes),	which	prevent	reassociation	of	denatured	
DNA	 strands	 after	 thermal	 annealing.	 This	 conceptual	 development	 indicates	 that	
detection	 of	 single-nucleotide	 polymorphism	 in	 dsDNA	 is	 indeed	 possible,	 but	 other	
strategies,	in	particular	colorimetric	assays	in	colloidal	phase,	could	facilitate	detection.	
	
Figure	 4.1.	Methodology	 to	 dissociate	 the	 double-stranded	DNA.	 Thermal	 treatment	
(95	ºC	for	15	min)	with	and	without	blocking	strategy.	Adapted	from	16.	
	
As	conclude	 in	Chapter	2,	 the	sensitivity	of	plasmon-assisted	SNP	detection	 in	
single-stranded	 DNA	 can	 be	 improved	 by	 the	 use	 of	 larger	 AuNPs	 –	 63	 nm	 in	
diameter.19	Larger	diameter	of	the	AuNPs	allowed	a	reduction	of	their	concentration	in	
the	assay,	which	was	critical	to	maximize	the	ratio	between	analyte	DNA	and	AuNPs.	It	
has	been	also	exploited	in	Chapter	3	that	assay	based	on	large	nanoparticles	serve	for	
the	 detection	 of	 single	 base	mutation	 in	 long	 ssDNA	 sequences,	 up	 to	 140	 bases,20	
showing	that	DNA-functionalized	nanoparticles	can	disrupt	the	secondary	structure	of	
ssDNA.	 This	 Chapter	 deals	 with	 a	 conceptually	 new	 strategy	 for	 the	 colorimetric	
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discrimination	of	SNP	in	binary	mixtures	of	double-stranded	DNA	containing	both	wild-
type	and	mutated	sequences.	The	novelty	of	the	strategy	involves	the	implementation	
of	thermal	annealing	and	the	use	of	two	short	ssDNA	–	blocking	probes	(BPs)	–	in	the	
solution	containing	the	target	dsDNA	(70	and	140	base	pairs)	and	DNA-functionalized	
AuNPs	(63	nm)	(Figure	4.2).	
	
Figure	 4.2.	 Detection	 strategy.	 The	 starting	 mixture	 (left)	 containing	 two	 types	 of	
nanoparticles,	blocking	probes	and	analyte	dsDNA	is	annealed	at	80	ºC	for	10	minutes	
(middle),	 followed	by	 cooling	 and	 signal	 readout	 (right).	 Blocking	probes	bind	 to	 the	
antisense	 sequence	 of	 the	 analyte	 DNA,	 preventing	 reannealing	 upon	 cooling.	 The	
target	sequence	that	remains	as	ssDNA	is	recognized	by	the	capture	probes,	leading	to	
selective	nanoparticle	aggregation.	
	
As	 shown	 in	 Figure	 4.1,	 whereas	 annealing	 of	 the	 solution	 at	 80	 ºC	 leads	 to	
denaturation	of	the	dsDNA,	the	cooling	process	allows	for	selective	binding	of	blocking	
probes	 to	 the	 antisense	 strand,	 at	 a	 position	 that	 is	 complementary	 to	 the	 capture	
probe.	As	such,	reannealing	of	dsDNA	strands	is	minimized,	and	colorimetric	detection	
is	 possible	 by	 selective	 AuNPs	 aggregation.	 Such	 approach	 is	 presumably	 the	 first	
colorimetric	 colloidal	 assay	 capable	 of	 differentiating	 <5%	of	mutated	 sequence	 in	 a	
binary	mixture	(5	nM)	of	mutated	and	wild	type	sequence	dsDNA,	without	the	need	for	
enzymatic	signal	amplification.	
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4.2	Experimental	Part	
	
4.2.1	Chemicals	
	
HAuCl4·	 3H2O	 was	 purchased	 from	 Alfa	 Aesar.	 Sodium	 dodecyl	 sulfate	 (SDS)	
(98%),	 sodium	 chloride	 (NaCl)	 (99.5%),	 sodium	 citrate	 tribasic	 dihydrate	 (98%),	 and	
phosphate	 buffer	 (PB)	 1	M,	 pH	 7.4,	 were	 purchased	 from	 Sigma-Aldrich.	 Phosphate	
buffered	saline	(PBS)	0.01	M,	pH	7.4,	containing	0.138	M	NaCl	and	2.7	mM	KCl	(Sigma-
Aldrich)	 was	 used	 to	 mimic	 physiological	 conditions.	 DNA	 targets	 and	 thiolated	
oligonucleotides	(Table	4.1)	were	purchased	from	Biomers	(Germany).	To	quantify	the	
concentration	of	DNA	loaded	on	NPs,	the	Quant-iT	Oli	Green	ssDNA	Kit	from	Thermo	
Fisher	Scientific	was	employed.	
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Name	 Oligonucleotide	Sequence	
Probe	DNA	conjugated	on	NPs	
WT	 HS-3’-C6-TTT-TTT-TTT-TGT-GTC-TAA-AA-5’	
MUT	 HS-5’-C6-TTT-TTT-TTT-TGT-TTG-GCC-CGC-CC-3’	
	 	
Target	DNA	for	hybridization	
Match	23mer	 5’-AGA-TCA-CAG-ATT-TTG-GGC-GGG-CCA-AAC-TGC-TGG-GT-3’	
Antisense	23mer	 5’-GTT-TGG-CCC-GCC-CAA-AAT-CTG-TG-3’	
Match	70mer	 5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCG-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-A-3’	
Mismatch	70mer	 5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCT-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-A-3’	
Antisense	70mer	 5’-TTT-CTC-TTC-CGC-ACC-CAG-CAG-TTT-GGC-CCG-CCC-AAA-ATC-
TGT-GAT-CTT-GAC-ATG-CTG-CGG-TGT-TTT-CAC-C-3’	
Match	140mer	 5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCG-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-AGA-ATA-
CCA-TGC-AGA-AGG-AGG-CAA-AGT-GCC-TAT-CAA-GTG-GAT-GGC-
ATT-GGA-ATC-AAT-TTT-ACA-CAG-AAT-CT-3’	
Mismatch	
140mer	
5’-GGT-GAA-AAC-ACC-GCA-GCA-TGT-CAA-GAT-CAC-AGA-TTT-
TGG-GCT-GGC-CAA-ACT-GCT-GGG-TGC-GGA-AGA-GAA-AGA-ATA-
CCA-TGC-AGA-AGG-AGG-CAA-AGT-GCC-TAT-CAA-GTG-GAT-GGC-
ATT-GGA-ATC-AAT-TTT-ACA-CAG-AAT-CT-3’	
Antisense	
140mer	
5’-AGA-TTC-TGT-GTA-AAA-TTG-ATT-CCA-ATG-CCA-TCC-ACT-TGA-
TAG-GCA-CTT-TGC-CTC-CTT-CTG-CAT-GGT-ATT-CTT-TCT-CTT-CCG-
CAC-CCA-GCA-GTT-TGG-CCC-GCC-CAA-AAT-CTG-TGA-TCT-TGA-
CAT-GCT-GCG-GTG-TTT-TCA-CC-3’	
	 	
Blocking	Sequences	
BP1	 5’-GCG-GGC-CAA-AC-3’	
BP2	 5’-CAC-AGA-TTT-TGG-3’	
Table	4.1.	DNA	sequences	related	to	EGFR	mutation	detection.	
	
4.2.2	Instrumentation	
	
UV−Vis	spectra	were	measured	at	room	temperature	on	an	Agilent	8453	UV−vis	
spectrophotometer,	 using	 UV	 Micro	 cuvettes	 with	 1.0	 cm	 optical	 path	 length.	
Transmission	 electron	 microscopy	 (TEM)	 was	 measured	 in	 a	 JEOL	 JEM-1400	 PLUS,	
operating	at	120	kV.	Dynamic	light	scattering	(DLS)	measurements	were	carried	out	in	
a	 Malvern	 NanoSizer.	 Fluorescence	 measurements	 were	 performed	 in	 a	 MicroPlate	
Reader.	A	ThermoBath	was	used	for	the	thermal	treatment	of	the	samples.	
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4.2.3	Synthesis	and	functionalization	of	Gold	Nanoparticles	(AuNPs,	63	nm)	
	
AuNPs	 were	 synthesized	 following	 a	 previously	 reported	 seeded	 growth	
method21.The	particles	were	then	functionalized	with	thiolated	oligonucleotides	(MUT	
and	 WT),	 according	 to	 the	 method	 reported	 by	 Hurst	 et	 al.22Briefly,	 to	 the	 AuNPs	
colloid	 (1.11	 mL)	 containing	 SDS	 (0.1%)	 and	 PBS	 (0.01	 M)	 was	 added	 a	 solution	 of	
oligonucleotides	 to	 reach	 a	 final	 concentration	 of	 1	 OD/mL.	 An	 excess	 of	
oligonucleotides	 was	 used	 in	 all	 the	 samples.	 The	 mixture	 of	 oligonucleotides	 and	
AuNPs	was	 incubated	 at	 room	 temperature	 for	 20	min.	 To	 improve	 oligonucleotide	
binding,	 a	 salt	 aging	 process	was	 carried	 out.	 A	 solution	 containing	NaCl	 (2	M),	 SDS	
(0.01%),	and	PBS	(0.01	M)	was	gradually	added	to	the	mixture	containing	AuNPs	and	
oligonucleotides,	in	the	following	aliquots:	5,	5,	15,	25,	and	50	μL,	reaching	a	final	NaCl	
concentration	of	0.2	M.	Each	salt	aging	step	was	alternated	with	sonication	(10	s)	and	
incubation	 (20	 min),	 followed	 by	 incubation	 for	 12	 h.	 To	 remove	 excess	
oligonucleotides,	 the	 solutions	 were	 centrifuged	 (8500	 rpm,	 10	 min,	 3	 times),	 each	
time	redispersed	in	SDS	(1	mL,	0.01%).	The	final	concentration	of	nanoparticles	was	0.4	
mM	in	terms	of	metallic	gold,	for	all	the	samples.	
4.2.4	Quantification	of	Oligonucleotides	Loaded	on	Gold	Nanoparticles	
	
To	determine	the	number	of	oligonucleotides	per	particle,	the	concentration	of	
NPs	 was	 first	 determined	 by	 UV-Vis	 spectroscopy.23	 Then,	 the	 oligonucleotide	
molecules	 were	 detached	 from	 the	 NPs	 surface	 using	 DTT	 using	 equal	 volumes	 of	
Au@DNA	 and	 DTT.	 After	 incubation	 (1	 hour)	 the	 gold	 precipitate	 was	 separated	 by	
centrifugation	and	discarded.	The	supernatant	(25	μL)	was	added	to	TE	buffer	(75	μL),	
followed	by	the	addition	of	OliGreen	reagent	(100	μL)	and	incubated	for	5	minutes	at	
room	 temperature,	protected	 from	 light.	 Fluorescence	was	measured	and	 compared	
to	a	standard	curve.	For	 fluorescence	measurements,	 the	fluorophore	was	excited	at	
485	nm	and	 the	emission	was	 recorded	at	535	nm.	The	amount	of	DNA	per	NP	was	
calculated	dividing	the	concentration	of	oligonucleotides	by	the	concentration	of	NPs.	
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4.2.5	Hybridization	of	AuNP-DNA	Probes	and	Detection	of	Short	ssDNA	
Targets	–	Blocking	Strategy	in	Non-Competitive	Assay	
	
Blocking	DNA	was	combined	with	the	solution	containing	antisense	strands	 in	
PBS	(x1,	325	μL),	and	left	undisturbed	for	1h,	followed	by	the	addition	of	a	mixture	(50	
μL)	 containing	PB	 (0.01	M)	and	NaCl	 (2	M).	Next,	 a	 solution	 containing	 sense	 strand	
was	added	to	the	above	mixture,	and	left	undisturbed	for	15	min.	The	above	solution	
was	transferred	to	a	UV-Vis	mikro	cuvette	containing	two	batches	of	DNA-coated	NPs	
(62.5	 µL	 each).	 The	 final	 volume	 of	 the	 mixture	 was	 0.5	 mL,	 the	 concentrations	 of	
blocking,	antisense	and	 sense	 strands	were	5	nM	and	 the	 final	 concentration	of	NPs	
was	13	pM.	UV−Vis	spectra	were	measured	at	room	temperature	during	30	minutes.	
4.2.6	Hybridization	of	AuNP-DNA	Probes	and	Detection	of	Short	ssDNA	
Targets	–	Blocking	Strategy	in	Competitive	Assay	
	
Blocking	DNA	was	combined	with	the	solution	containing	sense	strands	in	PBS	
(x1,	325	μL),	followed	by	the	addition	of	a	mixture	(50	μL)	containing	PB	(0.01	M)	and	
NaCl	 (2	 M).	 Next,	 a	 solution	 containing	 antisense	 strand	 was	 added	 to	 the	 above	
mixture.	 The	 solution	 was	 transferred	 to	 a	 UV-Vis	 mikro	 cuvette	 containing	 two	
batches	of	DNA-coated	NPs	(62.5	µL	each).	The	final	volume	of	the	mixture	was	0.5	mL,	
the	concentrations	of	blocking,	antisense	and	sense	strands	were	5	nM	and	the	 final	
concentration	of	NPs	was	13	pM.	UV−Vis	spectra	were	measured	at	room	temperature	
during	30	minutes.	
4.2.7	Hybridization	of	AuNP-DNA	Probes	and	Detection	of	Long	dsDNA	
Targets	–	Blocking	Strategy	
	
Equal	volumes	 (62.5	μL)	of	 two	batches	of	NPs	 (Au@WT	and	Au@MUT)	were	
combined	 into	 an	 Eppendorf	 tube,	 followed	 by	 addition	 of	 PBS	 (325	 μL).	 To	 this	
solution	we	added	50	μL	of	a	mixture	containing	PB	(0.01	M)	and	NaCl	(2	M),	to	reach	
the	final	volume	of	0.5	mL.	Equal	volumes	of	BP-1	and	BP-2	(2.5	μL)	were	added	to	the	
solution,	reaching	a	concentration	of	5	nM	for	each	BP.	Finally,	an	aliquot	of	70	or	140	
bases	 target	 dsDNA	 (either	 match	 or	 mismatch),	 at	 a	 concentration	 of	 5	 nM,	 was	
added	to	the	solution.	The	temperature	of	the	mixture	was	then	increased	from	25	ºC	
to	80	ºC	in	a	ThermoBath	and	maintained	for	10	min.	The	mixture	was	removed	from	
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the	 ThermoBath	 and	 cooled	 down	 to	 room	 temperature	 (10	 ºC/min),	 and	 then	
monitored	 by	 UV-Vis	 measurements	 every	 hour.	 Similarly,	 DLS	 measurements	 were	
performed	to	monitor	aggregation.	
4.2.8	Hybridization	of	AuNP-DNA	Probes	and	Detection	of	Long	dsDNA	
Targets	in	Binary	Mixtures	
	
Equal	volumes	 (62.5	μL)	of	 two	batches	of	NPs	 (Au@WT	and	Au@MUT)	were	
combined	 into	 an	 Eppendorf	 tube,	 followed	 by	 addition	 of	 PBS	 (325	 μL).	 To	 this	
solution	we	added	50	μL	of	a	mixture	containing	PB	(0.01	M)	and	NaCl	(2	M),	to	reach	
the	final	volume	of	0.5	mL.	Equal	volumes	of	BP1	and	BP2	(2.5	μL)	were	added	to	the	
mixture	to	reach	the	final	concentration	of	5	nM	for	each	BP.	Finally,	a	binary	mixture	
of	 target	 dsDNA	 (70	 bases,	 total	 concentration	 =	 5	 nM),	 containing	 match	 and	
mismatch	 sequences	 in	 different	 molar	 ratios,	 was	 added	 to	 the	 solution.	 The	
temperature	of	the	mixture	was	 increased	from	25	ºC	to	80	ºC	 in	a	ThermoBath	and	
maintained	 for	 10	min.	 The	mixture	was	 removed	 from	 the	 ThermoBath	 and	 cooled	
down	 to	 room	 temperature	 (10	 ºC/min),	 then	 monitored	 by	 UV-Vis	 measurement	
every	 hour.	 Alternatively,	 the	 mixture	 was	 left	 in	 ThermoBath	 once	 the	 thermal	
treatment	was	finished,	slowing	the	rate	of	cooling	process	down	to	1	ºC/min.	UV-Vis	
spectra	were	recorded	each	hour,	once	the	temperature	reached	25	ºC.	
4.2.9	Dynamic	Light	Scattering	Measurements	
	
The	conditions	for	the	DLS	experiments	were:	6	measurements	with	5	runs	of	5	
s	each.	The	study	was	carried	out	at	25	ºC	with	an	equilibration	time	of	the	sample	of	
30s.	
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4.3	Results	and	Discussion	
	
The	 proposed	 strategy	 for	 SNP	 discrimination	 in	 a	 binary	 mixture	 of	 dsDNA	
involves	the	following	steps:		
1) Preparation	of	a	stable	mixture	containing	both	types	of	nanoparticles,	namely	
Au@WT	 (complementary	 to	 the	 wild	 type	 sequence)	 and	 Au@MUT	
(complementary	to	the	mutated	sequence),	two	types	of	blocking	probes,	BP1	
(11	 bases)	 and	BP2	 (12	 bases),	 and	 analyte	 dsDNA	of	mutated	 and	wild	 type	
sequences;		
2) Thermal	treatment	of	the	mixture	for	10	min	at	80	ºC	followed	by	cooling	down	
to	room	temperature;		
3) Signal	 readout	 by	 UV-Vis	 spectroscopy,	 using	 the	 unitless	 magnitude	 R	 =	
Abs700/Abs540,	as	a	measure	of	the	degree	of	aggregation.24	
To	evaluate	the	performance	of	the	assay,	double-stranded	DNA	sequences	of	
70	bp	(as	a	first	approach)	and	140	bp	were	used	as	analyte,	which	 is	comparable	to	
the	 length	 of	 ctDNA	 in	 a	 real	 scenario.	 In	 addition,	 it	 proposed	 to	 detect	 L858R	
mutation,	which	occurs	in	the	Epidermal	Growth	Factor	Receptor	(EGFR)	gene,	a	point	
mutation	 found	 in	 the	 tumors	 of	 	 10-120%	 of	 non	 small	 cell	 lung	 cancer	 (NSCLC)	
patients.25The	selection	of	this	specific	biomarker	was	based	on	its	clinical	importance,	
as	the	presence	of	this	mutation	in	NSCLC	patients	is	an	FDA-approved	biomarker	for	
the	administration	of	tyrosine	kinase	inhibitors.	Since	the	key	parameters	in	the	assay	
are	 the	 presence	 of	 blocking	 probes	 and	 thermal	 treatment,	 a	 systematic	 study	 to	
identify	the	optimal	BP	concentrations	and	cooling	rate	were	performed.	
Since	 the	blocking	probes	are	 complementary	 to	 the	antisense	of	 the	analyte	
DNA,	 they	 are	 also	 complementary	 to	 the	 capture	 probes	 stabilizing	 the	 AuNPs.	
Therefore,	step	1)	in	the	assay	leads	to	spontaneous	association	of	blocking	probes	to	
the	 captures	 probes	 on	 the	 nanoparticles	 surface.	 Maeda	 and	 co-workers26,27	 have	
shown	that	the	transition	from	ssDNA	to	dsDNA	on	the	particles	surface	leads	to	non-
specific	aggregation	of	AuNPs	by	the	decrease	of	steric	repulsion	and	increase	of	van	
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der	Waals	attraction,	resulting	in	aggregation;	a	process	that	is	particularly	relevant	in	
the	present	case	because	we	use	unusually	larger	particles.	
The	non-specific	aggregation	of	AuNPs	through	blocking	probes	can	potentially	
induce	a	false	positive.	Thus,	it	was	aimed	at	finding	an	optimal	concentration	of	BPs,	
below	which	 no	 aggregation	 of	 AuNPs	would	 take	 place.	 For	 this	 reason,	 a	 stability	
experiments	were	performed	using	a	wide	range	of	BP	concentrations	(Figure	4.3).	A	
typical	 mixture	 (0.5	 mL)	 contained	 both	 types	 of	 NPs	 (13	 pM)	 and	 different	
concentrations	of	both	blocking	probes:	1,	5,	10,	20,	40,	80,	and	100	nM.	As	depicted	
in	 Figure	 4.4a,	 the	 non-specific	 aggregation	 of	 AuNPs	 is	 enhanced	 by	 increasing	 BP	
concentration.	
	
Figure	4.3.	UV-Vis	 spectra	of	both	 types	of	AuNPs	 in	 the	presence	of	blocking	probe	
sequences	in	different	concentrations:	a)	1	nM,	b)	5	nM,	c)	10	nM,	d)	20	nM,	e)	40	nM,	
f)	80	nM	and	g)	100	nM.	
	
The	 formation	 of	 dsDNA	 on	 the	 surface	 was	 further	 confirmed	 by	 plotting	
R@10min	vs	[BP],	showing	that	the	inflection	point	of	the	aggregation	rate	falls	at	a	BP	
concentration	of	20	nM	(Figure	4.4).	Fluorescence	assays	 revealed	 that	each	particle	
carries	 ~1500	 capture	 probes.	 Considering	 the	 number	 of	 DNA	 molecules	 on	 the	
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surface	of	the	particles	and	the	concentration	of	AuNPs	(13	pM)	in	0.5	mL	of	solution,	
the	total	concentration	of	capture	probe	in	the	solution	was	19.5	nM.	Therefore,	the	
inflection	point	at	20	nM	of	BPs	corresponds	to	the	total	value	of	the	capture	probe	on	
the	 particles	 surface,	 indicating	 full	 coverage	 of	 the	 nanoparticles	 with	 BPs	 at	 this	
concentration.	 Above	 20	 nM,	 aggregation	 was	 even	 faster,	 eventually	 reaching	 a	
plateau	 at	 80	 nM.	 A	 relevant	 observation	 is	 that,	 below	 5	 nM	 BP	 non-specific	
aggregation	 of	 AuNPs	 is	 barely	 observed	 (Figure	 4.4b	 –	 red	 area).	 Thus,	 the	
concentration	 of	 BP	 used	 in	 the	 following	 experiments	 is	 within	 a	 narrow	
concentration	window,	<	5	nM.	
	
Figure	 4.4.	 Stability	 of	 AuNPs	 in	 the	 presence	 of	 blocking	 probe	 sequences	 and	 the	
absence	of	dsDNA	analyte.	 a)	Kinetic	 study	 for	10	min,	 for	 various	 concentrations	of	
blocking	sequences,	between	1	and	100	nM.	b)	Degree	of	aggregation	at	10	min,	 for	
the	different	BP	concentrations.	
	
To	 understand	 the	 role	 of	 blocking	 probes,	 the	 experiments	were	 performed	
related	to	the	DNA-triggered	aggregation	of	gold	nanoparticles,	using	short	targets	of	
23	bases.	The	reason	of	using	shorter	target	sequences	is	that	they	exhibit	fast	binding	
kinetics.	Note,	 that	 these	short	23	bases	sequences	are	shorter	 fragment	of	 the	 long	
sequences	 comprising	 70	 and	 140	 base	 pairs.	 In	 addition,	 no	 thermal	 treatment	 is	
implemented	 since	 no	 dsDNA	 is	 used.	 Figure	 4.5	 shows	 different	 strategies	 for	
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noncompetitive	assay	by	mixing	sense	and	antisense	sequences	with	different	blocking	
probes.	 The	maximum	 aggregation	 degree	was	 observed	 for	 the	mixture	 containing	
nanoparticles	 and	 sense	 sequences	 (Figure	 4.5e).	 In	 contrast,	 the	 minimum	
aggregation	rate	was	observed	in	the	case	of	the	mixture	containing	gold	nanoparticles	
together	with	sense	and	antisense	couple,	since	the	double	strands	comprising	sense	
and	 antisense	 excluded	 the	 bridging	 of	 the	 nanoparticles	 with	 the	 sense	 sequence	
(Figure	4.5a).An	important	observation	was	that	the	aggregation	rate	correlated	with	
blocking	 ability.	 To	 test	 the	 blocking	 probe	 efficiencies	 the	 antisense	 strands	 with	
premixed	with	different	blocking	probes:	BP1,	BP2	and	the	combination	of	both.	The	
use	of	two	blocking	probes	(BP1	and	BP2)	inhibited	the	hybridization	of	the	sense	and	
antisense	 sequences	 (Figure	 4.5d),	 allowing	 the	 sense	 sequence	 to	 bridge	 the	
nanoparticles,	 hence	 increasing	 the	 aggregation	 rate.	 Comparative	 experiments	
showed	 that	 BP2	 blocks	 improve	 the	 formation	 of	 double	 strand	 (sense-antisense)	
than	BP1.	The	aggregation	rate	for	BP2	was	almost	double	as	compared	to	the	case	of	
BP1	 (compare	 Figure	 4.5c	 and	 b).	 These	 noncompetitive	 assays	 confirmed	 the	
efficiencies	of	the	blocking	probes.	
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Figure	 4.5.	 Efficiency	 of	 blocking	 probes	 in	 the	 selective	 aggregation	 of	 Au	
nanoparticles.	 (Upper)	 Schematic	diagrams	of	 the	performed	experiments.	Antisense	
sequences	 were	 mixed	 with	 the	 corresponding	 blocking	 probes	 and	 subsequently	
subjected	 to	 the	 sense	 sequence	 and	 colloidal	 solution	 of	 gold	 nanoparticles.	 (a,	 e)	
Control	 experiments,	 (b,	 c,	 d)	 blocking	of	 antisense	by	BP1,	BP2,	 and	 the	mixture	of	
BP1	 and	 BP2.	 (Lower)	 Aggregation	 rate	 vs.	 aggregation	 time	 for	 different	 blocking	
probes	and	control	experiments.	
	
To	 further	 evaluate	 if	 the	 action	of	 blocking	probes	 in	 competitive	 assay,	 the	
mixture	of	sense	sequence	and	blocking	probes	(no	interaction)	were	mixed	with	the	
antisense	 sequence	 and	 nanoparticles.	 These	 experiments	 allowed	 to	 evaluate	 the	
competition	 between	 BPs	 and	 sense	 strand	 toward	 the	 hybridization	 with	 the	
antisense	sequence	in	a	competitive	manner	(Figure	4.6).	By	plotting	the	aggregation	
degree	vs	time	for	different	blocking	scenario,	one	can	observe	that	the	best	blocking	
efficiency	 is	 achieved	when	both	blocking	 probes	 are	 used,	 instead	of	 each	blocking	
independently.	It	is	noteworthy	that	in	this	competitive	assay,	the	aggregation	degree	
(0.8	after	30	min)	was	 lower	 than	 in	 the	case	of	non	competitive	assay	 (1.2	after	30	
min),	 using	 the	 same	 two-blocking	 scenario.	 A	 possible	 explanation	 is	 that	 a	 small	
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fraction	of	 sense	strands	hybridizes	with	 the	antisense	sequence	 forming	 the	double	
stranded	 DNA,	 instead	 of	 hybridizes	 with	 the	 capture	 probes	 on	 the	 surface	 of	 the	
nanoparticles.	
	
Figure	 4.6.	 Efficiency	 of	 blocking	 probes	 in	 the	 selective	 aggregation	 of	 Au	
nanoparticles.	 (Upper)	 Schematic	 diagrams	 of	 the	 performed	 experiments.	 Sense	
sequences	were	mixed	with	 the	 blocking	 probes	 and	 subsequently	 subjected	 to	 the	
antisense	 sequence	 and	 colloidal	 solution	 of	 gold	 nanoparticles.	 (a,	 b,	 c)	 blocking	 of	
antisense	by	BP1,	BP2,	and	the	mixture	of	BP1	and	BP2.	(Lower)	Aggregation	rate	vs.	
aggregation	time	for	different	blocking	probes.	
	
By	 gaining	 the	 knowledge	on	blocking	 scenario,	 a	 series	of	 experiments	were	
performed	 in	which	different	blocking	scenarios	were	screened	 for	 longer	sequences	
of	 70	 and	 140	 base	 pairs.	 In	 analogous	 manner	 to	 previous	 experiments	 of	 short	
0 5 10 15 20 25 30
0.2
0.4
0.6
0.8
1.0
1.2
Ag
gr
eg
at
io
n 
R
at
e
(A
bs
62
0/A
bs
53
8)
Time (min)
a
b
c
a b c
4.3	Results	and	Discussion	 	
	
	
122	
	
sequences,	BP1	and	BP2	were	used	separately,	mixed	together	(BP1	+	BP2),	as	well	as	
no	BP.	Since,	in	the	following	experiments,	the	aggregation	of	AuNPs	was	monitored	in	
the	 presence	 of	 dsDNA	 (match	 or	mismatch,	 70	 and	 140	 bases,	 5	 nM),	 the	 thermal	
treatment	 step	 was	 implemented	 as	 shown	 on	 Figure	 4.2.	 It	 has	 been	 accordingly	
found	 that	 the	 scenario	 involving	 two	 blocking	 probes	 led	 to	 more	 pronounced	
aggregation	–	higher	blocking	power	–	as	compared	to	the	use	of	one	single	blocking	
probe	(Figure	4.7a).		
	
 
Figure	4.7.	Kinetic	study	for	different	blocking	strategies	(two-BPs,	only	BP2,	only	BP1),	
for	dsDNA	match	and	mismatch	analyte	of	a)	70	bases	and	b)	140	bases.	In	both	cases,	
blocking	probes	and	target	concentrations	were	kept	constant	(5	nM).	
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Interestingly,	BP2	exhibited	better	blocking	performance	 than	BP1,	which	can	
be	explained	by	 the	high	GC	content	 in	BP1	 (72%),	as	compared	to	only	42%	 in	BP2.	
Higher	 GC	 content	 increases	 the	 probability	 of	 self-dimerization,	 hindering	 the	
association	 of	 BP1	 with	 target	 antisense	 sequence.	 Next,	 blocking	 strategy	 was	
evaluated	 for	 a	 long	 dsDNA	 comprising	 140	 bases	 (Figure	 4.7b).	 As	 expected,	 the	
aggregation	rate	in	the	presence	of	long	sequences	(140	bases)	was	less	pronounced,	
which	 is	 related	 to	 the	 longer	 interparticle	 distance.20	 Nevertheless,	 the	 superior	
performance	 of	 the	 assay	 involving	 two	 blocking	 probes	 is	 related	 to	 the	 fact	 that	
these	small	sequences	hinder	the	nucleation	of	the	complementary	strands	(sense	and	
antisense).	 This	 nucleation	 process	 locates	 the	 middle	 of	 the	 strands28	 once	 the	
temperature	drops	below	Tm,	and	is	hindered	due	to	the	presence	of	blocking	probes.	
The	 blocked	 antisense	 sequence	 releases	 the	 sense	 sequence,	 which	 can	 then	 be	
captured	 by	 the	 AuNPs,	 leading	 to	 selective	 aggregation,	 and	 hence	 signal	
transduction.	
The	 performance	 of	 the	 two-blocking	 probes	 scenario,	 in	 the	 presence	 of	
perfect	 match	 sequence	 (Figure	 4.7	 –	 blue,	 red	 and	 black),	 was	 also	 evaluated	 the	
discrimination	of	a	single-base	mutation	in	dsDNA.	Indeed,	the	use	of	dsDNA	carrying	a	
mutation	in	the	sense	sequence	prevented	the	aggregation	of	AuNPs	(Figure	4.7	–	teal	
color).	 These	 data	 confirm	 that	 blocking	 the	 antisense	 sequence	 during	 thermal	
treatment	 allows	 for	 the	 selective	 aggregation	 of	 AuNPs,	 with	 the	 possibility	 of	
discriminating	mutations	 in	 long	 sequences	 of	 clinical	 relevance.	 Importantly,	 simple	
naked-eye	 inspection	 allowed	 to	 differentiate	 between	 match	 and	 mismatch	
sequences.	While	the	sample	containing	the	perfect	match	turned	purple,	the	sample	
containing	the	mismatch	sequence	retained	the	initial	red	color	(data	not	shown).	
A	 control	 experiment	 was	 carried	 out	 to	 confirm	 the	 need	 for	 using	 a	 BP.	 A	
typical	 experiment	 involved	 the	 use	 of	 no	 blocking	 probes,	 i.e.	 using	 a	 mixture	
containing	 Au@MUT	 and	 Au@WT,	 as	 well	 as	 dsDNA	 analyte	 carrying	 either	 perfect	
match	 or	 mismatch	 antisense	 sequences	 (Figure	 4.8).	 Thermal	 treatment	 of	 the	
mixture	(no	BPs)	caused	more	pronounced	AuNPs	aggregation	in	the	presence	of	the	
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match	sequences	(70	or	140	bases),	as	compared	to	the	mismatch	sequence.	 In	 fact,	
the	magnitude	of	the	aggregation	in	the	presence	of	match	sequence	was	comparable	
to	 that	 in	 the	presence	of	one	blocking	probe	 (BP2).	 Such	a	 selective	aggregation	of	
AuNPs	 in	 the	absence	of	BP	 is	 likely	due	 to	competitive	 interactions	between	sense-
antisense	and	sense-capture	probe	during	 the	cooling	process.	Although	 the	capture	
probes	 have	 limited	mobility	 (grafted	 on	 AuNPs	 surface),	 their	 population	 is	 ~4-fold	
higher	than	the	antisense	sequence.	Note	that	the	overall	concentration	of	the	capture	
probes	is	~19	nM,	while	the	sense	sequence	is	only	5	nM.	Thus,	the	kinetic	effect	might	
determine	the	selective	aggregation	of	AuNPs	in	the	absence	of	BPs.	
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Figure	 4.8.	 UV-Vis	 spectra	 for	 the	 detection	 of	 dsDNA	 a-b)	 70	 and	 c-d)	 140	 bases	
without	blocking	probes	as	control	experiments,	for	match	(a	and	c)	and	mismatch	(b	
and	 d)	 sequences.	 Kinetic	 study	 for	 the	 detection	 of	 dsDNA	 e)	 70	 and	 f)	 140	 bases	
without	blocking	probes	as	control	experiments.	
	
Thermal	treatment	was	equally	important	as	the	use	of	BP.	In	another	control	
experiment,	 it	was	demonstrated	 that	keeping	 the	mixture	at	 room	temperature	did	
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not	affect	 the	optical	properties	and	 therefore	 the	performance	of	 the	assay	 (Figure	
4.9).	Therefore,	 these	experiments	show	that	combination	of	 thermal	 treatment	and	
the	two-BPs	system	is	required	to	discriminate	SNP	in	dsDNA	with	high	selectivity.	
	
Figure	 4.9.	 a)	 Aggregation	 degree	 of	 the	 control	 experiment	 without	 thermal	
treatment	 and	 without	 blocking	 probes.	 b)	 DLS	 characterization	 of	 the	 control	
experiment	without	thermal	treatment	and	without	blocking	probes.	M:	match,	MM:	
mismatch.	
	
To	 further	 confirm	 the	 preferential	 aggregation	 of	 AuNPs	 in	 the	 presence	 of	
mismatch	 sequence,	 the	 assays	 comprising	 either	 two-BPs	 or	 no	 BPs	 was	 subjected	
toward	 the	 time-dependent	 dynamic	 light	 scattering	 measurements.	 Even	 when	
blocking	 probes	were	 used,	 the	 AuNPs	 did	 not	 aggregate	 in	 the	 presence	 of	 dsDNA	
containing	 a	 single	 point	mutation	 (Figure	 4.10	 –	 red	 line).	On	 the	 contrary,	 for	 the	
dsDNA	 analyte	 with	 a	 perfect	 match,	 gradual	 aggregation	 was	 observed	 over	 a	
measurement	time	of	4	hours.	 (Figure	10	–	black	 line).	As	expected,	the	presence	of	
two	blocking	probes	in	the	assay	allowed	for	more	pronounced	clustering	(400	nm),	as	
compared	to	the	assay	with	no	blocking	probe,	for	which	clusters	were	limited	to	300	
nm	in	diameter	(Figure	4.10).	
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Figure	4.10.	DLS	monitoring	of	the	aggregation	process	in	the	presence	of	match	and	
mismatch	sequence	of	70	bases	a)	with	BP1	and	BP2	and	b)	without	BP.	
	
To	 bring	 assay	 closer	 to	 real-world	 conditions,	 the	 discrimination	 of	 SNP	 in	 a	
binary	 mixture	 of	 the	 match	 and	 mismatch	 dsDNA	 was	 evaluated	 by	 varying	 the	
relative	target	molar	ratio	and	keeping	constant	its	total	concentration	at	5	nM	(Figure	
4.11).	These	experiments	 limited	 to	 the	use	of	 sequence	 containing	70	bases.	When	
increasing	 the	 concentration	 of	mismatch	 dsDNA	 (from	 0	 to	 5	 nM),	 the	 aggregation	
rate	was	found	to	decrease,	suggesting	that	the	assay	retains	specificity	toward	single-
base	mutation	 in	 the	 binary	 mixture	 (Figure	 4.11).	 Naked-eye	 inspection	 confirmed	
such	trend	(Figure	4.11).	 In	 the	presence	of	100%	match	dsDNA,	 the	solution	turned	
purple,	 accompanied	 by	 precipitation	 at	 extended	 times.	With	 a	 gradual	 increase	 of	
the	mismatch	concentration,	the	solution	preserved	the	initial	color,	showing	that	tiny	
changes	of	mismatch	concentration	affect	the	overall	optical	response.	
Detailed	 analysis	 of	 the	 aggregation	 rate	 revealed	 a	nearly	 linear	 relationship	
between	R@4h	and	[Mismatch]	in	the	binary	mixture,	over	the	entire	range	of	analyte	
concentration	 (Figure	 4.11d).	 However,	 differentiation	 of	 the	 mismatch	 at	
concentrations	<1	nM,	which	corresponds	to	<20%	of	total	dsDNA	amount,	was	rather	
poor	 (Figure	 4.11d,	 red	 area,	 and	 Figure	 4.12).	 (Note,	 that	 in	 a	 real	 sample	 the	
mismatch	sequence	constitutes	<1%	of	the	total	cfDNA).	
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Figure	 4.11.	 Differentiation	 of	 SNP	 in	 the	 binary	 mixture	 of	 match	 and	 mismatch	
dsDNA.	a)	Composition	of	the	starting	mixture.	b)	Time-dependent	AuNPs	aggregation	
at	 different	 mismatch:match	 molar	 ratios.	 c)	 Digital	 image	 of	 the	 corresponding	
solutions.	d)	Aggregation	degree	at	4h	vs.	mismatch	concentration;	the	red	solid	line	is	
a	linear	fit.	Inset:	temperature	profile	in	the	detection	experiments	with	a	cooling	rate	
of	1	ºC/min.	The	numbers	 indicate	different	 stages	of	 the	 thermal	cycle:	1	–	heating	
up,	 2	 –	 annealing	 at	 80	 ºC,	 3-	 cooling	 down,	 4	 –	 UV-Vis	 measurements	 at	 room	
temperature.	e)	Aggregation	degree	at	mismatch	concentrations	below	1	nM	(red	area	
in	 d).	 Inset:	 temperature	 profile	 in	 the	 detection	 experiments	 Corresponding	Author	
with	cooling	rate	of	10	ºC/min.	
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The	 poor	 differentiation	 at	 low	mismatch	 content	was	 presumably	 related	 to	
the	fast	cooling	process	once	thermal	annealing	 is	completed.	 In	all	experiments,	the	
mixtures	were	cooled	at	a	rate	of	10	ºC/min	prior	to	UV-Vis	monitoring	(Figure	4.11d	–	
inset).	 In	 recent	 work	 by	Mirkin	 and	 coworkers	 it	 has	 been	 showed	 that	 at	 a	 slow	
cooling	 rate	 the	 aggregation	of	Au@DNA	 is	 thermodynamically	 driven,	 thus	 favoring	
stable	conformations	by	avoiding	kinetically	frozen	states.29,30	Following	this	reasoning,	
it	is	expected	to	assume	that	by	avoiding	kinetic	traps	at	a	slow	cooling	rate,	the	ssDNA	
sense	 sequence	 can	 bridge	 efficiently	 adjacent	 AuNPs,	 thereby	 improving	 the	
differentiation	 of	 SNP.	 To	 evaluate	 such	 statement,	 a	 series	 of	 differentiation	
experiments	were	performed	in	which	the	cooling	rate	was	slowed	down	to	1	ºC/min	
and	 the	 range	 of	 mismatch	 concentration	 was	 kept	 constant,	 below	 1	 nM	 (Figure	
4.11e).	Importantly,	during	the	cooling	state,	the	solutions	were	left	undisturbed,	and	
UV-Vis	 monitoring	 commenced	 once	 the	 mixtures	 reached	 room	 temperature.	 As	
shown	 in	Figure	4.11e,	with	 increasing	the	relative	amount	of	mismatch	sequence	 in	
the	 assay,	 the	 aggregation	 rate	 gradually	 increased,	 suggesting	 an	 improved	
differentiation	between	match	and	mismatch	sequences.	
	
Figure	4.12.	Aggregation	degree	for	2	different	binary	mixtures	after	a	fast	decrease	of	
temperature.	
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4.4	Conclusions	
	
This	Chapter	dealt	with	a	plasmon-assisted	colorimetric	assay	for	discrimination	
of	SNP	in	binary	mixtures	of	dsDNA.	Studied	strategy	involved	the	combination	of	heat-
induced	denaturation	of	the	mixture	and	blockage	of	analyte	reannealing	using	short	
sequences	(blocking	probes),	to	facilitate	selective	AuNPs	aggregation.	It	was	showed	
that	 the	 use	 of	 two	 blocking	 sequences	 was	 necessary	 to	 prevent	 reannealing	 of	
complementary	 DNA	 sequences	 after	 thermal	 treatment.	With	 this	 methodology,	 it	
was	possible	to	detect	mutation	in	double-stranded	DNA	sequences	up	to	140	bases.	
Additionally,	 the	 selectivity	 of	 5%	 toward	 SNP	 in	 the	 binary	mixture	 (wild	 type	 and	
mutated	dsDNA)	was	obtained	at	a	slow	cooling	rate	(1o	C/min),	thereby	favoring	the	
thermodynamically	most	stable	conformation.		
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General	Conclusions	of	the	Thesis	
	
Altogether	this	thesis	represents	a	significant	advancement	in	the	development	
of	 plasmonic	 biosensors.	 Gold	 nanoparticles	 were	 successfully	 implemented	 for	 the	
detection	of	 biomarkers,	more	precisely	 single	nucleotide	polymorphism,	 considered	
as	relevant	biomolecules	related	with	breast	and	lung	cancer.	
In	each	chapter	of	this	thesis,	a	different	goal	or	parameter	has	been	addressed	
which	 are	 important	 for	 the	 implementation	 of	 colorimetric	 biosensors	 in	 the	
detection	of	single	nucleotide	polymorphism.	Different	advances	have	been	achieved	
in	 terms	 of	 sensitivity,	 selectivity	 and	 new	 approaches	 and	 strategies	 have	 been	
proposed	for	the	detection	of	long	single	stranded	DNA	and	long	double-stranded	DNA	
sequences.		
Although	 specific	 conclusions	 have	 been	 presented	 along	 with	 each	 of	 the	
chapters	 of	 this	 thesis,	 we	 present	 here	 a	 compilation	 of	 those	 we	 consider	 more	
relevant,	global	conclusions	of	the	work.	
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A) In	Chapter	2	the	effects	of	nanoparticle	size	on	the	sensitivity	and	selectivity	of	
a	colorimetric	detection	assay	of	the	BRCA1	mutation	were	analyzed.		
1. At	constant	gold	concentration	and	varying	particle	size,	the	best	sensitivity	
was	 obtained	 when	 using	 larger	 particles	 of	 63	 nm.	 This	 trend	 was	
explained	 in	 terms	 of	 a	 higher	 target-to-particles	 ratio,	 as	 compared	 to	
smaller	AuNPs.		
2. Using	63	nm	particles	we	could	differentiate	the	match	from	the	mismatch	
sequences	at	concentrations	down	to	10	pM.		
3. Particle	 size	 was	 also	 found	 to	 affect	 the	 selectivity	 of	 the	 assay.	 Larger	
particles	 are	 more	 selective	 at	 lower	 target	 concentrations,	 but	 less	
selective	at	larger	target	concentrations,	which	is	due	to	the	lower	surface	
curvature	increasing	the	probability	of	multiple	binding	events.		
4. The	 results	 of	 our	 study	 show	 that	 colloidal	 biosensors	 based	 on	 AuNP	
aggregation	 have	 an	 intrinsic	 limitation,	 related	 to	 the	 number	 of	 target	
molecules	per	particle.	
	
B) In	 Chapter	 3	 the	 effect	 of	 gold	 nanoparticles-DNA	probes	 in	 the	 detection	of	
long	DNA	sequences	related	with	EGFR	mutation	was	studied.		
1. 63	nm	particles	functionalized	with	DNA	strands	were	used	to	discriminate	
single-base	mutation	in	long	single	stranded	DNA	sequences	containing	70	
or	140	bases	within	1	h.	
2. Preincubation	 of	 the	 target	 sequence	 with	 only	 one	 type	 of	 Au@DNA	
facilitated	 the	 formation	 of	 a	 sandwich	 structure	 upon	 addition	 of	 the	
second	type	of	Au@DNA	and	discriminate	single-base	mutation	within	1	h.		
3. Spherical	 nucleic	 acids	 can	 disturb	 the	 secondary	 structure	 of	 long	 DNA	
sequences,	making	feasible	the	detection	of	relevant	mutations	in	biological	
targets.	
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C) In	 Chapter	 4	 a	 new	 methodology	 for	 the	 detection	 of	 single	 nucleotide	
polymorphism	related	with	EGFR	gene	in	double	stranded	DNA	sequences	was	
proposed.	
1. Our	strategy	involved	the	combination	of	heat-induced	denaturation	of	the	
mixture	containing	dsDNA	analyte	and	blockage	of	analyte	 reannealing	by	
the	 use	 of	 short	 sequences	 (blocking	 probes)	 to	 facilitate	 selective	
aggregation	of	the	nanoparticles.	
2. The	use	of	two	blocking	sequences	was	necessary	to	prevent	reannealing	of	
complementary	DNA	sequences	after	the	thermal	treatment.	
3. With	 this	 methodology,	 it	 was	 possible	 to	 detect	 double-stranded	 DNA	
sequences	up	to	140	bases	with	single	nucleotide	polymorphism.	
4. The	discrimination	of	SNP	was	also	performed	in	binary	mixtures	of	dsDNA	
containing	different	ratios	of	match	and	mismatch	sequences.	
5. The	selectivity	of	the	assay	toward	SNP	in	the	binary	mixture	was	improved	
by	slowing	down	the	rate	of	 the	cooling	stage	(1oC/min),	 thereby	favoring	
the	thermodynamically	most	stable	conformation.	
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Resumen	
	
Con	 este	 resumen	 se	 pretende	 dar	 una	 visión	 global	 de	 la	 presente	 tesis,	
exponiendo	 los	 principales	 resultados	 y	 conclusiones	 de	 cada	 uno	 de	 los	 diferentes	
capítulos.	
El	 tema	 principal	 de	 esta	 tesis	 se	 centra	 en	 el	 desarrollo	 de	 biosensores	
plasmónicos	 basados	 en	 la	 agregación	 de	 nanopartículas	 de	 oro	 funcionalizadas	 con	
diferentes	secuencias	de	ADN.	La	aplicación	de	estos	nanomateriales	se	centrará	en	la	
detección	de	un	 tipo	 concreto	de	biomarcadores,	 conocidos	 como	polimorfismos	de	
nucleótido	único,	relacionados	con	cáncer	de	pecho	y	de	pulmón.		
Además	 de	 la	 fabricación	 y	 caracterización	 de	 estos	 materiales	 a	 escala	
nanoscópica,	 también	 se	 ha	 llevado	 a	 cabo	 un	 exhaustivo	 trabajo	 en	 cuanto	 a	 la	
funcionalización	superficial	de	las	nanopartículas	de	oro	con	el	fin	de	obtener	la	mejor	
estabilización	 posible	 y	 a	 la	 vez	 conseguir	 una	 cinética	 de	 detección	 lo	 más	 rápida	
posible.		
El	 trabajo	 realizado	 ha	 requerido	 una	 buena	 base	 teórica	 en	 cuanto	 a	 los	
procesos	 relacionados	 con	 ADN	 y	 su	 hibridación,	 así	 como	 las	 propiedades	 de	 las	
diferentes	 secuencias	 de	 ADN	 tales	 como	 su	 estructura	 secundaria	 o	 sus	 puntos	 de	
fusión	en	función	de	la	secuencia	diseñada	en	cada	estudio.	
Además	de	intentar	mejorar	ciertos	parámetros	básicos	en	un	biosensor	como	
la	sensibilidad	y	la	selectividad,	también	se	han	abordado	diferentes	objetivos	como	la	
detección	de	largas	secuencias	de	ADN	de	cadena	simple	clínicamente	relevantes	con	
la	implementación	de	nuevas	estrategias,	o	la	detección	de		largas	secuencias	de	ADN	
de	 cadena	 doble	 mediante	 la	 aplicación	 de	 un	 nuevo	 método	 basado	 en	 una	
combinación	de	tratamiento	térmico	más	la	adición	de	cadenas	cortas	de	ADN.	
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1.	Introducción	
	
	 El	cáncer	es	una	de	 las	principales	causas	de	mortalidad	el	cual	ha	provocado	
aproximadamente	unas	8.8	millones	de	muertes	en	el	año	2015.	Su	origen	está	ligado	
a	 mutaciones	 genéticas	 que	 se	 acumulan	 poco	 a	 poco	 con	 el	 paso	 del	 tiempo,	
provocando	 una	 serie	 de	 procesos	 responsables	 de	 la	 carcinogeneis.	 Existen	 ciertas	
biomoléculas,	 denominadas	 biomarcadores,	 	 las	 cuales	 llevan	 información	 relevante	
para	 la	 diagnosis	 de	 cáncer.	 Un	 biomarcador	 se	 describe	 como	 una	 sustancia	 o	
actividad	que	puedes	ser	medida	y	evaluada	como	indicador	de	un	proceso	biológico	
normal,	 de	 un	 proceso	 patogénico	 o	 de	 una	 respuesta	 farmacológica.	 Los	
biomarcadores	 de	 cáncer	 están	 presentes	 en	 tejidos	 tumorales	 o	 serum	 y	 engloban	
una	gran	cantidad	de	moléculas	como	ADN,	mARN,	enzymas,	metabolitos,	factores	de	
transcripción	y	receptores	superficiales	celulares.	
	 El	polimorfismo	de	nucleótido	único	(SNP)	es	una	de	 las	formas	más	comunes	
de	variación	genética	en	el	genoma	humano.	El	polimorfismo	de	nucleótido	único	es	la	
variación	 de	 una	 sola	 base	 en	 una	 posición	 concreta	 de	 la	 secuencia	 de	 ADN.	 Esta	
variación	ocurre	con	una	frecuencia	de	1	cada	1000	bases,	aproximadamente	y	a	día	
de	hoy	se	conocen	aproximadamente	1.42	millones	de	modificaciones	de	este	tipo.	Las	
variaciones	en	secuencias	codificantes	de	los	genes	puede	provocar	modificaciones	en	
los	 aminoácidos	 correspondientes	 y	 por	 lo	 tanto	modificar	 la	 función	 de	 la	 proteína	
correspondiente.	Teniendo	esto	en	mente,	los	polimorfismos	de	nucleótido	único	han	
emergido	como	una	nueva	generación	de	biomarcadores	e	indicadores	en	el	campo	de	
diagnosis	 clínico	 y	 prognosis.	 En	 el	 contexto	 de	 esta	 tesis,	 nos	 centraremos	
principalmente	 en	 el	 estudio	 de	 dos	 polimorfismos	 de	 nucleótido	 único,	 uno	
relacionado	con	el	cáncer	de	pulmón	y	otro	relacionado	con	el	cáncer	de	pecho.	Los	
SNP	 relacionados	 con	 el	 cáncer	 de	 pulmón	 son	 considerados	 actualmente	 de	 gran	
relevancia	 debido	 a	 que	 el	 cáncer	 de	 pulmón	 es	 el	 que	 produce	más	muertes	 en	 el	
mundo.	 En	 concreto,	 la	 mutación	 que	 se	 estudiará	 relacionada	 con	 el	 cáncer	 de	
pulmón	 será	 L858R.	 Esta	 mutación	 aparece	 con	 una	 frecuencia	 del	 43%	 en	 los	
pacientes	con	cáncer	de	pulmón	relacionado	con	el	receptor	de	factor	de	crecimiento	
epidérmico.	 Por	 otro	 lado	 nos	 hemos	 centrado	 en	 el	 cáncer	 de	 pecho	 ya	 que	 es	 la	
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principal	causa	de	muerte	de	mujeres	a	nivel	mundial.	En	este	caso	nos	centraremos	
en	el	biomarcador	relacionado	con	mutaciones	en	el	gen	BRCA1.	
	 Por	 otra	 parte,	 las	 nanopartículas	 plasmónicas	 de	 oro	 han	 atraído	 una	 gran	
atención	 en	 diferentes	 campos,	 como	 biosensores,	 imagen,	 terapia,	 nanofotónica	 y	
catálisis	 debido	 a	 sus	 propiedades	 ópticas	 y	 electrónicas	 únicas.	 Este	 tipo	 de	
nanomaterials	 pueden	 exhibir	 fuertes	 colores	 en	 el	 rango	 de	 lo	 visible	 debido	 a	
resonancias	plasmónicas	 superficiales	 localizadas.	 LSPR),	mientras	que	 sus	agregados	
exhiben	diferentes	propiedades	ópticas	lineales	y	no	lineales.	Por	lo	que	interacciones	
químicas	 entre	 el	 analito	 y	 la	 superficie	 de	 las	 nanopartículas	 conduciría	 a	 cambios	
graduales	en	las	propiedades	ópticas.	Estos	cambios	podrían	ser	usados	como	métodos	
de	 detección,	 permitiendo	 un	 análisis	 cualitativo	 y	 en	 ciertos	 casos	 cuantitativo	 del	
analito	en	cuestión.	Por	lo	tanto,	los	sensors	plasmónicos	basados	en	la	agregación	de	
nanopartículas	ofrecen	una	detección	 selectiva,	 sensible	y	 simple	de	diferentes	 tipos	
de	analitos.	
	 En	 cuanto	 al	 estado	 del	 arte	 en	 este	 campo,	 como	 se	 expone	 al	 final	 del	
capítulo	 1,	 la	 mayoría	 de	 los	 métodos	 publicados	 emplean	 nanopartículas	 con	 un	
diámetro	de	13	nm	o	desarrollan	sistemas	de	detección	de	secuencias	cortas	de	ADN,	
las	cuales	no	guardan	relación	alguna	con	el	escenario	real.	En	este	contexto,	a	lo	largo	
de	los	siguientes	capítulos	se	expone	el	desarrollo	de	un	sistema	de	detección	basado	
en	 la	 agregación	 de	 nanopartículas	 de	 oro	 de	 un	 diámetro	 de	 63	 nm	 las	 cuales	
conducen	 a	 un	 límite	 de	 detección	más	 bajo.	 Además	 de	 optimizar	 este	 parámetro,	
también	se	han	aplicado	diferentes	estrategias	en	la	detección	de	secuencias	largas	de	
ADN	tanto	de	cadena	simple	como	doble.	
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2.	 Límite	 de	 Sensibilidad	 en	 Biosensores	 basados	 en	
Nanopartículas	en	la	Discriminación	de	Polimorfismos	de	
Nucleótido	Único	
	
	 En	 este	 capítulo	 se	 describe	 la	 detección	 de	 la	mutación	 de	 polimorfismo	 de	
nucleótido	 único	 relacionado	 con	 el	 cáncer	 de	 pecho.	 Además	 se	 ha	 identificado	 la	
concentración	 límite	de	moléculas	de	analito	necesarias	para	 inducir	cambios	ópticos	
en	 la	 disolución	 coloidal,	 como	 función	 del	 tamaño	 de	 nanopartícula	 empleada.	 La	
agregación	selectiva	de	nanopartículas	proporciona	una	detección	rápida	y	sencilla.	El	
número	 de	 moléculas	 de	 analito	 disponibles	 es	 el	 factor	 principal	 que	 limita	 la	
sensibilidad	de	este	tipo	de	sensores	coloidales.	El	ratio	entre	el	número	de	moléculas	
de	 analito	 y	 el	 número	 de	 nanopartículas	 es	 el	 cual	 induce	 la	 agregación	 de	 las	
partículas	y	por	lo	tanto	transduce	el	evento	en	una	señal	óptica.	
	 El	tamaño	de	partícula	es	un	factor	muy	importante	a	elegir	en	el	diseño	de	los	
ensayos	de	detección	ya	que	influye	directamente	en	la	modulación	del	ratio	entre	el	
número	de	moléculas	de	analito	y	el	número	de	nanopartículas,	manteniendo	en	todos	
los	casos	siempre	la	misma	concentración	de	oro	metal.	Normalmente	la	elección	del	
tamaño	de	partícula	 se	omite	en	el	diseño	de	 los	ensayos	de	detección	debido	a	 las	
dificultades	en	la	síntesis	y	la	funcionalización	de	nanopartículas	de	tamaños	grandes.	
En	 este	 capítulo	 se	 ha	 realizado	 un	 estudio	 sistemático	 de	 nanopartículas	 de	
oro	 de	 diferentes	 tamaños	 (13,	 46	 y	 63	 nm).	 Un	 aumento	 de	 hasta	 5	 veces	 en	 el	
tamaño	 de	 partícula	 ha	 conducido	 a	 una	mejora	 del	 límite	 de	 detección	 de	 hasta	 2	
órdenes	de	magnitud:	5,	0.1	y	0.05	nM	para	partículas	con	diámetros	de	13,	46	y	63	
nm,	respectivamente.	De	esta	forma	es	posible	detectar	SNP	hasta	una	concentración	
de	10	pM,	es	decir	11	fmol,	en	menos	de	10	minutos	(Figura	1).	
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Figura	 1.	 Selectividad	 entre	 las	 secuencias	 match	 y	 mismatch	 para	 diferentes	
concentraciones	de	analito,	usando	diferentes	tamaños	de	AuNPs.	a)	Diferencias	en	el	
grado	de	 agregación	 (Abs620/Absmax)	 para	 los	 diferentes	 tamaños	de	partícula,	 en	un	
rango	 de	 concentración	 de	 analito	 entre	 50	 y	 0.05	 nM.	 Los	 círculos	 representan	 el	
límite	 de	 seletividad	 (match/mismatch)	 los	 cuales	 corresponden	 a	 un	 ratio	
analito/nanopartícula	de	4.	b)	Diferencias	entre	los	valres	de	R	para	match	y	mismatch	
vs.	 La	 concentración	 de	 analito,	 mostrando	 que	 la	 selectividad	 es	 mejor	 cuando	 se	
emplean	 partículas	 con	 un	 diámetro	mayor.	 c)	 Concentración	 de	 analito	 a	 	 Rmatch	 −	
Rmismatch	=	0.3	vs	tamaño	de	partícula;	mostrando	una	dependencia	lineal	en	una	escala	
logarítmica.	
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3.	Discriminación	basada	en	Nanopartículas	de	
Polimorfismo	de	Nucleótido	Único	en	Secuencias	Largas	
de	ADN	
	
	 Como	se	discute	en	el	Capítulo	1,	las	moléculas	de	ADN	circulante	y	la	detección	
de	cáncer	asociada	a	mutaciones	mediante	la	realización	de	biopsias	líquidas	promete	
revolucionar	 la	detección	de	cáncer.	La	principal	dificultad,	sin	embargo,	 reside	en	 la	
longitud	de	los	fragmentos	de	ADN	circulante	que	es	aproximadamente	de	140	bases.	
Debido	a	su	longitud,	normalmente	tienen	unas	estructuras	secundarias	complejas	las	
cuales	pueden	impedir	la	detección	efectiva	de	estos	analitos.	
	 Este	 capítulo	muestra	 un	 ensayo	 basado	 en	 nanopartículas	 de	 oro	 las	 cuales	
permiten	 discriminar	 polimorfismos	 de	 nucleótido	 único	 en	 secuencias	 clínicamente	
relevantes	 de	 70	 y	 140	 bases.	 El	 paso	 previo	 de	 preincubación	 con	 un	 solo	 tipo	 de	
nanopartículas	es	de	crucial	importancia	ya	que	permite	la	hibridación	secuencial	entre	
Au@ADN	y	el	analito	(Figura	2),	pudiendo	diferenciar	de	esta	forma	el	analito	sano	del	
analito	con	la	mutación	hasta	una	concentración	de	100	pM.	
	
Figura	2.	Descripción	general	del	proceso	de	detección	basado	en	un	paso	previo	de	
preincubación	entre	el	analito	y	uno	de	los	tipos	de	nanopartículas	funcionalizadas	con	
ADN,	 y	 el	 posterior	 paso	 de	 adición	 del	 otro	 tipo	 de	 nanopartículas	 funcionalizadas,	
permitiendo	la	detección	selectiva	del	analito.	
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4.	Estrategia	de	Bloqueo	para	 la	Detección	Colorimétrica	
de	 Polimorfismo	 de	 Nucleótido	 Único	 en	 Secuencias	
Largas	de	ADN	de	Doble	Cadena	
	
	 Como	se	menciona	en	capítulos	anteriores,	 la	rápida	detección	de	mutaciones	
de	nucleótido	único	en	ADN	circulante	es	de	gran	importancia	en	el	campo	clínico.	Sin	
embargo,	 la	 especificidad	 en	 la	 detección	 es	 uno	 de	 los	 desafíos	más	 grandes	 en	 el	
ámbito	de	 la	detección	ya	que	 la	 secuencia	con	 la	mutación	 representa	una	 fracción	
muy	pequeña	(<1%)	en	comparación	con	la	secuencia	sin	la	mutación.	Además	de	esto,	
el	 empleo	 de	 técnicas	 basadas	 en	 hibridación	 requiere	 la	 separación	 de	 la	 doble	
cadena	de	ADN	en	ADN	de	cadena	simple.	
	 En	el	presente	capítulo,	se	propone	un	ensayo	sin	ningún	tipo	de	amplificación	
en	 la	detección	de	polimorfismo	de	nucleótido	único	en	mezclas	binarias	de	ADN	de	
cadena	 doble	 de	 secuencias	 con	 y	 sin	 mutación	 mediante	 la	 agregación	 de	
nanopartículas	de	oro	como	transductores	de	señal	del	proceso	de	hibridación.	
	 El	 método	 de	 detección	 se	 basa	 en	 la	 combinación	 de	 la	 desnaturalización	
térmica	 de	 la	 doble	 cadena	 de	 ADN	 y	 una	 estrategia	 de	 bloqueo	 selectivo	 de	 las	
cadenas	 desnaturalizadas,	 haciendo	 de	 este	 modo	 una	 detección	 más	 específica	
(Figura	3).	De	esta	forma	es	posible	discriminar	polimorfismos	de	nucleótido	único	en	
ADN	 de	 cadena	 doble	 	 con	 hasta	 una	 total	 de	 140	 bases.	 Además,	 también	 ha	 sipo	
posible	diferenciar	un	5%	de	la	secuencia	con	la	mutación	en	mezclas	binarias	de	ADN	
con	70	bases	de	longitud.	
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Figura	 3.	 Esquema	 de	 la	 estrategia	 de	 detección.	 La	 disolución	 inicial	 (izquierda)	
contiene	 ambos	 tipos	 de	 nanopartículas,	 las	 secuencias	 cortas	 de	 bloqueo	 y	 ambos	
analitos	de	cadena	doble	con	y	sin	la	mutación.	Esta	solución	es	calentada	durante	10	
minutos	a	80ºC	(centro),	seguido	por	un	proceso	de	enfriamiento	y	lectura	de	la	señal	
producida	 (derecha).	 Las	 secuencias	 cortas	 de	 bloqueo	 se	 unen	 a	 la	 secuencia	
antisense	previniendo	la	rehibridación	tras	el	proceso	de	enfriamiento.	El	analito	que	
permanece	como	ADN	de	cadena	simple	tras	el	tratamiento	térmico	es	reconocido	por	
las	 secuencias	 de	 ADN	 en	 la	 superficie	 de	 las	 nanopartículas	 produciendo	 una	
agregación	selectiva	de	las	nanopartículas	de	oro	debido	a	la	presencia	de	la	mutación.	
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